User Image Cart Icon 0 Search Image

Diabetes & cancer

  1. A case of advanced cervical esophageal cancer with liver cirrhosis and diabetes mellitus showing a complete response by radiation therapy after the operation for …
  2. A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus
  3. A case of central diabetes insipidus caused by metastatic small cell lung cancer
  4. A Case of Central diabetes Insipidus in Patient with Non-small Cell Lung cancer.
  5. A case of diabetes mellitus accompanied by tumor-forming pancreatitis that was difficult to distinguish from pancreatic cancer
  6. A case of effective weekly paclitaxel administration for advanced gastric cancer associated with diabetes mellitus-about the control of blood glucose when …
  7. A Case of Fulminant Type 1 diabetes Mellitus and Diabetic Ketoacidosis Caused by Adjuvant Chemotherapy for Colon cancer
  8. A case of lung cancer with pituitary metastases presented by diabetes insipidus
  9. A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer
  10. A Case of Pituitary Metastasis of Breast cancer Presenting as diabetes Insipidus and Panhypopituitarism.
  11. A case of small cell lung cancer associated with diabetes insipidus and Cushing’s syndrome
  12. A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins
  13. A Case of Ulcerative Colitis Combined with Follicular Thyroid cancer and Gestational diabetes Mellitus
  14. A case-control study of diabetes mellitus and cancer risk
  15. A Clinical Analysis of Endometrial cancer Accompanied by Hypertension and diabetes Mellitus
  16. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes
  17. A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes.
  18. A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes
  19. A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus
  20. A cohort study of the risk of cancer associated with type 2 diabetes
  21. A COMPARISON OF SPIRITUAL DEVELOPMENT BETWEEN HEALTHY INDIVIDUALS AND PATIENTS SUFFERING FROM cancer AND diabetes
  22. A Comprehensive Analysis of diabetes Self-Management among with Men with Prostate cancer in the United States: Evidence from the National Health and Nutrition …
  23. A Connecting Switch Among Aging, diabetes and Tumor: Avenue Leading to cancer Therapeutics
  24. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
  25. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan
  26. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)—Potsdam Study cohort
  27. A genetic link between type 2 diabetes and prostate cancer
  28. A genetic relationship between diabetes and cancer
  29. A high diet quality based on dietary recommendations is not associated with lower incidence of type 2 diabetes in the Malmö Diet and cancer Cohort
  30. A high rate of undiagnosed diabetes in new uterine cancer patients
  31. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
  32. A Hybrid Machine Learning Scheme to Analyze the Risk Factors of Breast cancer Outcome in Patients with diabetes Mellitus.
  33. A meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer
  34. A meta-analysis of diabetes mellitus and the risk of prostate cancer
  35. A molecular rheostat at the interface of cancer and diabetes
  36. A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time
  37. A new approach for diagnosis of diabetes and prediction of cancer using ANFIS
  38. A new ınsight ınto metformin action: diabetes, prostate cancer, and ıon channels
  39. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose
  40. A New Role for an Old Drug: Metformin Targets Micro RNA s in Treating diabetes and cancer
  41. A noninvasive method to detect diabetes mellitus and lung cancer using the stacked sparse autoencoder
  42. A novel approach for the diagnosis of diabetes and liver cancer using ANFIS and improved KNN
  43. A NOVEL APPROACH IN COLORECTAL cancer AND diabetes MANAGEMENT: ROLE OF METFORMIN AND RAPAMYCIN
  44. A novel design and analysis of high-sensitivity biosensor based on nano-cavity for detection of blood component, diabetes, cancer and glucose concentration
  45. A novel mechanistic pathway linking diabetes to colorectal cancer: Role of AMPK and mTOR
  46. A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record
  47. A Novel Pathway Linking Oxidative Stress and Inflammation: Prevention of cancer, Sepsis, Asthma, diabetes and Uveitis by Aldose Reductase Inhibition.
  48. A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
  49. A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a brenner tumor
  50. A pilot study evaluating steroid-induced diabetes after antiemetic dexamethasone therapy in chemotherapy-treated cancer patients
  51. A population-based cohort study of all-cause and site-specific cancer incidence among patients with type 1 diabetes mellitus in Taiwan
  52. A Potential Screening Strategy of Pancreatic cancer in New Onset diabetes Patients Using Serum CA19-9 in Combination With Age and BMI: 7
  53. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 diabetes and Prostate cancer
  54. A Progressive Stack Face-based Network for Detecting diabetes Mellitus and Breast cancer
  55. A prospective study of the associations between treated diabetes and cancer outcomes
  56. A Prospective Study of the Associations Between Treated diabetes Mellitus and cancer Outcomes
  57. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer
  58. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk
  59. A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer
  60. A retrospective study of the impact of diabetes mellitus on survival in patients with tung cancer
  61. A retrospective study on the role of diabetes and metformin in colorectal cancer disease progression.
  62. A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival
  63. A retrospective-analysis of the correlation between diabetes mellitus and cancer
  64. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer
  65. A review of current knowledge: Role of diabetes, cancer and cytochrome P450
  66. A review of the etiology and biomarkers of pancreatic cancer, with emphasis on the role of diabetes
  67. A Review of the Quality of Life of Hemodialysis, Breast cancer, and Type 2 diabetes Mellitus Patients
  68. A risk stratification schema for predicting diabetes mellitus in cancer survivors.
  69. A simple screening score to predict diabetes in cancer patients: A Korean nationwide population-based cohort study
  70. A Study of the People’s Medicine Scheme in Mumbai and Thane region, India with reference to cancer and diabetes medicines
  71. A study on implementation of national programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke in Udupi district, Karnataka
  72. A study on utilization of diagnostic and therapeutic services of National Program for Prevention and Control of cancer, diabetes and Cardiovascular Diseases …
  73. A SUCCESSFUL CASE OF GASTRIC cancer WITH diabetes MELLITUS IN 84 YEAR OLD MAN, TOTAL GASTRECTOMIZED WITH TRANSVERSE COLECTOMY
  74. A SURVEY ON IMPROVING THE PERFORMANCE OF cancer AND diabetes DETECTION BY USING NOVEL TECHNIQUE OF MACHINE LEARNING
  75. A Survey on The Roles of Life Style and Its Modification in The Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
  76. A systematic review of cases of diabetes mellitus following immune checkpoint inhibitor therapy for cancer
  77. A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
  78. A systematic review study on the communication between diabetes and cancer: The serious risk of cancer in diabetic patients
  79. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
  80. A ubiquitous membrane fusion protein αSNAP: a potential therapeutic target for cancer, diabetes and neurological disorders?
  81. Aberrant Expression of Sialidase in cancer and diabetes
  82. Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer
  83. Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering …
  84. ABO blood group and diabetes mellitus influence the risk for pancreatic cancer in a population from China
  85. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China
  86. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer
  87. Abolish cancer progenitor cells in a mouse model of diabetes associated hepatocellular carcinoma
  88. Aboriginal and Torres Strait islander health: Accuracy of patient self‐report of screening for diabetes, high cholesterol and cervical cancer
  89. Abstract A08: Human preadipocytes promote pancreatic cancer cellular growth in a diabetes-specific manner
  90. Abstract A23: cancer outcomes in the diabetes prevention program outcomes study
  91. Abstract A23: Metformin as a potent antiangiogenic factor: From diabetes to cancer angioprevention
  92. Abstract A27: Association between diabetes pharmacotherapies and bladder cancer: A Medicare epidemiologic study
  93. Abstract A58: Interaction of diabetes and obesity in postmenopausal breast cancer risk among black women
  94. Abstract A76: diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
  95. Abstract B026: Occurrence of comorbidities among diverse hospice cancer patients with and without diabetes
  96. Abstract B17: Type 2 diabetes, metformin, and ovarian cancer survival: An analysis of tumor registry and electronic medical record data.
  97. Abstract B43: Type 2 diabetes mellitus and colorectal cancer risk in Hispanics: A pilot case-control study
  98. Abstract B45: Obesity, diabetes, other comorbidities and survival in a cohort of women with ovarian cancer
  99. Abstract B94: Relationship of overweight and diabetes with prostate cancer stages in Mexican Americans: A population-based case-control study
  100. Abstract C077: The association between diabetes, plasma fructosamine, and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white …
  101. Abstract C28: An exploratory study of co-occurrence of breast cancer and diabetes in medically underserved Latinas
  102. Abstract CT198: Efficacy of metfOrmin in PrevenTIng glucocorticoid-induced diabetes in Melanoma, breAst or Lung cancer patients with brain metastases: The phase …
  103. Abstract GS2-09: diabetes risk reduction diet and survival following breast cancer
  104. Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus.
  105. Abstract LB-190: Ethnic differences in the relationship between diabetes, adiposity measures and breast cancer-specific mortality
  106. Abstract LB-278: Metformin exposure on survival in localized breast cancer patients with type II diabetes mellitus using electronic health records
  107. Abstract LB-285: Glycemia is positively associated with prostate cancer mortality in white and black men without diabetes when better classifying hyper-and …
  108. Abstract LB-296: Breast cancer metabolism in association with diabetes
  109. Abstract LB-421: diabetes pharmacotherapy: A potential modifier of breast cancer prognosis
  110. Abstract P1-08-05: Type 2 diabetes and survival outcomes among a multi-ethnic cohort of breast cancer patients
  111. Abstract P1-10-02: Type II diabetes and subtype-specific breast cancer risk in medically underserved black and white women
  112. Abstract P2-07-06: Obesity, dyslipidemia, and diabetes as risk factors for trastuzumab-related cardiotoxicity in breast cancer patients
  113. Abstract P2-08-11: High prevalence and incidence of new onset diabetes in metastatic breast cancer
  114. Abstract P2-11-09: Weight Change and Risk of Incident diabetes After Breast cancer
  115. Abstract P3-02-10: The possible association among breast cancer, diabetes mellitus and GLP-1 receptor
  116. Abstract P3-10-32: Breast cancer Patients with Type 2 diabetes Trend To Be Associated with Poor Prognosis
  117. Abstract P344: Association of diabetes and cancer Mortality in American Indians: The Strong Heart Study
  118. Abstract P4-12-07: diabetes Increases the Risk of Breast cancer
  119. Abstract P4-13-08: diabetes, Related Factors and Breast cancer Risk
  120. Abstract P5-12-04: Association of adjuvant endocrine therapy with diabetes among women with postmenopausal breast cancer in the Women’s Health Initiative (WHI)
  121. Abstract P6-09-05: Insulin Resistance, diabetes Mellitus and Breast cancer Risk in Pre-and Postmenopausal Women: Modification Effect by Moderate Physical …
  122. Abstract P6-10-03: The association between type-2 diabetes and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white women from …
  123. Abstract P6-10-12: Metformin increases survival in hormone receptor-positive, Her2-positive breast cancer patients with diabetes
  124. Abstract PD11-05: diabetes decreases overall survival in women with breast cancer in the southern community cohort study
  125. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors
  126. Abstract PL05-02: Current therapies for diabetes-will they reduce cancer risk?
  127. Abstract PO-159: Mediation of black/white race disparity in triple-negative breast cancer: Effect of type 2 diabetes mellitus
  128. Abstract PO-215: diabetes and the quality of adjuvant therapy in Medicaid-insured women with breast cancer
  129. Abstract PO-237: Colorectal cancer screening in patients with type 2 diabetes mellitus
  130. Abstract PS11-19: Metformin improves the survival in Chinese early invasive breast cancer patients with type 2 diabetes mellitus
  131. Abstract SY02-02: Shared risk factors for diabetes, cardiovascular disease, and cancer in a low-income population
  132. Abstract SY02-04: Risk factors associated with cancer, type 2 diabetes, and cardiovascular disease in the multiethnic cohort: Comparisons across ethnic groups
  133. Abstract# 2111: Effect of IGF gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
  134. Abstract# 2938: Treatment for diabetes mellitus-2 could prevent pancreatic cancer cell growth
  135. Acanthosis nigricans—decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin
  136. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
  137. ACS/ADA/AHA issue core recommendations for preventing cancer, cardiovascular disease, and diabetes
  138. Activation of cancer-related and mitogen-activated protein kinase signaling pathways in human mature osteoblasts isolated from patients with type 2 diabetes
  139. Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
  140. Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
  141. ADA, ACS Spotlight diabetes–cancer Links
  142. Adapted geometric semantic genetic programming for diabetes and breast cancer classification
  143. Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster
  144. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
  145. Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes
  146. Addressing different biases in analysing drug use on cancer risk in diabetes in non‐clinical trial settings—what, why and how?
  147. Adenosine monophosphate–activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection
  148. Adherence to a healthy Nordic food index is associated with a lower risk of type-2 diabetes—The Danish diet, cancer and health cohort study
  149. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010
  150. Adherence to Dietary Indexes by diabetes and Hypertension Status among PLCO cancer Screening Trial Participants
  151. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment
  152. Adherence to the Danish food-based dietary guidelines and risk of type 2 diabetes: the Danish diet, cancer, and health cohort
  153. Adiponectin as a potential key player in metabolic syndrome: Insights into atherosclerosis, diabetes and cancer
  154. Adiposity and diabetes in breast and prostate cancer
  155. Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the UK Biobank, and their modification by smoking
  156. Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women
  157. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
  158. Adopting Nrf2 and NF-κB from cancer: Is there any role of the duo in diabetes?
  159. ADRB2 G–G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity
  160. Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood
  161. Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus
  162. Advanced glycation end products in diabetes, cancer and phytochemical therapy
  163. Advances in the studies of the link between diabetes and cancer
  164. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes–focus on pancreatitis and pancreas cancer
  165. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
  166. African American breast and endometrial cancer survivors with type 2 diabetes: Perceived barriers and preferred components for a physical activity program
  167. Age-related differences in the consequences of obesity on cardiovascular disease, type 2 diabetes, osteoarthritis, cancer, physical function, osteoporosis, cognitive …
  168. Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis
  169. AIDS, diabetes, and lung cancer mortality at the northern Mexican border: 1979-1997
  170. Akt enzyme: new therapeutic target in cancer and diabetes?
  171. Akt2 Redox-regulation in Breast cancer and diabetes
  172. Alarmins in chronic noncommunicable diseases: atherosclerosis, diabetes and cancer
  173. All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the …
  174. All‐cause cancer mortality over 15 years in multi‐ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance
  175. Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
  176. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes and cancer
  177. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N‐terminal peptide (NT‐S100A8)
  178. Alternative splicing of insulin receptor mRNA in cancer and type 2 diabetes mellitus: a review
  179. American diabetes Association 60th Scientific Sessions, 2000: glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics
  180. AMP-activated protein kinase: a target for old drugs against diabetes and cancer
  181. AMPK activators as a drug for diabetes, cancer and cardiovascular disease
  182. AMPK-a nutrient and energy sensor with roles in diabetes, cancer and viral infection
  183. AMPK: a target for drugs and natural products with effects on both diabetes and cancer
  184. AMPK: therapeutic target for diabetes and cancer prevention
  185. An analysis of the impact of irrational beliefs and illness representation in predicting distress in cancer and type II diabetes patients
  186. An assessment of the shared allelic architecture between type II diabetes and prostate cancer
  187. An Australian man who stays he developed bladder cancer after using a diabetes drug is taking legal action against the drug’s manufacturer and distributor
  188. An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes
  189. An ecological association between the prevalence of diabetes Mellitus and the incidence of colorectal cancer
  190. An elevated HbA1c level is associated with short-term adverse outcomes in patients with gastrointestinal cancer and type 2 diabetes mellitus
  191. An epidemiology study of the relationship between pancreatic cancer and diabetes mellitus
  192. An experimental model of diabetes and cancer in rats
  193. An extended Myc network contributes to glucose homeostasis in cancer and diabetes
  194. An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience
  195. An integrative hypothesis linking cancer, diabetes and atherosclerosis: the role of mutations and epigenetic changes
  196. An optimization approach to improve classification performance in cancer and diabetes prediction
  197. An uncommon case of T1b breast cancer with diabetic mastopathy in type II diabetes mellitus
  198. An Unusual Case of Emphysematous Cystitis in Non diabetes Metastatic Lung cancer Patient Undergoing Chemotherapy
  199. Anabolic and pro-metabolic functions of CREB-CRTC in skeletal muscle: advantages and obstacles for type 2 diabetes and cancer cachexia
  200. Analysis and prediction of breast cancer and diabetes disease datasets using data mining classification techniques
  201. Analysis of cardiovascular events or diabetes mellitus during androgen deprivation therapy in Korean prostate cancer patients
  202. Analysis of clinical data in breast cancer patients with type 2 diabetes
  203. Analysis of clinical features in colorectal cancer patients with Type 2 diabetes
  204. ANALYSIS OF CLINICAL FEATURES OF COLORECTAL cancer PATIENTS COMBINED TYPE 2 diabetes MELLITUS
  205. Analysis of Drug Use in Clinical Comprehensive Therapy for Advanced Lung cancer Patients with diabetes Mellitus
  206. Analysis of functional genetic polymorphisms in prostate cancer and type 2 diabetes: Mucin 1 and growth hormone receptor
  207. Analysis of gene expression patterns and metabolomics correlated to obesity, diabetes, and outcomes in patients with epithelial ovarian cancer
  208. Analysis of microrna signatures as biomarker to investigate interlink between type 2 diabetes and breast cancer
  209. Analysis of perioperative treatment on 43 cases of gastric cancer complicated with diabetes mellitus [J]
  210. Analysis of Serum Growth Differentiation Factor-15 in Progression of Breast cancer in Type II diabetes Mellitus Patients
  211. Analysis of the association of diabetes mellitus with cancer using autopsy records
  212. Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors
  213. Analysis of the efficacy of surgical treatment for 80 elderly laryngeal cancer patients with type 2 diabetes
  214. Analysis on 57 cases of saving anus surgery for rectal cancer patients incorporated diabetes
  215. Analyzing Targeted Nucleosome Position and Occupancy in cancer, Obesity, and diabetes
  216. Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors
  217. Androgen Deprivation Therapy in Patients with Advanced Prostate cancer and Type 2 diabetes Impairs Glucose and Lipid Metabolism: 64
  218. Androgen deprivation therapy increases the risk of diabetes and non-cancer mortality in prostate cancer patients: a meta-analysis
  219. Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer
  220. Androgen receptor overexpression in prostate cancer in type 2 diabetes
  221. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer
  222. Androgens, diabetes and prostate cancer
  223. Angiogenesis and inflammation at the crossroads between diabetes and cancer: PS226
  224. Angiopoietin-like protein 2 is a useful biomarker for pancreatic cancer that is associated with type 2 diabetes mellitus and inflammation
  225. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study
  226. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists
  227. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung diabetes Study
  228. Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai
  229. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis
  230. Anti-Diabetic Medications and Risk of Pancreatic cancer in Patients With diabetes Mellitus: A Systematic Review and Meta-Analysis
  231. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
  232. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis
  233. Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
  234. Antidiabetic medication, statins and the risk and prognosis of non-endometrioid endometrial cancer in women with type 2 diabetes
  235. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
  236. Antidiabetic medications and mortality risk in individuals with pancreatic cancer–related diabetes and postpancreatitis diabetes: a nationwide cohort study
  237. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis
  238. Antidiabetic medications use and cancer risk in type 2 diabetes
  239. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer
  240. Application of microbiological and immunological enteral nutrition in patients with gastrointestinal cancer complicated with diabetes mellitus
  241. Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer
  242. Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
  243. Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes
  244. ARE diabetes MELLITUS AND CHROMOSOME 17Q12 GENETIC VARIANTS ASSOCIATED WITH PROSTATE cancer AGGRESSIVENESS?
  245. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
  246. Are the Different diabetes Subgroups Correlated With All-Cause, cancer-Related, and Cardiovascular-Related Mortality?
  247. Are We doing a Better Job of Understanding Co-morbidity Conditions in Health Care (cancer, Tuberculosis, Hypertension, diabetes, etc.?
  248. Aspects épidémiologiques de l’association diabète et cancer: Epidemiological features of the diabetes–cancer association
  249. Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a ‘case study’
  250. Assessing the relationship between institutional cancer and diabetes mortality rates using National Death Index data
  251. Assessment of Blood Donation Safety by People Diagnosed with diabetes, Hypertension, Malaria and cancer
  252. Assessment of classification algorithms in the diagnosis of diabetes and breast cancer
  253. ASSESSMENT OF diabetes MELLITUS AS A MADHUMEHA AND cancer RISK–A REVIEW
  254. Assessment of implementation of the national programme for the prevention and control of cancer, diabetes, cardiovascular diseases, and stroke at …
  255. Assessment of quality of life in patients with cancer and diabetes 2 in Northern Greece
  256. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
  257. Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort …
  258. Association Between Breast cancer and diabetes
  259. Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study
  260. Association between cancer prevalence and use of thiazolidinediones: results from the Vermont diabetes Information System
  261. Association between consumption of dairy products and incident type 2 diabetes—insights from the European Prospective Investigation into cancer study
  262. Association between diabetes and cancer in Indian and US Populations using Longitudinal Study Design
  263. Association between diabetes and colorectal cancer risk in a homogeneous canadian population
  264. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population
  265. Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer
  266. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
  267. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature
  268. Association between diabetes mellitus and kidney cancer
  269. Association between diabetes mellitus and lung cancer: meta‐analysis
  270. Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy
  271. Association between diabetes mellitus and subsequent ovarian cancer in women: A systematic review and meta-analysis of cohort studies
  272. Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis
  273. Association between diabetes, diabetes treatment and risk of developing endometrial cancer
  274. Association between diagnosed diabetes and self-reported cancer among US adults: findings from the 2009 Behavioral Risk Factor Surveillance System
  275. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
  276. Association between exposure to desalinated sea water and ischemic heart disease, diabetes mellitus and colorectal cancer; A population-based study in Israel
  277. Association between gestational diabetes mellitus and subsequent risk of cancer: a systematic review of epidemiological studies
  278. Association between glucose‐lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
  279. Association between metabolic syndrome, diabetes mellitus and prostate cancer risk
  280. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review
  281. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
  282. Association between metformin use and mortality after cervical cancer in older women with diabetes
  283. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population …
  284. Association between pancreatic cancer and metformin use in patients with type 2 diabetes
  285. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: a long-term historical cohort study …
  286. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes
  287. Association Between Statins and cancer Incidence in diabetes: a Cohort Study of Japanese Patients with Type 2 diabetes
  288. Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses
  289. Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013
  290. Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study
  291. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
  292. Association between type 2 diabetes mellitus (T2DM), diabetic therapies and clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC).
  293. Association between type 2 diabetes mellitus risk factors with breast cancer in Mexican women
  294. Association between type 2 diabetes, curative treatment and survival in men with intermediate‐and high‐risk localized prostate cancer
  295. Association between type II diabetes and colon cancer among Japanese with reference to changes in food intake
  296. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study
  297. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective …
  298. Association of Adipose Tissue Distribution With Type 2 diabetes in Breast cancer Patients
  299. ASSOCIATION OF ANGIOTENSIN-RECEPTOR BLOCKERS WITH cancer RISK IN PATIENTS WITH TYPE 2 diabetes MELLITUS
  300. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
  301. Association of arterial hypertension, diabetes mellitus and inflammation with cancer incidence and mortality
  302. Association of breast cancer and diabetes mellitus in Korean postmenopausal women
  303. Association of Comorbid diabetes With Clinical Outcomes and Healthcare Utilization in Colorectal cancer Survivors.
  304. Association of Delta-6-Desaturase expression with aggressiveness of cancer, diabetes mellitus, and multiple sclerosis: a narrative review
  305. Association of diabetes and cancer mortality in American Indians: the Strong Heart Study
  306. Association of diabetes and cancer-diagnoses in primary care practices in Germany.
  307. Association of diabetes and diabetes treatment with incidence of breast cancer
  308. Association of diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast cancer Treatment for Breast cancer
  309. Association of diabetes and perineural invasion in pancreatic cancer
  310. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
  311. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer
  312. Association of diabetes mellitus with biological behaviors of colorectal cancer
  313. Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer.
  314. Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population
  315. Association of diabetes mellitus with prostate cancer: nested case–control study (Prostate testing for cancer and treatment study)
  316. Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
  317. Association of diabetes Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lung cancer: a Retrospective Study in Japan
  318. Association of diabetes Susceptibility Gene Calpain-10 with Pancreatic cancer Among Smokers
  319. Association of diabetes with colorectal cancer treatment and outcomes.
  320. Association of diabetes with colorectal cancer treatment and outcomes.
  321. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study
  322. Association of diabetes with oral cancer-an enigmatic correlation
  323. Association of diabetes with perineural invasion and overall survival in surgically resected patients with pancreatic cancer.
  324. Association of diabetes with prostate cancer risk in the multiethnic cohort
  325. Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer
  326. Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer
  327. Association of endometrial hyperplasia and cancer with a history of gestational diabetes
  328. Association of endometrial hyperplasia or cancer with a history of gestational diabetes-results from a population-based study in Washington State, 1987-2013
  329. association of Family history of Type 2 diabetes with Prostate cancer: a national cohort study
  330. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
  331. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
  332. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis
  333. Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: a GRADE-assessed systematic review and meta-analysis
  334. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon cancer in Patients With Type 2 diabetes
  335. Association of serum anti-gad antibody and hla haplotypes with type 1 diabetes mellitus triggered by nivolumab in patients with non–small cell lung cancer
  336. Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes
  337. Association of serum paraoxonase 1 activities, polymorphisms and oxidative stress in breast cancer patients with type 2 diabetes mellitus
  338. Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
  339. Association of the consumption of common food groups and beverages with mortality from cancer, ischaemic heart disease and diabetes mellitus in Serbia, 1991 …
  340. Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes
  341. Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case–control study
  342. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
  343. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women
  344. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
  345. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review
  346. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate cancer Cohort Consortium
  347. Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people
  348. Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the …
  349. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data
  350. Associations between diabetes and quality of life among breast cancer survivors
  351. Associations between diabetes medication use and risk of second breast cancer events and mortality
  352. Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian diabetes, Obesity and Lifestyle Study
  353. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
  354. Associations of hemoglobin A1c with risk of diabetes-related cancers in the cancer Prevention Study-II Nutrition Cohort (CPS-II NC)
  355. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
  356. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
  357. Associations of Telomere Length and diabetes with Pancreatic cancer
  358. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
  359. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer
  360. At the intersection of diabetes and cancer: the role of angiogenesis and inflammation
  361. Atezolizumab-induced autoimmune diabetes in a patient with metastatic lung cancer
  362. Atrial natriuretic peptide and type 2 diabetes development, evidence of causal association from the prospective Malmö diet and cancer study
  363. Attitude toward death in healthy people and patients with diabetes and cancer
  364. Attitudes, perceptions, and family coping in pediatric cancer and childhood diabetes
  365. Atypical diabetes insipidus in small cell lung cancer: paraneoplastic syndrome or metastatic disease?
  366. Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells
  367. Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
  368. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, diabetes, Breast and Prostate cancer
  369. Authors’ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer
  370. Autoimmune diabetes superimposed on type 2 diabetes in a patient initiated on immunotherapy for lung cancer
  371. Automatic Extraction of Useful Information from Food-Health Articles related to diabetes, Cardiovascular Disease and cancer
  372. Award of the Foundation for the State of Kuwait Prize for the Control of cancer, Cardiovascular Diseases and diabetes in the Eastern Mediterranean Region
  373. Bamboo extract in the prevention of diabetes and breast cancer
  374. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the ‘cerebral diabetes paradigm’
  375. Benefits of screening for pancreatic cancer in new-onset diabetes mellitus
  376. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer
  377. Beyond diabetes mellitus: role of metformin in non-muscle invasive bladder cancer
  378. Biguanide therapy for diabetes and cancer & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in many cancers
  379. Bio-Inspired and Nanotechnology-Enabled Drug Delivery for diabetes and Brain cancer
  380. Bioactive Flavonoid Apigenin and Its Nanoformulations: A Promising Hope for diabetes and cancer
  381. Biochemical mechanisms connecting diabetes and cancer. Effects of methormine
  382. Biogenesis of silver nanoparticles to treat cancer, diabetes, and microbial infections: a mechanistic overview
  383. Biologic evaluation of diabetes and local recurrence in non-small cell lung cancer
  384. Biology of circulating nucleic acids and possible roles in diagnosis and treatment in diabetes and cancer.
  385. Bitter melon as a therapy for diabetes, inflammation, and cancer: a panacea?
  386. Bittergourd (Momordica charantia) scavenges free radicals by enhancing the expression of superoxide dismutase in in vitro models of diabetes and cancer
  387. Blacks more likely to die of cancer and diabetes
  388. Bladder cancer In Patients With Type 2 diabetes Treated With Pioglitazone, A Comparative Study
  389. Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis
  390. BMI and weight: their relation to diabetes, CVD, cancer and allcause mortality
  391. Body fat distribution, diabetes, and prostate cancer in Afro-Caribbean men: the Tobago Prostate cancer Survey
  392. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam study
  393. Body mass index and cancer risk among Chinese patients with type 2 diabetes mellitus
  394. Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
  395. Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
  396. Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis
  397. Body mass index and obesity-and diabetes-associated genotypes and risk for pancreatic cancer
  398. Body mass index and obesity-related cancer risk in men and women with type 2 diabetes (ZODIAC-56)
  399. Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center diabetes Database
  400. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)–Potsdam Study–
  401. Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the liver cancer pooling project and meta-analysis
  402. Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-Survey
  403. Body mass index, diabetes, and triple-negative breast cancer prognosis
  404. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study …
  405. Body mass index, type 2 diabetes, and insulin prescription in adolescents and young adults with cancer
  406. Body mass index, waist circumference, diabetes, and risk of liver cancer for US adults
  407. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study
  408. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
  409. Breast and prostate cancer survivors in a diabetic cohort: results from the Living with diabetes Study
  410. Breast cancer and diabetes mellitus
  411. Breast cancer and diabetes mellitus: Complex interactions
  412. Breast cancer and diabetes.
  413. Breast cancer in women with diabetes mellitus type 2
  414. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase
  415. Breast cancer increases diabetes risk
  416. Breast cancer patients with diabetes mellitus: Defining the population and assessing outcomes.
  417. Breast cancer Radiotherapy Associated diabetes Mellitus Case Reports
  418. Breast cancer resistance protein and diabetes
  419. Breast cancer with diabetes insipidus
  420. Breast cancer, diabetes mellitus and usefulness of immunonutrition
  421. Breast cancer: Increased Risk of Cardiotoxicity Found with Trastuzumab for Elderly Patients with Heart Disease, diabetes
  422. Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
  423. Brief report: the risk of posttraumatic stress disorder in mothers of children diagnosed with pediatric cancer and type I diabetes
  424. Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation
  425. Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030
  426. Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors
  427. Burden of diabetes and oral cancer in India
  428. Burden of diabetes in cancer inpatients
  429. Burden of Health Disparities in Chronic Illnesses: A Report on Cardiovascular Disease, diabetes, and cancer in La Crosse County
  430. Cadmium exposure and incidence of diabetes mellitus-results from the Malmö Diet and cancer study
  431. Can a diabetes Drug Prevent cancer Death?
  432. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population‐based cohort study
  433. Can diabetes Change the Intrinsic Subtype Specificity of Breast cancer
  434. Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models
  435. Can luteolin be a therapeutic molecule for both colon cancer and diabetes?
  436. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2
  437. Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol
  438. cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden
  439. cancer among patients with type 2 diabetes mellitus: a population-based cohort study in northeastern Italy
  440. cancer and cholesterol: understanding the V-shaped association in patients with diabetes
  441. cancer and diabetes
  442. cancer and diabetes
  443. cancer and diabetes
  444. cancer and diabetes mellitus a review of the literature
  445. cancer and diabetes mellitus based on autopsy data
  446. cancer and diabetes‐a follow‐up study of two populationbased cohorts of diabetic patients
  447. cancer and diabetes, an increasing common combination: Improving knowledge among oncology nurses.
  448. cancer and diabetes: are there similarities?
  449. cancer and diabetes: are we ready for prime time?
  450. cancer and diabetes: new links and new challenges
  451. cancer and diabetes: two pathological conditions in which adrenomedullin may be involved
  452. cancer as a metabolic disease and diabetes as a cancer risk?
  453. cancer biology and prevention in diabetes
  454. cancer biology in diabetes
  455. cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment,
  456. cancer detection rates following enrolment in a disease management programme for type 2 diabetes
  457. cancer has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2 diabetes patients: A population‐based study (The Ayrshire diabetes …
  458. cancer in diabetes patients: Basing a wrong conclusion on a wrong or on a correct analyses.
  459. cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
  460. cancer in south Karnataka and its paradoxical relation to diabetes mellitus
  461. cancer incidence among Finnish people with type 2 diabetes during 1989–2014
  462. cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
  463. cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
  464. cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai
  465. cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
  466. cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden
  467. cancer incidence in patients with type 2 diabetes mellitus in Minhang District of Shanghai
  468. cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
  469. cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
  470. cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity.
  471. cancer incidence in type 1 diabetes: A 5-country study of 9,000 cancers in type 1 diabetic individuals Electronic Supplementary Material
  472. cancer incidence in type 2 diabetes patients-first results from a feasibility study of the D2C cohort
  473. cancer morbidity in patients with diabetes mellitus
  474. cancer of the breast, diabetes and pathological glucose tolerance
  475. cancer of the organs of the reproductive system in women with type 2 diabetes. Effects of antidiabetic therapy
  476. cancer of unknown primary is associated with diabetes
  477. cancer Patients with Undiagnosed and Poorly Managed diabetes Mellitus
  478. cancer patients with undiagnosed and poorly managed diabetes mellitus.
  479. cancer prediction for type-2 diabetes using machine learning
  480. cancer prevention with a diabetes pill?
  481. cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data …
  482. cancer recording in patients with type 2 diabetes in primary care and hospital admission data: IJPDS (2017) Issue 1, Vol 1: 314 Proceedings of the IPDLN …
  483. cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population‐based cohort study in Sweden
  484. cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China
  485. cancer risk among patients with type 2 diabetes: A real‐world study in Shanghai, China
  486. cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation
  487. cancer risk associated with insulin glargine among adult type 2 diabetes patients–a nationwide cohort study
  488. cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis
  489. cancer risk due to type 2 diabetes
  490. cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis
  491. cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data
  492. cancer risk in dialyzed patients with and without diabetes
  493. cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
  494. cancer risk in patients with diabetes mellitus
  495. cancer risk in patients with type 2 diabetes mellitus and their relatives
  496. cancer Risk in Patients with Type 2 diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
  497. cancer risk in people with diabetes: does physical activity and adiposity modify the association? Prospective data from the HUNT Study, Norway
  498. cancer risk in people with type 1 and type 2 diabetes in Australia
  499. cancer risk in type 2 diabetes
  500. cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations
  501. cancer risk is higher in years before and shortly after type 2 diabetes diagnosis, study shows
  502. cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan
  503. cancer risks from diabetes therapies: evaluating the evidence
  504. cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment–a clinical appraisal
  505. cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
  506. cancer Signaling Transcriptome Is Upregulated in Type 2 diabetes Mellitus
  507. cancer specific mortality in insulin-treated type 2 diabetes patients
  508. cancer stem cells generated by alcohol, diabetes, and hepatitis C virus
  509. cancer susceptibility in two rat models of spontaneous diabetes
  510. cancer treatment and cellular stress induced type 2 diabetes mellitus
  511. cancer with diabetes: Prevalence, metabolic control, and survival in a general oncology practice.
  512. cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice
  513. cancer-related side effects and diabetes self-management.
  514. cancer-suppressing enzyme adds a link to type 2 diabetes
  515. cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer
  516. cancer, diabetes, and angiotensin blockade: a question of hypohydration.
  517. cancer, Heart Disease, and diabetes in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo- p -dioxin
  518. cancer, heart, and diabetes societies join to publicise uninsured Americans
  519. cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis
  520. cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
  521. cancer, type 2 diabetes, and ageing: news from flies and worms
  522. Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans
  523. Capnocytophaga sputigena pneumonia and bacteremia in a patient with diabetes and gastric cancer
  524. Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
  525. Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition–Netherlands (EPIC-NL) study
  526. Cardiorespiratory fitness as a predictor of cancer mortality among men with pre-diabetes and diabetes
  527. Cardiovascular comorbidity and ovarian cancer patient survival: history of hypertension, heart disease, and diabetes, evidence from the Ovarian cancer Association …
  528. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission
  529. Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory
  530. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
  531. Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre‐existing diabetes: A nationwide study
  532. Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications
  533. Care of esophageal cancer patients with diabetes mellitus–preoperative management and treatment
  534. Care Plan for Resuming the Physical Activity of Patients With Pancreatic cancer and diabetes After Surgery
  535. CARING (cancer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants-a systematic review and a …
  536. Case of small cell lung cancer complicated with diabetes insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion
  537. Case report of severe Cushing’s syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception …
  538. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan
  539. Case–control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women
  540. Causal Evaluation of Laboratory Markers in Type 2 diabetes on cancer and Vascular Diseases Using Various Mendelian Randomization Tools
  541. Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview
  542. Cause of death for those with diabetes and/or cancer provides further support for an important role of vitamin D in reducing risk of many types of disease
  543. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication
  544. Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)
  545. Causes of death in men with prevalent diabetes and newly diagnosed high-versus favorable-risk prostate cancer
  546. Central diabetes insipidus and Cushing’s syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report
  547. Central diabetes insipidus caused by pituitary metastasis of lung cancer
  548. Central diabetes insipidus caused by pituitary metastasis of lung cancer
  549. Central diabetes insipidus caused by pituitary metastasis of lung cancer
  550. Central diabetes Insipidus: An Unusual Initial Presentation of Lung cancer
  551. Ceritinib aggravates glycemic control in insulin-treated patients with diabetes and metastatic ALK-positive lung cancer
  552. Challenges and perspectives in the treatment of diabetes associated breast cancer
  553. Challenges and Rewards of Pharmacotherapy Selection in Patients Newly Diagnosed with Lung cancer and diabetes Mellitus
  554. Challenges in the management of people with diabetes and cancer
  555. Challenges of imaging for cancer in patients with diabetes and obesity
  556. Change in the incidence of diabetes mellitus in oral cancer patients based on a long-term comparative study
  557. Changes in blood glucose of elderly patients with gastric cancer combined with type 2 diabetes mellitus after radical operation and the effect of mediation …
  558. Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
  559. Changes in intake of dairy product subgroups and risk of type 2 diabetes: modelling specified food substitutions in the Danish Diet, cancer and Health cohort
  560. Changes in medication management after a diagnosis of cancer among medicare beneficiaries with diabetes
  561. Changes on blood glucose of different operation scheme after gastrectomy for gastric cancer in patients complicated with diabetes mellitus
  562. Characteristics and prognosis of breast cancer patients with type-2 diabetes mellitus
  563. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors
  564. Characteristics of the clinical course of breast cancer in patients with diabetes mellitus
  565. Characteristics of treatment of patients with breast cancer and diabetes mellitus
  566. Characterizing hyperglycemia in cancer patients with diabetes in an Emergency Center
  567. Chemical Investigations of diabetes Mellitus, Malaria, and Castrate-Resistant Prostate cancer
  568. Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer
  569. Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis
  570. Childhood cancer Survivors Have More diabetes
  571. Childhood cancer, type 1 diabetes and other immune diseases: healthcare visits in the year before diagnosis in Taiwan
  572. Chinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan: A case–control study
  573. Cholesterol drugs improve breast cancer prognosis in women with diabetes mellitus
  574. Christian Religious Coping with HIV, cancer, and diabetes: African American Women and the Church’s Response
  575. Chronic diseases and health care: new trends in diabetes, arthritis, osteoporosis, fibromyalgia, low back pain, cardiovascular disease, and cancer
  576. Chronic Low‐grade Inflammation in Obesity and diabetes associated Colorectal cancer Development.
  577. Chronic pancreatitis, type 3c diabetes, and pancreatic cancer risk
  578. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.
  579. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
  580. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
  581. Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical …
  582. Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients
  583. Classification of cancer for Type 2 diabetes Using Machine Learning Algorithm
  584. Clinical analysis of breast cancer patients with type 2 diabetes mellitus in Xinjiang
  585. Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension
  586. Clinical challenges in caring for patients with diabetes and cancer
  587. Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus
  588. Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes
  589. Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer
  590. Clinical effects of postoperative early enteral nutrition for the gastric cancer patients with diabetes [J]
  591. Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China
  592. Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus
  593. Clinical improvement of diabetes mellitus type 1 by bD-mannuronic acid (M2000) in a breast cancer patient—as a case report
  594. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor?
  595. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
  596. Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study
  597. Clinical Research on the Relationship between Type 2 diabetes Mellitus and Colorectal cancer
  598. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy
  599. Clinical significance of serum lncRNA cancer susceptibility candidate 2 (CASC2) for chronic renal failure in patients with type 2 diabetes
  600. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer
  601. Clinical study of cytidine deaminase in serum of cancer thalassemia and diabetes patients
  602. Clinical Translational Research: cancer, diabetes, and Cardiovascular Disease
  603. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study
  604. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer
  605. Clinicopathologic characteristics and prognostic analysis of luminal B breast cancer patients with diabetes
  606. Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China
  607. Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus
  608. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus
  609. Clinicopathological characteristics of colorectal cancer complicated with type 2 diabetes mellitus: analysis of clinicopathological data from 3, 202 colorectal cancer …
  610. Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer
  611. Clinicopathological features of pancreatic cancer-related diabetes.
  612. Close Relationship between diabetes and cancer
  613. Co-existing prostate cancer and diabetes mellitus: implications for patient outcomes and care
  614. Co-Managing Patients with Type 1 diabetes and cancer
  615. Co-morbilities and survival of patients initially diagnosed with extensive-stage small cell lung cancer: Impact of hypertension, diabetes and chronic hepatitis B …
  616. Co-occurrence of diabetes and breast cancer among women by ethnicity
  617. Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data
  618. Codon 72 polymorphisms of p53 are associated with obesity, diabetes, and race in breast cancer
  619. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer
  620. Cohort profile: the Australian and New Zealand diabetes and cancer collaboration (ANZDCC)
  621. Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological cancer …
  622. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes
  623. Cohort study of pioglitazone and cancer incidence in patients with diabetes
  624. Colon cancer Patients with diabetes Have Increased Risk of Recurrence
  625. Colorectal and prostate cancer risk in diabetes: metformin, an actor behind the scene
  626. Colorectal cancer and diabetes
  627. Colorectal cancer associated with BMI, physical activity, diabetes, and blood glucose.
  628. Colorectal cancer in patients with type 2 diabetes mellitus: A single-center experience
  629. COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY
  630. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis
  631. Colorectal cancer Risks According to Sex Differences in Patients With Type II diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
  632. Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics
  633. Colorectal cancer, diabetes and survival: epidemiological insights
  634. Colorectal cancer: another complication of diabetes mellitus?
  635. Colorectal cancer: Histopathologic differences in tumor characteristics between patients with and without diabetes
  636. Combination of type 2 diabetes and smoking increases total cancer mortality in Japanese men using competing risk analysis: the Tanno-Sobetsu study
  637. Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
  638. Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
  639. Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women
  640. Comment A turning point for chronic kidney disease in diabetes Perioperative FLOT: new standard for gastric cancer?
  641. Comment on “Personal History of diabetes as Important as Family History of Colorectal cancer for Risk of Colorectal cancer: A Nationwide Cohort Study”
  642. Comment on Andersen et al, Pancreatitis–diabetes–Pancreatic cancer: Summary of an NIDDK-NCI Workshop
  643. Comment on: Need for Differentiating diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding cancer Survival
  644. Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung cancer in Patients With Type 2 diabetes. diabetes Care 2013; 36: 124–129
  645. Comment on: Suissa and Azoulay. Metformin and the risk of cancer: time-related biases in observational studies. diabetes Care 2012; 35: 2665–2673
  646. Comment on: Suissa and Azoulay. Metformin and the Risk of cancer: Time-Related Biases in Observational Studies. diabetes Care 2012; 35: 2665–2673
  647. Comment on: Torres-Mejía et al. Moderate-Intensity Physical Activity Ameliorates the Breast cancer Risk in Diabetic Women. diabetes Care 2012; 35: 2500–2502
  648. Commentary on “Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus.” Kalakota K, Liauw SL …
  649. Comments on” Use of metformin and risk of kidney cancer in patients with type 2 diabetes“, Chin-Hsiao Tseng, Eur J cancer, 2016, No. 52, pp. 19-25.
  650. Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm
  651. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature
  652. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study
  653. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer
  654. Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries with cancer but not heart disease or diabetes
  655. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study
  656. Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes
  657. Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus
  658. Comparing Survival Functions with Doubly Interval-Censored Data: An Application to diabetes Surveyed by Korean cancer Prevention Study
  659. Comparing the patterns of hypertension and type 2 diabetes mellitus in patients with colorectal cancer
  660. Comparison of AIS and fuzzy c-means clustering methods on the classification of breast cancer and diabetes datasets
  661. Comparison of Bee and BMI Based on Charted Versus Measured Height and Weight of diabetes Mellitus and cancer Patients
  662. Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey
  663. Comparison of Health Hardness and Life Expectancy in Patients with diabetes and Breast cancer
  664. Competing interests in a lung cancer with metastasis to the pituitary gland: syndrome of inappropriate ADH secretion versus diabetes insipidus
  665. Complete Healing from cancer diabetes Leukemia and Other Chronic Disorders
  666. Computational analysis of single nucleotide polymorphisms (SNPs) in PPAR gamma associated with obesity, diabetes and cancer
  667. Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer
  668. Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.
  669. Confounding Factors of the diabetes-Metformin-cancer Relationship
  670. Connecting the Dots Between Obesity, diabetes and cancer
  671. Considerations for developing chronic care system for traumatic brain injury based on comparisons of cancer survivorship and diabetes management care
  672. Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: from concept to reality
  673. Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
  674. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening
  675. Contribution of diabetes to the incidence and prevalence of comorbid conditions (cancer, periodontal disease, fracture, impaired cognitive function, and depression): a …
  676. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings …
  677. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the …
  678. Control of luminal type A intrinsic subtype enriched transcription factor network by insulin: implications of diabetes on breast cancer classification.
  679. Controversies Related to diabetes and Risk of Bladder cancer.
  680. Controversy regarding gastric cancer and diabetes
  681. Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis
  682. Convergence and divergence of genetic and modular networks between diabetes and breast cancer
  683. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and cancer Study cardiovascular cohort
  684. Correction to: Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study
  685. Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.
  686. Correction: Sex-specific Association between Family History of diabetes and Risk of Colorectal cancer: Two Prospective Cohort Studies
  687. Correction: Survival Benefits of Metformin for Colorectal cancer Patients with diabetes: A Systematic Review and Meta-Analysis
  688. Correlates Between Colorectal cancer Screening and diabetes Mellitus Among Residents of Ohio Appalachia: 1455
  689. Correlation between blood glucose level and the prognosis of postoperative pancreatic cancer patients with diabetes
  690. Correlation between BMI, diabetes Mellitus, and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladder cancer
  691. Correlation Between Body Mass Index, diabetes and Outcome in a Cohort of Egyptian Early Breast cancer Patients
  692. Correlation between circadian rhythm related genes, type 2 diabetes, and cancer: insights from metanalysis of transcriptomics data
  693. Correlation between diabetes prevalence and subsequent cancer mortality in North Carolina counties
  694. Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data
  695. Correlation between treatment of diabetes mellitus and development cancer
  696. Correlations of microRNA-124a and microRNA-30d with clinicopathological features of breast cancer patients with type 2 diabetes mellitus
  697. Cost-effectiveness of adjuvant therapy for treatment of stage II colon cancer in patients with diabetes.
  698. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
  699. Critical role of Dipeptidyl Peptidase IV: A therapeutic target for cancer & diabetes
  700. Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer
  701. Cullin-1 promotes cell proliferation in human breast cancer and is related to diabetes
  702. Cultural worldviews and perceived risk of colon cancer and diabetes
  703. Current drug information: Pioglitazone associated with increased risk of bladder cancer among people with type 2 diabetes
  704. Current drug information: Thiazolidinediones associated with increased risk of bladder cancer among adults with type 2 diabetes
  705. Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
  706. Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis
  707. Cytokine synergism in apoptosis: its role in diabetes and cancer
  708. Cytokines in the interface of metabolomics based cancer and type-2 diabetes
  709. Cytolysis and karyopyknosis in postmenopausal vaginal smears as markers of endometrial cancer, diabetes and obesity. Studies based on a ten-year follow-up.
  710. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration
  711. Dapagliflozin Protects Doxorubicin-induced Cardiotoxicity in Breast cancer Patients With diabetes via Suppressing ER Stress
  712. Data mining applications to dermatological diseases, colorectal cancer, diabetes, cardiology and medical audit systems
  713. Data mining Twitter for cancer, diabetes, and asthma insights
  714. Data on BMI, diabetes mellitus and non-muscle invasive bladder cancer recurrence and progression from the Nijmegen Bladder cancer study conducted in The …
  715. Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer
  716. Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
  717. Death by lung cancer or by diabetes? The unintended consequences of quitting smoking
  718. Debating cancer and diabetes in Vienna
  719. Decavanadate salts of cytosine and metformin: a combined experimental-theoretical study of potential metallodrugs against diabetes and cancer
  720. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
  721. Deciphering the scalene association among type‐2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease‐gene …
  722. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study
  723. Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study
  724. Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus
  725. Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
  726. Defective Lipolysis In diabetes And cancer
  727. Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease
  728. Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
  729. Delivery of small molecule and RNA for the treatment of type 1 diabetes and prostate cancer
  730. Demodex species positivity among patients with cancer, on hemodialysis and with diabetes mellitus
  731. Demographic changes in the burden of diabetes and cancer
  732. Demographic Characteristics, Survival and Prognostic Factors of Early Breast cancer Patients with Type 2 diabetes Mellitus: A Hospital-Based Cohort Study
  733. Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study
  734. Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated cancer Patients with Type 2 diabetes Mellitus
  735. Determination of polymorphism of K-ras and DPC4 genes in pancreatic cancer in the background of diabetes mellitus
  736. Determining the Impact of a cancer Diagnosis on diabetes Management: A Systematic Literature Review
  737. Developing a clinical and genetic risk prediction model for diabetes mellitus among survivors of childhood cancer
  738. Development and characterisation of a multifunctional hybrid nano-flora composite for the prevention and management of cancer, diabetes, blood pressure and …
  739. Development of a prediction model for colorectal cancer among patients with type 2 diabetes mellitus using a deep neural network
  740. Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
  741. Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network
  742. Development of the national Expected Screening Rate for cardiovascular disease, type 2 diabetes, cervical cancer and colorectal cancer as a benchmark for …
  743. Development of the RapidMist drug delivery system for the treatment of diabetes, cardiovascular diseases and breakthrough cancer pain
  744. Development of type 1 diabetes after cancer immunotherapy
  745. Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes
  746. Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity
  747. diabetes after hormone therapy in breast cancer survivors: a case-cohort study
  748. diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
  749. diabetes and adiposity: a heavy load for cancer
  750. diabetes and altered carbohydrate metabolism in patients with cancer
  751. diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
  752. diabetes and body mass index are associated with neuropathy and prognosis in colon cancer patients treated with capecitabine and oxaliplatin adjuvant …
  753. diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
  754. diabetes and breast cancer in T aiwanese women: a detection bias?
  755. diabetes and breast cancer mortality in Black women
  756. diabetes and breast cancer risk in a population-based case-control study of Hispanic and white, non-Hispanic women living in US Southwestern states
  757. diabetes and breast cancer risk: a meta-analysis
  758. diabetes and breast cancer subtypes
  759. diabetes and breast cancer: the women’s healthy eating & living study
  760. diabetes and cancer
  761. diabetes and cancer
  762. diabetes and cancer
  763. diabetes and cancer
  764. diabetes and cancer
  765. diabetes and cancer
  766. diabetes and cancer
  767. diabetes and cancer
  768. diabetes and cancer
  769. diabetes and cancer
  770. diabetes and cancer
  771. diabetes and cancer
  772. diabetes and cancer
  773. diabetes and cancer
  774. diabetes and cancer
  775. diabetes and cancer
  776. diabetes and cancer
  777. diabetes AND cancer
  778. diabetes and cancer
  779. diabetes and cancer
  780. diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
  781. diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
  782. diabetes AND cancer AMONG VETERANS
  783. diabetes and cancer I: risk, survival, and implications for screening
  784. diabetes and cancer II: role of diabetes medications and influence of shared risk factors
  785. diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia
  786. diabetes and cancer mortality: a multifaceted association
  787. diabetes and cancer risk for all and specific sites among Japanese men and women
  788. diabetes and cancer risk in the REDUCE trial.
  789. diabetes and cancer risk: A Mendelian randomization study
  790. diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky
  791. diabetes and cancer screening: a win-win situation or a zero game?
  792. diabetes and cancer Screening: A Win-Win Situation or a Zero Game?—Reply
  793. diabetes and cancer-a dangerous liaison?
  794. diabetes and cancer-Related Mechanisms.
  795. diabetes and cancer—an AACE/ACE consensus statement
  796. diabetes and cancer, common threads and missing links
  797. diabetes and cancer: 5 years into the recent controversy
  798. diabetes and cancer: a 2013 synopsis
  799. diabetes and cancer: A comprehensive review
  800. diabetes and cancer: a consensus report
  801. diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links
  802. diabetes and cancer: a postulated relationship
  803. diabetes and cancer: a review of current knowledge
  804. diabetes and cancer: an injurious association
  805. diabetes and cancer: Associations, mechanisms, and implications for medical practice
  806. diabetes and cancer: cancer should be screened in routine diabetes assessment
  807. diabetes and cancer: could vitamin D provide the link?
  808. diabetes and cancer: Debating the link through Ca2+/cAMP signalling
  809. diabetes and cancer: Epidemiologic and physiopathogenic links
  810. diabetes and cancer: epidemiological and biological links
  811. diabetes and cancer: Epidemiological evidence and molecular links
  812. diabetes and cancer: Epidemiological Evidence and Molecular Links
  813. diabetes and cancer: Epidemiological Evidence and Molecular Links Series [Book Review]
  814. diabetes and cancer: epidemiological, clinical, and experimental perspectives
  815. diabetes and cancer: Epidemiological, Clinical, and Experimental Perspectives
  816. diabetes and cancer: epidemiology and potential mechanisms
  817. diabetes and cancer: Evidence for Risk, Methodology and Implications
  818. diabetes and cancer: findings from the REACTION study: REACTION.
  819. diabetes and cancer: impact on health-related quality of life
  820. diabetes and cancer: is diabetes causally related to cancer?
  821. diabetes and cancer: Is there a Link?
  822. diabetes and cancer: looking at the multiligand/RAGE axis
  823. diabetes and cancer: pathophysiological fundamentals of a ‘dangerous affair’
  824. diabetes and cancer: placing the association in perspective
  825. diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong diabetes Registry
  826. diabetes and cancer: The Problem of Reverse Causality and Missing Links
  827. diabetes and cancer: The Road Ahead
  828. diabetes and cancer: two diseases with obesity as a common risk factor
  829. diabetes and cancer: Unraveling the Complexity
  830. diabetes and cancer.
  831. diabetes AND cancer.
  832. diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
  833. diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer
  834. diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
  835. diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer
  836. diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (Alliance)
  837. diabetes and colorectal cancer incidence in the cohort of Swedish men
  838. diabetes and colorectal cancer prognosis: a meta-analysis
  839. diabetes and colorectal cancer screening among men and women in the USA: National Health Interview Survey: 2008, 2010
  840. diabetes And Colorectal cancer: Could Ampk Signaling Pathway Explains The Link?
  841. diabetes and differences in detection of incident invasive breast cancer
  842. diabetes and endometrial cancer
  843. diabetes and endometrial cancer in the Iowa women’s health study
  844. diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors
  845. diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors.
  846. diabetes and endometrial cancer: an Italian case‐control study
  847. diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension
  848. diabetes and gastric cancer: the potential links
  849. diabetes and hyper-insulinemia as predictors of colorectal cancer risk in a prospective cohort of women
  850. diabetes and infarcted papillary thyroid cancer.
  851. diabetes and insulin therapy, but not metformin, are related to hepatocellular cancer risk
  852. diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime
  853. diabetes and its relationship with pancreatic cancer
  854. diabetes and kidney cancer outcomes: a propensity score analysis
  855. diabetes and kidney cancer risk among post-menopausal women: The Iowa women’s health study
  856. diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
  857. diabetes and kidney cancer: A direct or indirect association?
  858. diabetes and liver cancer risk: A stronger effect in Whites than Blacks?
  859. diabetes and lung cancer among postmenopausal women
  860. diabetes and metabolic syndrome in survivors of childhood cancer
  861. diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast cancer Patients
  862. diabetes and mortality in men with locally advanced prostate cancer: analyses of RTOG 92–02
  863. diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02
  864. diabetes and mortality in patients with prostate cancer: a meta-analysis
  865. diabetes and Obesity and Their Association with Increased Acute Urinary Symptoms in Prostate cancer Patients After Receiving Interstitial LDR Brachytherapy
  866. diabetes AND OBESITY INDUCE TRANSCRIPTOMIC AND METABOLOMIC CHANGES ENHANCING PANCREATIC cancer AGGRESSIVENESS
  867. diabetes and onset of natural menopause: results from the European Prospective Investigation into cancer and Nutrition
  868. diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast cancer Survivorship Consortium (CBCSC)
  869. diabetes AND OUTCOMES AFTER RADICAL PROSTATECTOMY-ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL …
  870. diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database
  871. diabetes and overall survival among breast cancer patients in the US military health system
  872. diabetes and pancreatic cancer
  873. diabetes and pancreatic cancer
  874. diabetes and pancreatic cancer
  875. diabetes and pancreatic cancer
  876. diabetes and pancreatic cancer
  877. diabetes and pancreatic cancer
  878. diabetes and pancreatic cancer
  879. diabetes and pancreatic cancer
  880. diabetes and pancreatic cancer
  881. diabetes and pancreatic cancer
  882. diabetes and pancreatic cancer survival: a prospective cohort study
  883. diabetes and pancreatic cancer survival: a prospective cohort-based study
  884. diabetes and Pancreatic cancer—A Dangerous Liaison Relying on Carbonyl Stress
  885. diabetes and Pancreatic cancer: A Bidirectional Relationship Perspective
  886. diabetes and pancreatic cancer: both cause and effect
  887. diabetes and pancreatic cancer: chicken or egg?
  888. diabetes and Pancreatic cancer: Reply
  889. diabetes and prognosis in a breast cancer cohort
  890. diabetes and prognosis in older persons with colorectal cancer
  891. diabetes and prostate cancer (CaP): Clinical characteristics and disparity in outcomes
  892. diabetes and Prostate cancer Aggressiveness at Diagnosis and Progression in White Americans and Black Americans from the North Carolina-Louisiana Prostate …
  893. diabetes and prostate cancer risk in the REDUCE trial
  894. diabetes and prostate cancer screening in black and white men
  895. diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
  896. diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
  897. diabetes and risk of bladder cancer: evidence from a case‐control study in New England
  898. diabetes and risk of breast cancer in Asian-American women
  899. diabetes and risk of cancer
  900. diabetes and risk of cancer
  901. diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy
  902. diabetes and risk of early-onset colorectal cancer
  903. diabetes and Risk of Endometrial cancer: a Meta-analysis [J]
  904. diabetes and risk of endometrial cancer: a population-based prospective cohort study
  905. diabetes and risk of incident cancer: a large population-based cohort study in Israel
  906. diabetes and risk of incident colorectal cancer in a prospective cohort of women
  907. diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
  908. diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies
  909. diabetes and risk of prostate cancer in a prospective cohort of US men
  910. diabetes and risk of prostate cancer: a study using the National Health Insurance
  911. diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan
  912. diabetes and sex-specific colorectal cancer risks in Newfoundland and Labrador: a population-based retrospective cohort study
  913. diabetes and smoking as predictors of cancer in Indigenous adults from rural and remote communities of North Queensland–A 15‐year follow up study
  914. diabetes and the cancer Patient
  915. diabetes and the Development of Pancreatic cancer [J]
  916. diabetes and the risk for colorectal cancer
  917. diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
  918. diabetes and the Risk of cancer Death: A Case-Cohort Study in Taiwanese Men
  919. diabetes and the risk of death in men with favorable or high-risk prostate cancer following radiation therapy
  920. diabetes and the risk of lung cancer
  921. diabetes and the risk of non-Hodgkin’s lymphoma and multiple myeloma in the European Prospective Investigation into cancer and Nutrition.
  922. diabetes and the risk of pancreatic cancer
  923. diabetes and the risk of pancreatic cancer
  924. diabetes and the risk of prostate cancer
  925. diabetes and the risk of prostate cancer: the role of diabetes treatment and complications
  926. diabetes and Thyroid cancer in Chinatown: Diversity and Acculturation
  927. diabetes and thyroid cancer mortality: a 12‐year prospective follow‐up of Taiwanese
  928. diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study
  929. diabetes and thyroid cancer risk: literature review
  930. diabetes and urothelial cancer risk: the Multiethnic Cohort study
  931. diabetes as a predictor of colon cancer prognosis: A single institution based retrospective data analysis.
  932. diabetes as a presenting feature of pancreatic cancer: A case report
  933. diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy
  934. diabetes as a Risk Factor for Breast cancer
  935. diabetes as a risk factor for death following endometrial cancer
  936. diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population
  937. diabetes as a risk factor of pancreatic cancer
  938. diabetes as a risk factor to cancer: Functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer
  939. diabetes as Independent Risk Factor for cancer after Heart and Lung Transplantation
  940. diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
  941. diabetes associated with abnormal p53 immunohistochemical patterns in colorectal cancer
  942. diabetes associated with short survival in pancreatic cancer
  943. diabetes association of polyps and colon cancer.
  944. diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study
  945. diabetes but not insulin is associated with higher colon cancer mortality
  946. diabetes care after cancer diagnosis in patients with type 2 diabetes and colorectal-or breast cancer treated with curative intent
  947. diabetes care management during cancer treatment.
  948. diabetes Care Management in the cancer Center: Challenging Current Models of Care to Optimize Outcomes for a Complex Population
  949. diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study
  950. diabetes Comorbidity and All-Cause, Cardiovascular, and cancer Mortality in US Adults
  951. diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan
  952. diabetes Could Be a Warning Sign of Pancreatic cancer: A Case Report and Literature Review
  953. diabetes decreases FDG accumulation in primary lung cancer
  954. diabetes drug helps towards immunity against cancer
  955. diabetes drug is linked with bladder cancer risk
  956. diabetes drug may be associated with increase in risk of bladder cancer
  957. diabetes Genes and Prostate cancer in the Atherosclerosis
  958. diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study
  959. diabetes has protective effect against metastasis in patients with non-small cell lung cancer
  960. diabetes in cancer Patients: Risks, Goals and Management
  961. diabetes in elderly patients with breast cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)–Medicare …
  962. diabetes in midlife and risk of cancer in late life: a nationwide Swedish twin study
  963. diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China
  964. diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis
  965. diabetes increases risk of gastric cancer after Helicobacter pylori eradication: a territory-wide study with propensity score analysis
  966. diabetes increases the risk of breast cancer: a meta-analysis
  967. diabetes increases the risk of colorectal cancer in Puerto Rico
  968. diabetes increases the risk of liver, pancreas, and gastric cancer among the Puerto Rican population
  969. diabetes influences cancer risk in patients with increased carotid atherosclerosis burden
  970. diabetes insipida por cancer de pulmon
  971. diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer
  972. diabetes insipidus and anterior pituitary insufficiency due to breast cancer metastasis
  973. diabetes insipidus and breast cancer
  974. diabetes insipidus and breast cancer-planning radiotherapy by the use of MRT
  975. diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer
  976. diabetes insipidus as a main symptom of cancer
  977. diabetes insipidus as the first symptom caused by lung cancer metastasis to the pituitary glands: clinical presentations, diagnosis, and management
  978. diabetes insipidus as the initial symtom in a patient with lung cancer: Case report
  979. diabetes insipidus caused by isolated intracranial metatstases in patient with breast cancer
  980. diabetes insipidus caused by pituitary gland metastasis accompanied by iris metastasis of small cell lung cancer: case presentation and review of the literature
  981. diabetes insipidus due to pituitary metastasis from bladder cancer
  982. diabetes insipidus due to pituitary metastasis of breast cancer
  983. diabetes insipidus in a patient with small-cell lung cancer: a paradox?
  984. diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer
  985. diabetes is an important risk factor for metastasis in non-muscle-invasive bladder cancer
  986. diabetes is associated with chronic liver disease and liver cancer in the adult population of Puerto Rico
  987. diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer
  988. diabetes Is Associated With Socioeconomic Disparities and More Comorbidities in Colorectal cancer Surgery: A Nationwide Inpatient Sample Study: 2041
  989. diabetes is not a predisposing factor for pancreatic cancer-new evidence
  990. diabetes Is Not Associated With Longer Survival in Patients With Lung cancer—Reply
  991. diabetes management and self-care education for hospitalized patients with cancer
  992. diabetes Management and Self-Care Education for Hospitalized Patients With cancer
  993. diabetes management before and after cancer diagnosis: missed opportunity
  994. diabetes management in cancer patients
  995. diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway
  996. diabetes May Increase Women’s Risk Of Developing Colorectal cancer
  997. diabetes medication use in association with survival among patients of breast, colorectal, lung, and gastric cancer
  998. diabetes medication use in association with survival among patients of breast, colorectal, lung, or gastric cancer
  999. diabetes medications and cancer risk: review of the literature
  1000. diabetes medications and cancer: A way out of uncertainty
  1001. diabetes Medications, Prostate-Specific Antigen Values, and the Chemoprevention of Prostate cancer
  1002. diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer
  1003. diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer
  1004. diabetes mellitus among cancer survivors
  1005. diabetes mellitus and age are risk factors of interval colon cancer: a case-control study
  1006. diabetes mellitus and bladder cancer—an epidemiological relationship?
  1007. diabetes mellitus and breast cancer
  1008. diabetes mellitus and breast cancer
  1009. diabetes mellitus and breast cancer
  1010. diabetes MELLITUS AND BREAST cancer OUTCOMES
  1011. diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis
  1012. diabetes mellitus and breast cancer: a retrospective population-based cohort study
  1013. diabetes mellitus and breast cancer. A retrospective follow-up study
  1014. diabetes mellitus and cancer
  1015. diabetes mellitus and cancer
  1016. diabetes Mellitus and cancer
  1017. diabetes mellitus and cancer in Werner syndrome
  1018. diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study
  1019. diabetes mellitus and cancer of the digestive organs: an Italian population-based cohort study
  1020. diabetes mellitus and cancer risk in a network of case-control studies
  1021. diabetes mellitus and cancer risk in a population‐based case–controlstudy among men from Montreal, Canada
  1022. diabetes mellitus and cancer risk: a multisite case-control study
  1023. diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan
  1024. diabetes mellitus and cancer risk: review of the epidemiological evidence
  1025. diabetes mellitus and cancer: the different expression of these diseases in Israeli Arabs and Jews
  1026. diabetes mellitus and cancer.
  1027. diabetes mellitus and carbohydrate metabolism in patients with cancer
  1028. diabetes Mellitus and Colorectal cancer Risk
  1029. diabetes mellitus and colorectal cancer risk.
  1030. diabetes mellitus and colorectal cancer–a revealed connection
  1031. diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study
  1032. diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives
  1033. diabetes mellitus and HbA1c levels associated with high grade prostate cancer
  1034. diabetes mellitus and health‐related quality of life in prostate cancer: 5‐year results from the Prostate cancer Outcomes Study
  1035. diabetes Mellitus and Hypertension are Risk Factor for Endometrial cancer
  1036. diabetes mellitus and hypertension increase the risk of colorectal cancer mortality; a robust Bayesian adjustment analysis
  1037. diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
  1038. diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis
  1039. diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis
  1040. diabetes Mellitus and Incidence of Bladder and Kidney cancer: An Exposure-Control Matched Study
  1041. diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
  1042. diabetes Mellitus and Incident Gastroenteric cancer
  1043. diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis
  1044. diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs
  1045. diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of cancer Risk (JACC Study)
  1046. diabetes mellitus and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population
  1047. diabetes mellitus and long‐term mortality of ovarian cancer patients. A systematic review and meta‐analysis of 12 cohort studies
  1048. diabetes Mellitus and Metformin Are Not Associated With Breast cancer Pathologic Complete Response
  1049. diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health …
  1050. diabetes mellitus and obesity among participants receiving screening for cancer in the Republic of the Marshall Islands
  1051. diabetes mellitus and obesity as risk factors for pancreatic cancer
  1052. diabetes Mellitus and Oral cancer: Are They Connected?
  1053. diabetes Mellitus and Oral cancer: Is There a Causal Association?
  1054. diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta‐analysis
  1055. diabetes mellitus and outcomes of colorectal cancer
  1056. diabetes mellitus and ovarian cancer (Sweden)
  1057. diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies
  1058. diabetes mellitus and ovarian cancer: More complex than increasing risk
  1059. diabetes mellitus and ovarian cancer: more complex than just increasing risk
  1060. diabetes mellitus and pancreas cancer
  1061. diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
  1062. diabetes mellitus and pancreatic cancer-cause or result?
  1063. diabetes mellitus and pancreatic cancer-cause or result?
  1064. diabetes mellitus and pancreatic cancer: a case-control study in Greater Montreal, Quebec, Canada
  1065. diabetes Mellitus and Pancreatic cancer: A Risk Assessment
  1066. diabetes mellitus and pancreatic cancer: why the association matters?
  1067. diabetes mellitus and primary liver cancer: risk factor or real cause?
  1068. diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis
  1069. diabetes mellitus and prostate cancer metabolism: Is there a relationship?
  1070. diabetes mellitus and prostate cancer risk
  1071. diabetes mellitus and prostate cancer risk
  1072. diabetes mellitus and prostate cancer risk among older men: population-based case–control study
  1073. diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis
  1074. diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian cancer Screening Trial
  1075. diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis
  1076. diabetes mellitus and prostate cancer risk; a nationwide case–control study within PCBaSe Sweden
  1077. diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment
  1078. diabetes mellitus and risk of bladder cancer: a meta-analysis
  1079. diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies
  1080. diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies
  1081. diabetes mellitus and risk of breast cancer: a meta‐analysis
  1082. diabetes mellitus and risk of cancer in T akayama: A population‐based prospective cohort study in J apan
  1083. diabetes mellitus and risk of cancer-specific mortality among patients with clear cell renal cell carcinoma undergoing nephrectomy.
  1084. diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study
  1085. diabetes mellitus and risk of colorectal cancer mortality in Japan: the Japan Collaborative Cohort Study
  1086. diabetes mellitus and risk of colorectal cancer: a meta-analysis
  1087. diabetes mellitus and risk of endometrial cancer: a meta-analysis
  1088. diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies
  1089. diabetes mellitus and risk of kidney cancer: a meta-analysis
  1090. diabetes mellitus and risk of large bowel cancer
  1091. diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies
  1092. diabetes mellitus and risk of pancreatic cancer in China: A meta-analysis based on 26 case-control studies
  1093. diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies
  1094. diabetes mellitus and risk of prostate cancer (United States)
  1095. diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into cancer and Nutrition
  1096. diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into cancer and Nutrition.
  1097. diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study
  1098. diabetes mellitus and risk of prostate cancer-A focus on shared risk factors and survivor bias
  1099. diabetes mellitus and risk of prostate cancer: a meta-analysis
  1100. diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies
  1101. diabetes mellitus and risk of thyroid cancer: a meta-analysis
  1102. diabetes mellitus and site-specific colorectal cancer risk in Korea: a case-control study
  1103. diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study
  1104. diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study
  1105. diabetes mellitus and survival after a diagnosis of breast cancer: A meta-analysis
  1106. diabetes mellitus and survival of esophageal cancer patients after esophagectomy: a systematic review and meta-analysis
  1107. diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis
  1108. diabetes mellitus and the incidence and mortality of colorectal cancer: a meta‐analysis of 24 cohort studies
  1109. diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis
  1110. diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies
  1111. diabetes Mellitus and the Risk for Developing cancer
  1112. diabetes mellitus and the risk of bladder cancer: a PRISMA-compliant meta-analysis of cohort studies
  1113. diabetes mellitus and the risk of bladder cancer: an Italian case–control study
  1114. diabetes mellitus and the risk of cancer formation: Possible link and review of literature
  1115. diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan
  1116. diabetes mellitus and the risk of cancer.
  1117. diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies
  1118. diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies
  1119. diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies
  1120. diabetes mellitus and the risk of postmenopausal breast cancer: A retrospective population-based cohort study.
  1121. diabetes mellitus and the risk of primary liver cancer
  1122. diabetes mellitus and the risk of prostate cancer
  1123. diabetes mellitus and the risk of prostate cancer in Italy
  1124. diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis
  1125. diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
  1126. diabetes mellitus as a result of pancreatic cancer
  1127. diabetes mellitus as a risk factor for cancer: stress or viral etiology?
  1128. diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans
  1129. diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis
  1130. diabetes mellitus as a risk factor for prostate cancer progression after radical prostatectomy in an Hispanic population
  1131. diabetes Mellitus as a Risk Factor of Interval Colon cancer
  1132. diabetes mellitus as a risk-factor for colorectal cancer literature review–current situation and future perspectives
  1133. diabetes mellitus as an early symptom of pancreatic cancer diagnosed three years later
  1134. diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies
  1135. diabetes mellitus carries a risk of esophageal cancer: a meta-analysis
  1136. diabetes mellitus carries a risk of gastric cancer: a meta-analysis
  1137. diabetes mellitus correlates with increased risk of pancreatic cancer: a population‐based cohort study in Taiwan
  1138. diabetes MELLITUS DOES NOT INCREASE THE RISK OF METASTATIC COLON cancer: A CASE CONTROL STUDY: 353
  1139. diabetes mellitus following platinum-based chemotherapy in gynecologic cancer patients
  1140. diabetes mellitus following platinum-based chemotherapy in gynecologic cancer patients
  1141. diabetes mellitus in cancer patients treated with combination interleukin 2 and α-interferon
  1142. diabetes mellitus in childhood and young adult cancer survivors: A meta-analysis.
  1143. diabetes mellitus in long-term survivors of childhood cancer: increased risk associated with radiation therapy: a report for the childhood cancer survivor study
  1144. diabetes mellitus in major head and neck cancer surgery
  1145. diabetes mellitus in major head and neck cancer surgery: Systematic review and meta‐analysis
  1146. diabetes mellitus in pancreatic cancer and the need for diagnosis of asymptomatic disease
  1147. diabetes mellitus in pancreatic cancer follow-up.
  1148. diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences
  1149. diabetes mellitus in pancreatic cancer: is it a causal relationship?
  1150. diabetes Mellitus in the Middle-Aged and Elderly Population (> 45 Years) and Its Association with Pancreatic cancer: An Updated Review
  1151. diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients
  1152. diabetes mellitus increases postoperative mortality in non-small cell lung cancer
  1153. diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis
  1154. diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies
  1155. diabetes mellitus increases the risk of early gastric cancer development
  1156. diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
  1157. diabetes MELLITUS IS A RISK FACTOR FOR COLON cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 352
  1158. diabetes MELLITUS IS A RISK FACTOR FOR PANCREATIC cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 168
  1159. diabetes mellitus is an independent risk factor for colorectal cancer
  1160. diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study
  1161. diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction.
  1162. diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta‐analysis of 11 cohort studies
  1163. diabetes Mellitus is Associated with High Grade and High Stage in Urinary Bladder cancer
  1164. diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma
  1165. diabetes mellitus is associated with occult cancer in endometrial hyperplasia
  1166. diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer
  1167. diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
  1168. diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases
  1169. diabetes Mellitus raise the Risk for Interval Colorectal cancer and Advanced Colorectal Adenomas
  1170. diabetes mellitus reduces prostate cancer risk-no function of age at diagnosis or duration of disease
  1171. diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
  1172. diabetes Mellitus Type 2 and Prolonged Exposure to Estrogen as Risk Factors for Development of Breast cancer in Women of Age 35-70 in Yerevan: A Case-Control …
  1173. diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer
  1174. diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
  1175. diabetes mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung …
  1176. diabetes mellitus type 2–an independent risk factor for cancer?
  1177. diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
  1178. diabetes Mellitus–A Prognostic Factor in Breast cancer?
  1179. diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
  1180. diabetes mellitus, family history, and colorectal cancer
  1181. diabetes mellitus, genetic variants in the insulin‐like growth factor pathway and colorectal cancer risk
  1182. diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into …
  1183. diabetes mellitus, hyperglycaemia and cancer
  1184. diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
  1185. diabetes mellitus, metformin and head and neck cancer
  1186. diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
  1187. diabetes mellitus, other medical conditions and pancreatic cancer: a case‐control study
  1188. diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy
  1189. diabetes mellitus, race, and the odds of high-grade prostate cancer in men diagnosed with prostate cancer in the United States.
  1190. diabetes Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectal cancer Risk
  1191. diabetes mellitus: a risk factor for pancreatic cancer?
  1192. diabetes mellitus: A significant co‐morbidity in the setting of lung cancer?
  1193. diabetes mellitus: influences on cancer risk
  1194. diabetes outcomes in patients with a history of breast cancer.
  1195. diabetes outcomes in patients with breast cancer.
  1196. diabetes pharmacotherapies and bladder cancer: a medicare epidemiologic study
  1197. diabetes Phenotypes in Transgenic Pancreatic cancer Mouse Models
  1198. diabetes Plus Weight Loss Signals Increased Pancreatic cancer Risk
  1199. diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats
  1200. diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+ mice
  1201. diabetes Protects from Prostate cancer by Downregulating
  1202. diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model
  1203. diabetes risk in childhood cancer survivors: a population-based study
  1204. diabetes Self-Management among cancer Survivors: Differences by Diagnosis and Treatment
  1205. diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
  1206. diabetes therapies affect pancreatic cancer risk
  1207. diabetes therapy and cancer risk: causal effects and other plausible explanations
  1208. diabetes therapy and cancer risk: Where do we stand when treating patients?
  1209. diabetes therapy and lung cancer
  1210. diabetes Treatment and Risks of Adverse Breast cancer Outcomes Among Elderly Breast cancer Patients: A SEER-Medicare Analysis
  1211. diabetes treatments and cancer risk: the importance of considering aspects of drug exposure
  1212. diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: a SEER-medicare analysis
  1213. diabetes type 2 and pancreatic cancer: a history unfolding
  1214. diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands
  1215. diabetes-associated angiotensin activation enhances liver metastasis of colon cancer
  1216. diabetes-related complications and pancreatic cancer incidence in the Multiethnic Cohort
  1217. diabetes-Specific Modulation of Peripheral Blood Gene Expression Signatures in Colorectal cancer
  1218. diabetes–associated dysregulated cytokines and cancer
  1219. diabetes, abnormal glucose, dyslipidemia, hypertension, and risk of inflammatory and other breast cancer
  1220. diabetes, and Incident Colorectal cancer in Men and Women: A Prospective Analysis from the European Prospective Investigation into cancer–Norfolk Study
  1221. diabetes, Antidiabetic Medications and cancer Risk in Type 2 diabetes: Focus on SGLT-2 Inhibitors
  1222. diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic cancer Case-Control Consortium
  1223. diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic cancer Case-Control Consortium
  1224. diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
  1225. diabetes, blood glucose lowering drugs and cancer risk
  1226. diabetes, body fatness, and insulin prescription among adolescents and young adults with cancer
  1227. diabetes, body size, and risk of endometrial cancer
  1228. diabetes, breast cancer and mammographic density in the Minnesota breast cancer family study
  1229. diabetes, cancer and iron
  1230. diabetes, cancer and obesity: unequivocal association
  1231. diabetes, cancer and treatment–a mini-review
  1232. diabetes, cancer and weight: a Metabolic Typing survey
  1233. diabetes, cancer Link Is New Research Focus
  1234. diabetes, cancer, and metformin: connections of metabolism and cell proliferation
  1235. diabetes, chronic kidney disease and cancer risk
  1236. diabetes, colon cancer and Wnt beta-catenin signaling pathways
  1237. diabetes, colorectal cancer and cyclooxygenase 2 inhibition
  1238. diabetes, diabetes risk factors and treatments, and breast cancer
  1239. diabetes, diabetes therapies and cancer: what’s the link?
  1240. diabetes, diabetes treatment and breast cancer prognosis
  1241. diabetes, diabetes treatment, and mammographic density in Danish Diet, cancer, and Health cohort
  1242. diabetes, diabetes treatment, and risk of thyroid cancer
  1243. diabetes, gall stone disease, and pancreatic cancer.
  1244. diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms
  1245. diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
  1246. diabetes, Glycated Hemoglobin, and Risk of cancer in the UK Biobank Study
  1247. diabetes, hypoglycemic drugs and pancreatic cancer
  1248. diabetes, insulin and cancer risk
  1249. diabetes, insulin and cancer risk The molecular role of insulin signaling and hyperinsulinemia in cancer development and progression in diabetes patients
  1250. diabetes, insulin and cancer risk: you and your patient
  1251. diabetes, Insulin Resistance, and cancer: An Update
  1252. diabetes, insulin therapy, and colorectal cancer
  1253. diabetes, insulin treatment, and cancer risk: what is the evidence?
  1254. diabetes, insulin use, and cancer risk: are observational studies part of the solution–or part of the problem?
  1255. diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese
  1256. diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan
  1257. diabetes, insulin-use and risk of colorectal cancer in a US cohort study
  1258. diabetes, insulin, and risk of cancer
  1259. diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
  1260. diabetes, metformin and breast cancer: a tangled web
  1261. diabetes, metformin and cancer risk in myotonic dystrophy type I
  1262. diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: results from the women’s health initiative
  1263. diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
  1264. diabetes, metformin use, and colorectal cancer survival in postmenopausal women
  1265. diabetes, metformin use, and colorectal cancer survival in women: A retrospective cohort study.
  1266. diabetes, metformin, and breast cancer in postmenopausal women
  1267. diabetes, Metformin, and Lung cancer: Retrospective Study of the Korean NHIS-HEALS Database
  1268. diabetes, obesity and cancer: risk and anti-risk factors
  1269. diabetes, obesity, and breast cancer
  1270. diabetes, obesity, and cancer—pathophysiology and clinical implications
  1271. diabetes, obesity, and subsequent risk of postmenopausal breast cancer among white and black women in the Southern Community Cohort Study
  1272. diabetes, obesity, and survival in a large cohort of early-stage breast cancer patients.
  1273. diabetes, obesity, and the metabolic syndrome as prognostic factors in stages I to III colorectal cancer patients
  1274. diabetes, obesity, insulin resistance: different pathways to cancer?
  1275. diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay
  1276. diabetes, pancreatic cancer and vitamin D. Is there a link?
  1277. diabetes, pancreatic cancer, and metformin therapy
  1278. diabetes, pancreatogenic diabetes, and pancreatic cancer
  1279. diabetes, physical activity and breast cancer among Hispanic women
  1280. diabetes, physical activity and endometrial cancer
  1281. diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people
  1282. diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million C hinese adults and a meta‐analysis of 22 cohort studies
  1283. diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people
  1284. diabetes, prediabetes and cancer mortality
  1285. diabetes, prostate cancer screening and risk of low-and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million …
  1286. diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis
  1287. diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations
  1288. diabetes, Weight Change, and Pancreatic cancer Risk
  1289. diabetes: diabetes therapy and cancer risk
  1290. diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease?
  1291. Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report
  1292. Diabetic Status after Radical Gastrectomy in Gastric cancer Patients with Type 2 diabetes Mellitus
  1293. Diagnosing and monitoring endocrine dysfunction, diabetes, and obesity in a cohort of adult survivors of childhood cancer
  1294. Diagnosis and survival of pancreatic cancer in relation to depression and diabetes history: A population-based study in Finland
  1295. Diagnosis and treatment of 17 cases of pulmonary tuberculosis complicated by diabetes misdiagnosed lung cancer
  1296. Diagnosis of Breast cancer and diabetes using Hybrid Feature Selection Method
  1297. Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus
  1298. Diastatic activity of the blood in cancer, syphilis and diabetes
  1299. Diet quality and risk of type 2 diabetes: a prospective study in the Malmo Diet and cancer cohort
  1300. Diet, diabetes and cancer–How and Why?
  1301. Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of cancer (EPIC)-Norfolk Study
  1302. Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of cancer-Norfolk study
  1303. Dietary intake of carbohydrates and risk of type 2 diabetes: The European Prospective Investigation into cancer-Norfolk study
  1304. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-NL study
  1305. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition: the EPIC-InterAct study
  1306. Differences in Biological Behavior of Colorectal cancer between Patients With and Without diabetes: 590
  1307. Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource
  1308. Differences in Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Levels between Pancreatic cancer Patients with or Without diabetes Mellitus
  1309. Different domains of self-reported physical activity and risk of type 2 diabetes in a population-based Swedish cohort: the Malmö diet and cancer study
  1310. Differential expression and signaling activation of insulin receptor isoforms A and B: a link between breast cancer and diabetes
  1311. Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes …
  1312. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases
  1313. Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults
  1314. Diminishing differences in treatment between colorectal cancer patients with and without diabetes: a population-based study
  1315. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population‐based study
  1316. Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
  1317. Discriminant, identifiable plasma metabolites in pancreatic cancer-associated diabetes-candidate early-detection biomarkers
  1318. Discriminant, identifiable plasma metabolites in pancreatic cancer–associated diabetes.
  1319. Discussion on the surgical treatment of cancer of esophageal and cardiac with diabetes——Clinical report of 31 cases
  1320. Disease Detection Analytics: A Simple Linear Convex Programming Algorithm for Breast cancer and diabetes Incidence Decisions
  1321. Disease-Proof: Slash Your Risk of Heart Disease, cancer, diabetes, and More–by 80 Percent
  1322. Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
  1323. Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus
  1324. Diseases of Civilization–cancer, diabetes, Obesity and Acne–the Implication of Milk, IGF-1 and mTORC1
  1325. Diseases of malfunction of body mechanisms.(Heart disease, diabetes, cancer etc.) risk by occupation, and correlation, male and female, with vehicle travel
  1326. Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods
  1327. Dissecting mechanisms involved in the aetiological overlap between Type 2 diabetes and cancer
  1328. Distances over Incomplete diabetes and Breast cancer Data Based on Bhattacharyya Distance
  1329. Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer
  1330. DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer.
  1331. Do colorectal cancer resections improve diabetes in long-term survivors? A case–control study
  1332. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A …
  1333. Do variants associated with susceptibility to pancreatic cancer and type 2 diabetes reciprocally affect risk?
  1334. Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
  1335. Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?
  1336. Does A1c predict surgical complications? A retrospective chart review of patients with Type II diabetes Mellitus and Endometrial cancer
  1337. Does Aspirin Decrease Risk of Specific Breast cancer Subtype in Women with diabetes?
  1338. Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer?
  1339. Does body mass index and adult height influence cancer incidence among Chinese living with incident type 2 diabetes?
  1340. Does body mass index and adult height influence cancer incidence among people living with incident type 2 diabetes
  1341. Does cancer risk increase with HbA 1c, independent of diabetes?
  1342. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort …
  1343. Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
  1344. Does diabetes affect [18 F] FDG standardised uptake values in lung cancer?
  1345. Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?
  1346. Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study …
  1347. Does diabetes mellitus as a comorbid condition affect the health‐related quality of life in prostate cancer survivors? Results of a population‐based observational study
  1348. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
  1349. Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?
  1350. Does diabetes mellitus influence standardized uptake values of fluorodeoxyglucose positron emission tomography in colorectal cancer?
  1351. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
  1352. Does diabetes mellitus influence the prognosis of patients with lung cancer?
  1353. Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
  1354. Does diabetes mellitus play an independent prognostic role in kidney cancer?
  1355. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study
  1356. Does diabetes really impact on postoperative survival in patients with colorectal cancer?
  1357. Does diabetes therapy influence the risk of cancer?
  1358. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama
  1359. Does Hyperinsulinemia in Type-II diabetes Mellitus Influence Disease Presentation and Long-Term Treatment Outcomes of Localized Prostate cancer?
  1360. Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
  1361. Does Metformin Protect the Bone Marrow of Patients with diabetes Treated with 131I for 
Thyroid cancer?
  1362. Does pre-existing diabetes affect prostate cancer prognosis? A systematic review
  1363. Does the hospitalization after a cancer diagnosis modify adherence to process indicators of diabetes care quality?
  1364. Does the use of incretin‐based medications increase the risk of cancer in patients with type‐2 diabetes mellitus?
  1365. Does Type 2 diabetes increase the risk of developing cancer?
  1366. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
  1367. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six‐year population‐based cohort study
  1368. Dose-dependent relationship between metformin and colorectal cancer occurrence among patients with Type 2 diabetes—A nationwide cohort study
  1369. Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients
  1370. DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate …
  1371. Drug-induced liver injury after switching from tamoxifen to anastrozole in a patient with a history of breast cancer being treated for hypertension and diabetes
  1372. Drug–subphenotype interactions for cancer in type 2 diabetes mellitus
  1373. Drugs, diabetes and cancer
  1374. Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Women’s Health Study (IWHS) cohort
  1375. Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer
  1376. Early Life: Epigenetic Effects on Obesity, diabetes, and cancer
  1377. Editorial (Thematic Issue: Nutrition And Immunology In diabetes, cancer and Infectious Diseases)
  1378. Effect of aspirin on cancer chemoprevention in Japanese patients with type 2 diabetes: 10-year observational follow-up of a randomized controlled trial
  1379. Effect of Billroth Ⅱ Gastrectomy on Type 2 diabetes Mellitus in Patients with Gastric cancer
  1380. Effect of blood glucose level on the prognosis of breast cancer patients with type 2 diabetes mellitus
  1381. Effect of diabetes and Obesity on Disparities in Prostate cancer Outcomes
  1382. Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
  1383. Effect of diabetes Mellitus and Glycemic Control on the Prognosis of Non-muscle Invasive Bladder cancer: A Retrospective Study
  1384. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL
  1385. Effect of diabetes mellitus on outcomes of colorectal cancer
  1386. Effect of diabetes Mellitus on Patients Receiving Robotic-Assisted Laparoscopic Radical Prostatectomy for Prostate cancer
  1387. Effect of diabetes mellitus on survival in patients with gallbladder cancer: a systematic review and meta-analysis
  1388. Effect of diabetes Mellitus on Survival in Patients with Gallbladder cancer: A Systematic Review and Meta-analysis
  1389. Effect of diabetes mellitus on survival in patients with pancreatic cancer: a systematic review and meta-analysis
  1390. Effect of diabetes mellitus on the development of radiation pneumonitis in patients with non-small cell lung cancer
  1391. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer
  1392. Effect of diabetes on endometrial cancer recurrence and survival
  1393. Effect of diabetes on neurological adverse effects and chemotherapy induced peripheral neuropathy in advanced colorectal cancer patients treated with different …
  1394. Effect of diabetes Treatment on Breast cancer Outcomes: A Systematic Review and Meta-analysis
  1395. Effect of different chemotherapy combined with radiotherapy for the treatment of non small cell lung cancer complicated with type 2 diabetes
  1396. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: an observational population-based study
  1397. Effect of digestive tract reconstructions after distal gastrectomy on gastric cancer patients complicated with diabetes
  1398. Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study
  1399. Effect of glitazones on cancer mortality in type 2 diabetes
  1400. Effect of human insulin on breast cancer risk in Taiwanese women with type 2 diabetes.
  1401. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: a meta-analysis
  1402. Effect of hypoglycemic agents on survival outcomes of patients with lung cancer and diabetes mellitus: A systematic review and meta-analysis.
  1403. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
  1404. Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
  1405. Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies
  1406. Effect of multimodal information delivery for diabetes care on colorectal cancer screening uptake among individuals with type 2 diabetes
  1407. Effect of nursing intervention on patients with breast cancer accompanied by diabetes during the perioperative period
  1408. Effect of Nuts on Markers of cancer and Coronary Heart Disease Risk in Type 2 diabetes: A Dose Response Study
  1409. Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer
  1410. Effect of perioperative nursing on blood sugar and complication of patients with gastric cancer complicated with diabetes mellitus
  1411. Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives
  1412. Effect Of Secoisolariciresinol Diglucoside (Sdg) On Colon cancer Associated With diabetes Mellitus.
  1413. Effect of Three Procedures of Digestive Tract Reconstructions after Distal Gastrectomy on Blood Sugar of Gastric cancer Patients Complicated with diabetes
  1414. Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer
  1415. Effect of type 2 diabetes mellitus on prognosis of nonmetastatic renal cell cancer
  1416. Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk
  1417. Effect of uncontrolled diabetes on outcomes after cystectomy in patients with bladder cancer: a population-based study
  1418. Effect of yoga on chemo-radiotherapy induced diabetes and hypertension (CRID-H) among cervical cancer patients at a regional cancer institute in south India
  1419. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes
  1420. Effects of aspirin or clopidogrel on colorectal cancer chemoprevention in patients with type 2 diabetes mellitus
  1421. Effects of Breast cancer and Type 2 diabetes Mellitus on Pulmonary Volumes and Pressures in Adult Women
  1422. Effects of Breast cancer and Type 2 diabetes Mellitus on Pulmonary Volumes and Pressures in Adult Women
  1423. Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program)
  1424. Effects of continuing nursing care on postoperative quality of life and blood glucose control in patients with bladder cancer and diabetes mellitus
  1425. Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients
  1426. Effects of diabetes on Ovarian cancer: Data Analysis and Modeling Study
  1427. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6‐year follow‐up study
  1428. Effects of metformin on breast cancer risk and mortality in patients with type 2 diabetes
  1429. Effects of Metformin on Breast cancer Risk and Mortality in Type 2 diabetes Mellitus: A Systematic Review and Meta-analysis
  1430. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
  1431. Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis
  1432. Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: A systematic review and meta-analysis
  1433. Effects of Newly Diagnosed cancer on Medication Management of Prevalent diabetes
  1434. Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type 2 diabetes mellitus and gastric cancer
  1435. Efficacy of metformin for locally advanced rectal cancer complicating diabetes mellitus.
  1436. Elderly diabetes and the correlation of colorectal cancer research
  1437. Electronic nose: A non-invasive technology for breath analysis of diabetes and lung cancer patients
  1438. Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes
  1439. Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes
  1440. Emerging link between diabetes and cancer
  1441. Emerging roles of cadmium and heme oxygenase in type-2 diabetes and cancer susceptibility
  1442. Emerging trends in pancreatic cancer and diabetes.
  1443. Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer
  1444. Empirically supported treatments of disease-related symptoms in pediatric psychology: asthma, diabetes, and cancer.
  1445. Enabling the nation’s schools to help prevent heart disease, stroke, cancer, COPD, diabetes, and other serious health problems
  1446. Endocrinopathy in Pancreatic cancer Is Characterized by Reduced Islet Size and Density with Preserved Endocrine Composition as Compared to Type 2 diabetes …
  1447. Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
  1448. Enhanced System to Achieve Better Classification Performance in Forecasting diabetes and Breast cancer
  1449. Enhancement of O‑linked N‑acetylglucosamine modification promotes metastasis in patients with colorectal cancer and concurrent type 2 diabetes mellitus
  1450. Enhancing ensemble prediction accuracy of breast cancer survivability and diabetes diagnostic using optimized EKF-RBFN trained prototypes
  1451. Epidemiological bases and molecular mechanisms linking obesity, diabetes, and cancer
  1452. Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies
  1453. Epidemiological evidence of a relationship between type‐1 diabetes mellitus and cancer: a review of the existing literature
  1454. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer
  1455. Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare
  1456. Epidemiology of diabetes and cancer
  1457. Epidemiology of diabetes and cancer: Lessons learnt
  1458. Epigenetic mechanisms of breast cancer prevention by the Type II diabetes mellitus agent metformin
  1459. Epithelial Mesenchymal Transition and Progression of Breast cancer Promoted by diabetes Mellitus in Mice Are Associated with Increased Expression of Glycolytic …
  1460. Epithelial-mesenchymal transition phenotype, metformin, and survival for colorectal cancer patients with diabetes mellitus II
  1461. Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
  1462. Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
  1463. Essential roles for the non-canonical IκB kinases in linking inflammation to cancer, obesity, and diabetes
  1464. Estimating the causal effect of BMI on mortality risk in people with heart disease, diabetes and cancer using Mendelian randomization
  1465. Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast cancer Health Disparities Study
  1466. Ethno-medicinal plants for treatment of diabetes, cancer and heart diseases: Evidence based documentation from dependent stakeholders
  1467. European Association for the Study of diabetes Annual Conference Explores Links Between diabetes and cancer
  1468. Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method
  1469. Evaluating the prevalence of diabetes mellitus subtypes in childhood cancer survivors: a systematic review protocol
  1470. EVALUATING THE ROLE OF diabetes AND THE diabetes RELATED GENE, TCF2, IN PROSTATE cancer RISK AMONG AFRICAN-AMERICAN, CAUCASIAN …
  1471. Evaluation of a mixed meal test for diagnosis and characterization of pancrEaTogEniC diabetes secondary to pancreatic cancer and chronic pancreatitis …
  1472. Evaluation of lipid peroxidation activity at intravenous administration of gold nanorods in rats with simulated diabetes and transplanted liver cancer
  1473. Evaluation of National Programme for Prevention and Control of cancer, diabetes, Cardiovascular disease and Stroke (NPCDCS) in Gandhinagar district, Gujarat.
  1474. Evaluation of siRNA mediated Silencing of IKKα in Prostate cancer and CD40 in Type-1 diabetes
  1475. Evaluation of the association between gestational diabetes mellitus at first pregnancy and cancer within 10 years postpartum using National health insurance data in …
  1476. Evaluation of the impact of diabetes mellitus on the biology of prostate cancer
  1477. Evaluation the Rate of cancer Risk in Patients with diabetes: A Systematic Review
  1478. Evidence for DNA damage as a biological link between diabetes and cancer
  1479. Examination of cause-of-death data quality among New York City deaths due to cancer, pneumonia, or diabetes from 2010 to 2014
  1480. Examination of the complex relationships among dietary components, type II diabetes, weight change, and breast cancer risk among Singaporean Chinese women
  1481. Examining known diabetes risk variants for association with prostate cancer in a multiethnic population
  1482. Examining patterns of multivariate, longitudinal symptom experiences among older adults with type 2 diabetes and cancer via cluster analysis
  1483. Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus
  1484. Examining the effects of metformin on survival outcome in stage II/III colorectal cancer patients with diabetes mellitus.
  1485. Examining the Impact of First Nations Status on the Relationship Between diabetes and cancer
  1486. Examining the multilevel influences on diabetes and hypertension clinical care management among breast cancer patients
  1487. Examining the relationship between diabetes and prostate cancer through changes in screening guidelines
  1488. Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish National diabetes Register–register-based cohort study …
  1489. Excess body weight, diabetes and cancer: epidemiologic evidence implicating hormonal and metabolic mechanisms
  1490. Excess risk of primary liver cancer in patients with diabetes mellitus
  1491. Excess risk of thyroid cancer in individuals with type 1 diabetes compared to those without diabetes in Finland; nationwide study
  1492. Excessive weight, inflammation, diabetes, and cancer: Relationships and differences by race
  1493. Exercise and patient populations: A community-based exercise intervention on cancer and Type 2 diabetes
  1494. Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes
  1495. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy
  1496. Exosomes: Mediators and Therapeutic Targets of diabetes and Pancreatic cancer
  1497. Expanding the therapeutic spectrum of metformin: from diabetes to cancer
  1498. Experience on Treating Oesophagus Cardia cancer Combined with diabetes 52 Cases in Peri-operation Period
  1499. Exploiting the cancer and diabetes metabolic connection for therapeutic purposes
  1500. Exploratory study of impact of cancer‐related posttraumatic stress symptoms on diabetes self‐management among cancer survivors
  1501. Exploring online support spaces: using cluster analysis to examine breast cancer, diabetes and fibromyalgia support groups
  1502. Exploring opportunities for colorectal cancer screening and prevention in the context of diabetes self-management: an analysis of the 2010 National Health Interview …
  1503. Exploring the association between diabetes and breast cancer morbidity: considerations for quality care improvements among Latinas
  1504. Exploring the association between diabetes and breast cancer outcomes among Latinas.
  1505. Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study
  1506. Exploring the complex and paradoxical relationships between Type 2 diabetes, obesity and cancer, as a framework for risk prediction models
  1507. Exploring the impact of metformin on cancer risk in diabetes patients
  1508. Exploring the link between diabetes and pancreatic cancer
  1509. Exploring the therapeutic ability of fenugreek against type 2 diabetes and breast cancer employing molecular docking and molecular dynamics simulations
  1510. Exposure to Electric and Magnetic Fields (EMF) Linked to Neuro-Endocrine Stress Syndrome: Increased Cardiovascular Disease, diabetes, & cancer
  1511. Expression and significance of SIRT1 in breast cancer with diabetes meilitus
  1512. Expression and significance of SIRT1 in breast cancer with diabetes mellitus
  1513. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus
  1514. Expression of HIF-1α and correlation with angiogenesis in tissue of breast cancer complicated with diabetes
  1515. Expression of long non-coding RNA H19 in colorectal cancer patients with type 2 diabetes
  1516. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
  1517. Expression of protein kinase p70S6K in leukocytes of patients with cancer and diabetes mellitus
  1518. Extracellular matrix glycation and RAGE activation. A missing piece in the puzzle of the association between diabetes and cancer
  1519. Factors associated with cancer-and non-cancer-related deaths among Taiwanese patients with diabetes after 17 years of follow-up
  1520. Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence
  1521. Factors that may influence the risk of cancer in diabetes
  1522. Familial diabetes frequency as a factor in diabetics suffering from cancer
  1523. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
  1524. Family caregivers’ strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving
  1525. Family diabetes and its consequences in cancer patients
  1526. Family disease history and perceived risk for Type 2 diabetes, cardiovascular disease, cancer and depression
  1527. Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer
  1528. Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression
  1529. Family history of diabetes and pancreatic cancer
  1530. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study
  1531. Fasting Plasma Glucose Variability and Gastric cancer Risk in Individuals Without diabetes Mellitus: A Nationwide Population-Based Cohort Study
  1532. Fasting‐Mimicking Diet and Risk Factors for Aging, diabetes, cancer and Cardiovascular Disease
  1533. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer
  1534. Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis
  1535. Features immuno-genetic, clinical and morphological characteristics of breast cancer in patients with type 2 diabetes melliuts
  1536. Fight against chronic diseases (high blood pressure, stroke, diabetes and cancer) in Pakistan; cost-effective interventions
  1537. Financial Burden Over Time in Older Adults with cancer, Heart Disease, or diabetes
  1538. Food patterns in relation to weight change and incidence of type 2 diabetes, coronary events and stroke in the Malmö Diet and cancer cohort
  1539. For better or worse: FFAR1 and FFAR4 signaling in cancer and diabetes
  1540. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis
  1541. Forecasting of breast cancer and diabetes using ensemble learning
  1542. Formulation of a Multifunctional Flora Composite for the Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
  1543. Foundation for the state of Kuwait prize for the control of cancer, cardiovascular diseases and diabetes in the Eastern Mediterranean
  1544. Foundation for the state of Kuwait prize for the control of cancer, cardiovascular diseases and diabetes in the Eastern Mediterranean Region
  1545. Four lifestyle factors prevent cancer, diabetes, and CVD
  1546. Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort
  1547. Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer
  1548. Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer
  1549. Frequency of type 2 diabetes in family and it’s changes in diabetic patients affected or not affected with cancer
  1550. From diabetes to cancer: Glucose makes the difference
  1551. From diabetes to cancer: New applications for targeting AMPK in the clinical setting
  1552. From obesity to diabetes and cancer: epidemiological links and role of therapies
  1553. Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors
  1554. Fucoidan Structure and Its Impact on Glucose Metabolism: Implications for diabetes and cancer Therapy
  1555. FUMARATE METABOLISM IN cancer AND TYPE 2 diabetes
  1556. Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk
  1557. Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic cancer–Associated diabetes
  1558. Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients
  1559. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK
  1560. Gastrointestinal cancer incidence in type 2 diabetes mellitus: results from a large retrospective population-based cohort study
  1561. Gastrointestinal tract cancer and diabetes mellitus
  1562. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study
  1563. GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets
  1564. GDF-15 is associated with cancer incidence in patients with type 2 diabetes
  1565. Gender‐specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus
  1566. Gene polymorphisms and their association with diabetes and hypertension in African American and Latina breast cancer patients
  1567. Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
  1568. Gene-and pathway-based genomics of breast cancer and type 2 diabetes in African American women
  1569. Generation and biological characteristics of a mouse model of breast cancer that copresents with diabetes mellitus
  1570. Genes and molecular mechanisms affecting the correlation between liver cancer and diabetes mellitus
  1571. Genes Associated with cancer, Schizophrenia and Type 2 diabetes in the Circassian and Chechen Populations in Jordan
  1572. Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota
  1573. Genes–environment interactions in obesity-and diabetes-associated pancreatic cancer: a GWAS data analysis
  1574. Genetic Architecture of diabetes Mellitus in Long-term Survivors of Childhood cancer
  1575. Genetic Basis Linking Variants for diabetes and Obesity with Breast cancer
  1576. Genetic polymorphisms of diabetes‐related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast cancer …
  1577. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry
  1578. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk
  1579. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer
  1580. Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes
  1581. Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes
  1582. Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancer
  1583. Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortium
  1584. Genomewide gene-diabetes and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreatic cancer Cohort Consortium and Pancreatic cancer …
  1585. Genomic Epidemiology of Human Papillomavirus (HPV), Prostate cancer, and diabetes
  1586. Genomic prediction of 16 complex disease risks including heart attack, diabetes, breast and prostate cancer
  1587. Gestational diabetes and risk of breast cancer in African American women
  1588. Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel
  1589. Gestational diabetes and risk of incident primary cancer: A large population-based cohort study in Israel.
  1590. Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study
  1591. Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study
  1592. Gestational diabetes may increase risk of endometrial cancer later in life: Results of a population-based study in Washington State, 1987–2012
  1593. Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature
  1594. Gestational diabetes mellitus and risk of incident primary cancer: A population-based retrospective cohort study.
  1595. Gestational diabetes mellitus and subsequent cancer risk: shared risk factors, causality or confounding?
  1596. Gestational diabetes mellitus may be associated with increased risk of breast cancer
  1597. Gestational diabetes, type II diabetes, and mammographic breast density in a US racially diverse population screened for breast cancer
  1598. GI hormonal changes in diabetes influence pancreatic cancer growth
  1599. Glargine safety, diabetes and cancer
  1600. Global and regional effects of bladder cancer risk associated with pioglitazone therapy in patients with diabetes
  1601. GLP-1 based therapy for diabetes and potential of thyroid cancer
  1602. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
  1603. GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
  1604. Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy for diabetes to growth inhibition of breast cancer cells.
  1605. Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice …
  1606. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus
  1607. Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes
  1608. Glucose transporters: their abnormalities and significance in type 2 diabetes and cancer
  1609. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
  1610. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
  1611. Glucose-Regulated TET2 Activity Links cancer to diabetes
  1612. Glucose‐lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all‐cause mortality, cardiovascular events and cancer
  1613. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis
  1614. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of cancer and Nutrition (EPIC-Norfolk)
  1615. Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into cancer (EPIC)–Norfolk prospective …
  1616. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography
  1617. Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study
  1618. Glycemia control using A1C level in terminal cancer patients with preexisting type 2 diabetes
  1619. Glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer and diabetes.
  1620. Glycemic control and survival of patients with coexisting diabetes mellitus and gastric or esophageal cancer
  1621. Glycemic equilibrium of cancer patients with diabetes
  1622. Glycemic Status, Insulin Resistance, and Risk of Pancreatic cancer Mortality in Individuals With and Without diabetes
  1623. Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
  1624. GO-25: Dose diabetes medication reduce recurrence of endometrial cancer?
  1625. Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?
  1626. Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer
  1627. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus
  1628. Greater development of 1, 2-dimethylhydrazine-induced colon cancer in a rat model of type 2 diabetes mellitus
  1629. Growth defect blocks cancer and diabetes
  1630. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and cancer–Cardiovascular Cohort
  1631. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans
  1632. GSK3 inhibitors in the therapeutic development of diabetes, cancer and neurodegeneration: past, present and future
  1633. Guest editorial: are diabetes-related wounds and amputations worse than cancer
  1634. GW28-e0695 High-Density Lipoprotein Cholesterol and cancer Risk Among Chinese with or without diabetes Mellitus in Kailuan Cohort
  1635. H eterogeneity in risk of prostate cancer: AS wedish population‐based cohort study of competing risks and T ype 2 diabetes mellitus
  1636. HbA1C and cancer risk in patients with type 2 diabetes–a nationwide population-based prospective cohort study in Sweden
  1637. HDL cholesterol and cancer risk among patients with type 2 diabetes
  1638. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis
  1639. HE LINK BETWEEN diabetes, diabetes TREATMENT AND cancer
  1640. Head and neck cancer patients: impact of diabetes mellitus on surgical outcomes
  1641. Health literacy and behavior related to cancer and diabetes among higher secondary students
  1642. Health professionals’ views of current treatment pathways for cancer patients with comorbid diabetes
  1643. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE
  1644. Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus
  1645. Healthy gardens/healthy lives: Navajo perceptions of growing food locally to prevent diabetes and cancer
  1646. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
  1647. Heart disease risk factors, diabetes, and prostatic cancer in an adult community
  1648. Helicobacter pylori infection and Hyperglycemia/diabetes are associated with an increased risk of gastric cancer
  1649. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
  1650. Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients
  1651. Herbal Medicines for diabetes and cancer—A Global Perspective
  1652. High glucose and diabetes increase cancer risk
  1653. High Norepinephrine Status Induced Growth of Colorectal cancer With Type 2 diabetes Mellitus Benefited From ADP-Ribosyltransferase 1
  1654. High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey
  1655. High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: a hospital based study of 4610 patients with benign tumors or …
  1656. High processed meat consumption is a risk factor of type 2 diabetes in the Alpha-Tocopherol, Beta-Carotene cancer Prevention study
  1657. High rates of endometrial cancer among Pacific women in New Zealand: the role of diabetes, physical inactivity, and obesity
  1658. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 …
  1659. High‐density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells
  1660. Higher Circulating Adiponectin Concentrations Predict Incident cancer in Type 2 diabetes–The Adiponectin Paradox
  1661. Higher Concentrations of Glucose or Insulin Increase the Risk of Various Types of cancer in Obesity or Type 2 diabetes by Decreasing the Expression of …
  1662. Higher expression of proteins in IGF/IR axes in colorectal cancer is associated with type 2 diabetes mellitus
  1663. Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes
  1664. Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes
  1665. Higher Prevalence of Prostate cancer among Veterans with Type 2 diabetes
  1666. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation
  1667. Higher risk of mortality from lung cancer in Taiwanese people with diabetes
  1668. Higher whole-grain intake is associated with lower risk of type 2 diabetes among middle-aged men and women: the Danish diet, cancer, and health cohort
  1669. Hijacking of endocrine and metabolic regulation in cancer and diabetes
  1670. Hijacking of Endocrine and Metabolic Regulation in cancer and diabetes
  1671. Hints that Glitazones, diabetes Drugs, May Work Against Breast cancer
  1672. Histone deactylase inhibitors as novel target for cancer, diabetes, and inflammation
  1673. History of cancer and the use of ACE inhibitors: results from the Vermont diabetes information system.
  1674. History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium
  1675. History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.
  1676. History of diabetes mellitus and risk of breast cancer in asian women: A meta-epidemiological analysis of population-based cohort studies
  1677. History of diabetes mellitus and risk of prostate cancer in physicians
  1678. History of diabetes Mellitus and Risk of Prostate cancer: A Meta-Epidemiological Study of Population-Based Cohort Studies in East Asian Men
  1679. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study
  1680. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
  1681. History of diabetes mellitus as a risk factor for pancreatic cancer: The Iowa Women’s Health study
  1682. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE TM (United States)
  1683. History of gestational diabetes mellitus and risk of incident invasive breast cancer among parous women in the Nurses’ Health Study II prospective cohort
  1684. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium
  1685. History of lower-limb complications and risk of cancer death in people with type 2 diabetes
  1686. History of treated hypertension and diabetes mellitus and risk of renal cell cancer
  1687. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
  1688. Homeostasis, diabetes and cancer
  1689. Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women
  1690. Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes
  1691. Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes
  1692. Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
  1693. How do people interpret their family histories of diabetes, coronary disease, or cancer?
  1694. How does diabetes Mellitus Influence Early Postoperative Results and Survival in Rectal cancer?
  1695. How shift work and a destabilized circadian system may increase risk for development of cancer and type 2 diabetes
  1696. Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research
  1697. Human insulin to increase breast cancer risk in Taiwanese women with type 2 diabetes.
  1698. Hybrid feature selection based weighted least squares twin support vector machine approach for diagnosing breast cancer, hepatitis, and diabetes
  1699. Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes
  1700. Hyperglycemia among hospitalized cancer patients with co-existing diabetes mellitus.
  1701. Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast cancer Patients without diabetes
  1702. Hyperglycemia, classified with multiple biomarkers simultaneously in men without diabetes, and risk of fatal prostate cancer
  1703. Hyperinsulinemia and type 2 diabetes: impact on cancer
  1704. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors
  1705. Hypertension, diabetes, cognitive impairment, renal cancer, polymyalgia rheumatica and chronic hemodialysis treatment: so many diseases or just only one?
  1706. Hypophysial disorder in mammary cancer and its relation to diabetes insipidus
  1707. IDDF2019-ABS-0075 Serum metabonomic analysis and establishment of diagnostic model of pancreatic cancer associated diabetes
  1708. IDDF2020-ABS-0051 Association between type-2 diabetes mellitus and platelet distribution width in patients with primary liver cancer
  1709. Identification of key candidate genes and pathways for relationship between ovarian cancer and diabetes mellitus using bioinformatical analysis
  1710. Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics
  1711. Identification of Therapeutic Targets in diabetes induced Breast cancer Metastasis
  1712. Identifying clinical factors associated with an increased risk of diabetes Mellitus among cancer survivors.
  1713. Illuminating the diabetes–cancer link
  1714. Immunologic predictors of diabetes mellitus in menopausal breast cancer patients
  1715. Immunomodulatory perspectives of potential biological spices with special reference to cancer and diabetes
  1716. Impact of cancer on adherence to glucose lowering drugs in individuals with diabetes
  1717. Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
  1718. Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms
  1719. Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F
  1720. Impact of cancer related stress on illness beliefs and glycemic control in breast cancer survivors with comorbid diabetes.
  1721. Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting
  1722. Impact of consumption of animal products on cardiovascular disease, diabetes, and cancer in developed countries
  1723. Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus
  1724. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy
  1725. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy.
  1726. Impact of diabetes and hyperglycemia on outcomes in advanced breast cancer patients.
  1727. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients
  1728. Impact of diabetes and Hyperglycemia on Survival in Advanced Breast cancer Patients
  1729. Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704
  1730. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
  1731. Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two …
  1732. Impact of diabetes Complications on Breast cancer Screening, Diagnosis, and Prognosis among Elderly Women with Pre-existing diabetes Using the SEER …
  1733. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk
  1734. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the cancer Prevention Study-II Nutrition Cohort
  1735. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study
  1736. Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis
  1737. Impact of diabetes mellitus on clinical presentation and prognosis of pancreatic cancer
  1738. Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.
  1739. Impact of diabetes mellitus on clinicopathological factors and relation with radiation pneumonitis in 332 patients with lung cancer
  1740. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer
  1741. Impact of diabetes mellitus on complications of chemotherapy and outcomes in older patients with breast cancer
  1742. Impact of diabetes mellitus on epithelial ovarian cancer survival
  1743. impact of diabetes Mellitus on Head and neck cancer patients Undergoing concurrent chemoradiotherapy
  1744. Impact of diabetes Mellitus on Head and Neck cancer Patients Undergoing Concurrent Chemoradiotherapy
  1745. Impact of diabetes mellitus on head and neck cancer patients undergoing surgery
  1746. Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer
  1747. Impact of diabetes mellitus on outcomes in patients with colon cancer
  1748. Impact of diabetes Mellitus on Outcomes in Patients With Stage II and III Colon cancer
  1749. Impact of diabetes mellitus on postoperative outcomes in individuals with non-small-cell lung cancer: A retrospective cohort study
  1750. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)‐core prostate biopsy
  1751. Impact of diabetes mellitus on the outcome of colon cancer
  1752. Impact of diabetes mellitus on the outcome of pancreatic cancer
  1753. Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
  1754. Impact of diabetes Mellitus on the Treatment Outcomes of Chemotherapy in Women with Breast cancer—A Population-Based Prospective Cohort Study
  1755. Impact of diabetes mellitus on treatment outcomes in patients with nasopharyngeal cancer
  1756. Impact of diabetes on cancer chemotherapy outcome: A retrospective analysis.
  1757. Impact of diabetes on clinicopathologic and genetic features of colorectal cancer formation.
  1758. Impact of diabetes on Colorectal cancer Outcomes
  1759. Impact of diabetes on Colorectal cancer Screening Rates in US Adults
  1760. Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study
  1761. Impact of diabetes on early complications after pancreaticoduodenectomy in patients with pancreatic cancer
  1762. Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer
  1763. Impact of diabetes on outcome and toxicity of neoadjuvant (chemo) radiation for rectal cancer
  1764. Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients
  1765. Impact of diabetes on postoperative outcomes following colon cancer surgery
  1766. Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy
  1767. Impact of diabetes on site-specific oncologic outcome in stage I-III colorectal cancer.
  1768. Impact of diabetes on the outcomes of patients with castration-resistant prostate cancer treated with docetaxel: a pooled analysis of three phase III studies
  1769. Impact of diabetes status and medication on presentation, treatment, and outcome of stage II colon cancer patients
  1770. Impact of diabetes Status on Long Term Oncological Outcome of Stage II Colorectal cancer
  1771. Impact of diabetes type II and chronic inflammation on pancreatic cancer
  1772. Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2–positive primary breast cancer …
  1773. Impact of glycemic control and metformin use on the recurrence and progression of non-muscle invasive bladder cancer in patients with diabetes mellitus
  1774. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
  1775. Impact of Gonadotropin-releasing Hormone Agonist on Cardiovascular Disease and diabetes Mellitus in Prostate cancer Patients: A Nationwide Population-based …
  1776. Impact of improvement of diabetes on survival after radical pancreatic resection in patients with pancreatic cancer and diabetes
  1777. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes
  1778. Impact of metformin on survival in patients with type II diabetes and metastatic colorectal cancer.
  1779. Impact of Metformin Use on Survival in Patients with Gastric cancer and diabetes Mellitus Following Gastrectomy
  1780. Impact of obesity during adulthood on chronic disease: diabetes, hypertension, metabolic syndrome, cardiovascular disease, and cancer.
  1781. Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study
  1782. Impact of socio‐economic status on breast cancer screening in women with diabetes: a population‐based study
  1783. Impact of stress on diabetes self-management in cancer survivors.
  1784. Impact of the duration of diabetes mellitus (DM) on the outcomes of metastatic pancreatic cancer (mPC) treated with gemcitabine (G): A retrospective study
  1785. Impact of the duration of diabetes mellitus on the outcome of metastatic pancreatic cancer treated with gemcitabine: a retrospective study
  1786. Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes on diabetes and cancer
  1787. Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes on diabetes and cancer
  1788. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a …
  1789. Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China
  1790. Impact on different type of gastrectomy reconstruction in patients with gastric cancer and diabetes
  1791. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer
  1792. Impacts of New-Onset and Longstanding diabetes on the Incidence and Mortality of Pancreatic cancer: Population Based Big-Cohort Study.
  1793. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
  1794. Implications of breast cancer with diabetes mellitus on patient outcomes and care
  1795. Implications of pancreatic cancer with diabetes mellitus on patient outcomes and care: A matched case-control study.
  1796. Implications of prostate cancer with diabetes mellitus on patient outcomes and care: A matched case-control study.
  1797. Implications of the hyperinsulinaemia-diabetes–cancer link for preventive efforts.
  1798. Implications of type1/2 diabetes mellitus in breast cancer development: a general female population-based cohort study
  1799. Importance of diabetes in inhibition of pancreatic cancer by streptozotocin
  1800. Importance of glycemic control in cancer patients with diabetes: treatment through end of life
  1801. Improve the performance of cancer and diabetes detection using novel technique of machine learning
  1802. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent …
  1803. Improvement of type 2 diabetes in a lung cancer patient treated with Erlotinib
  1804. Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy
  1805. Improving Coordination of Care Among Healthcare Professionals and Patients With diabetes and cancer.
  1806. Improving health engagement and lifestyle management for breast cancer survivors with diabetes
  1807. Improving lifestyle behaviors after breast cancer treatment among African American women with and without diabetes: Role of health care professionals
  1808. Improving Māori access to cancer, diabetes and cardiovascular health care: Key informant interviews
  1809. Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical …
  1810. Improving prediction accuracy of breast cancer survivability and diabetes diagnosis via RBF networks trained with EKF models
  1811. In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection)
  1812. Incidence and mortality risks of cancer in patients with type 2 diabetes: a retrospective study in Shanghai, China
  1813. Incidence and peculiarities of thyroid cancer in patients with type 2 diabetes mellitus
  1814. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle diabetes Study
  1815. Incidence and Predictors of diabetes Mellitus after a Diagnosis of Early-Stage Breast cancer in the Elderly Using Real-World Data
  1816. Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas
  1817. Incidence of bladder cancer in type 2 diabetes mellitus patients: A population-based cohort study
  1818. Incidence of breast cancer in women with type 2 diabetes
  1819. Incidence of cancer in a population-based cohort of patients with type 2 diabetes
  1820. Incidence of carbapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients
  1821. Incidence of diabetes after cancer development: a Korean national cohort study
  1822. Incidence of diabetes among patients with colorectal cancer.
  1823. Incidence of diabetes among postmenopausal breast cancer survivors
  1824. Incidence of diabetes and its predictive factors in cancer patients treated with phosphatidylinositol 3 kinase inhibitors
  1825. Incidence of diabetes in colorectal cancer survivors
  1826. Incidence of diabetes mellitus, cardiovascular diseases, and cancer in patients undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) …
  1827. Incidence of human papillomavirus‐related anogenital precancer and cancer in women with diabetes: A nationwide registry‐based cohort study
  1828. Incidence of medication-treated depression and anxiety associated with long-term cancer, cardiovascular disease, diabetes and osteoarthritis in community …
  1829. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients
  1830. Incidence of Pancreatic cancer Associated Insulin Dependent diabetes at an Inner City Hospital
  1831. Incidence of type 2 diabetes among oral cancer patients in Hungary
  1832. Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the European Prospective Investigation of cancer–Norfolk cohort: implications for preventive …
  1833. Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment
  1834. Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
  1835. Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts
  1836. Increased 30-day Mortality in Patients with diabetes Mellitus Undergoing Surgery for Colorectal cancer
  1837. Increased 30-Day Mortality Risk in Patients With diabetes Mellitus After Colon cancer Surgery: A Mediation Analysis
  1838. Increased 30‐day mortality in patients with diabetes undergoing surgery for colorectal cancer
  1839. Increased cancer incidence around the time of type 2 diabetes diagnosis (ZODIAC-49)
  1840. Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
  1841. Increased cancer mortality in type 2 diabetes (ZODIAC-3)
  1842. Increased cancer risk with drug use among patients with diabetes: Are the biased methods the culprit?
  1843. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin
  1844. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
  1845. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider
  1846. Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate cancer Tissues of Men with Type 2 diabetes
  1847. Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania
  1848. Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
  1849. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
  1850. Increased prevalence of prior breast cancer in women with newly diagnosed diabetes
  1851. Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis
  1852. Increased risk of cancer death with type 2 diabetes, finds Asian study
  1853. Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China
  1854. Increased risk of colon cancer in men in the pre-diabetes phase
  1855. Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality
  1856. Increased risk of kidney cancer in a cohort of Lithuanian diabetes mellitus patients
  1857. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer
  1858. Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study
  1859. Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study
  1860. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes
  1861. Increased survival in lung cancer patients with diabetes mellitus: A large cohort study
  1862. Increasing risk of diabetes mellitus in postmenopausal women with newly diagnosed primary breast cancer
  1863. Incretin-based drugs and the incidence of colorectal cancer in patients with type 2 diabetes
  1864. Incretin-based therapy and risk of pancreatic cancer in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
  1865. Incretin-Based Therapy and Risk of Pancreatic cancer in Patients with Type 2 diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.: 20
  1866. Incretin‐based drugs and risk of lung cancer among individuals with type 2 diabetes
  1867. Incretin‐based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
  1868. Incretins and cancer of the bile duct in type 2 diabetes
  1869. Incretins, diabetes, pancreatitis and pancreatic cancer: what the GI specialist needs to know
  1870. Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based …
  1871. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
  1872. Indispensability of Chemotherapy in Estrogen Receptor–Negative Early Breast cancer in Elderly Women with diabetes Mellitus
  1873. Individuals with diabetes Have an Increased Risk of Colon cancer: A Cross-Sectional Analysis: 1073
  1874. Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer
  1875. Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case–control study in patients with Type 2 diabetes mellitus
  1876. Infectious and allergic diseases, cancer, and diabetes
  1877. Infectious tenosynovitis of the long head of the biceps caused by methicillin-resistant Staphylococcus aureus in a patient with diabetes and small cell lung cancer
  1878. Inflammation in Colorectal cancer Inflammatory Bowel Disease, and diabetes Mellitus: The Link
  1879. Inflammation, Type 2 diabetes, and cancer: Identifying Biomarkers Associated with Colorectal cancer and Type 2 diabetes, and the Use of microRNA Molecules as a …
  1880. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
  1881. Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)
  1882. Influence of age on incident diabetes (DM) and cardiovascular disease (CVD) among prostate cancer survivors receiving androgen deprivation therapy (ADT).
  1883. Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy
  1884. Influence of alimentary tract reconstruction on gastric cancer patients complicated with type 2 diabetes mellitus (a report of 67 cases)
  1885. Influence of Breast cancer and Metastases on Incidence of diabetes
  1886. Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer.
  1887. Influence of diabetes Melitus, BMI, and HBA1C in High Grade Prostate cancer
  1888. Influence of diabetes mellitus and nodal distribution in endometrial cancer and correlation to clinico-pathological prognostic factors.
  1889. Influence of diabetes mellitus on changes in plasma osmotic pressure during bowel preparation in patients undergoing radical resection for colon cancer
  1890. Influence of diabetes mellitus on mortality in breast cancer patients
  1891. Influence of diabetes mellitus type 2 and prolonged estrogen exposure on risk of breast cancer among women in Armenia
  1892. Influence of diabetes on susceptibility to experimental pancreatic cancer
  1893. Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer
  1894. Influence of diabetes on the risk of urothelial cancer according to body mass index: a 10-year nationwide population-based observational study
  1895. INFLUENCE OF DIFFERENT GASTROINTESTINAL RECONSTRUCTIONS ON TYPE Ⅱ diabetes IN PATIENTS WITH DISTAL GASTRIC cancer
  1896. Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m2
  1897. Influence of Hypertension and diabetes on Postoperative Outcomes In cancer Patients Undergoing Moderate/High Risk Surgical Procedures
  1898. Influence of Hypertension on the Survival of Non-Small Cell Lung cancer Patients with Type 2 diabetes Mellitus
  1899. Influence of insulin therapy for type 2 diabetes mellitus on cancer incidence.
  1900. Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
  1901. Influence of pathogenetic factors of type 2 diabetes on activation of PI3K/AkT/mTOR pathway and on the development of endometrial and breast cancer
  1902. Influence of Preexisting diabetes on Survival After a Breast cancer Diagnosis in First Nations Women in Ontario, Canada
  1903. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients
  1904. INFLUENCE OF TYPE Ⅱ diabetes ON SHORT-TERM SURGICAL OUTCOMES OF PATIENTS WITH GASTRIC cancer
  1905. Influence on blood sugar and nutrition indicators from EN or TPN for postoperative patients with gastric cancer and diabetes [J]
  1906. Influences from the treatment of thyroid disease and diabetes mellitus on breast cancer prognosis
  1907. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
  1908. Innovative approaches in oral, inhalational, and transdermal drug delivery for cancer and diabetes treatment.
  1909. Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of β-catenin signaling
  1910. Insights into the relationships between diabetes, prediabetes, and cancer
  1911. Insulin glargine and cancer risk in patients with diabetes: a meta-analysis
  1912. INSULIN RESISTANCE IN PATIENTS WITH PANCREATIC AND COLORECTAL cancer DIAGNOSED AGAINST THE BACKGROUND OF TYPE 2 diabetes …
  1913. Insulin Resistance Is a Common Core Tethered to diabetes and Pancreatic cancer Risk
  1914. Insulin Resistance, Metabolic Syndrome and diabetes in Women at High Risk for Breast cancer
  1915. Insulin therapy and cancer in type 2 diabetes
  1916. Insulin therapy and cancer risk in diabetes mellitus
  1917. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
  1918. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
  1919. Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta‐analysis of observational studies
  1920. Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis
  1921. Insulin therapy in diabetes and cancer risk: current understanding and implications for future study
  1922. Insulin therapy, duration of diabetes linked to cancer risk
  1923. Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies
  1924. Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes
  1925. Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
  1926. Insulin-increasing diabetes therapies raise risk of death from cancer
  1927. Insulin-like growth factor genetic variation, colorectal cancer and diabetes
  1928. Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer
  1929. Insulin-like growth factor-I, interleukin-1 α and β in pancreatic cancer: role in tumor invasiveness and associated diabetes
  1930. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes
  1931. Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
  1932. Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries
  1933. Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition-Netherlands cohort …
  1934. Intensive glucose control and risk of cancer in patients with type 2 diabetes
  1935. Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
  1936. Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial
  1937. Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial
  1938. Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients
  1939. Interactions between diabetes and cancer
  1940. Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2 diabetes and colon cancer
  1941. Interim Report-September 2011 Cohort Study of Pioglitazone and cancer Incidence in Patients with diabetes Mellitus Extended Follow-up (1997-2009)
  1942. Interrelationship between oxidative stress, DNA damage and cancer risk in diabetes (Type 2) in Riyadh, KSA
  1943. Intersections and clinical translations of diabetes mellitus with cancer promotion, progression and prognosis
  1944. Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
  1945. Investigating the Mechanisms Underlying the Link Between diabetes and cancer
  1946. Investigation of the biological function of fibroblast activation protein and its potential as a therapeutic target in cancer and diabetes
  1947. Investigation of the presence of polymorphism in exons 2 and 3 of the DIRAS3 gene in women with breast cancer and diabetes
  1948. Involvement of Adrenomedullin Expression in Tumor Cells and Stroma in the Development of diabetes in Pancreatic cancer Patients
  1949. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer
  1950. Is cancer incidence different between type 2 diabetes patients compared to non-diabetics in hemodialysis? A study from the REIN registry
  1951. Is colorectal cancer associated with diabetes mellitus?
  1952. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms
  1953. Is diabetes a risk factor for colorectal cancer?
  1954. Is diabetes Associated with Progression to Dysplasia or cancer in Barrett’s Esophagus?: 49
  1955. Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?
  1956. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
  1957. Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer?
  1958. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States)
  1959. Is diabetes mellitus a risk factor for pancreatic cancer?
  1960. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?
  1961. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort …
  1962. Is diabetes mellitus associated with poorly differentiated prostate cancer (PCA)?
  1963. Is diabetes mellitus associated with prostate cancer incidence and survival?
  1964. Is there a link between BRCA1 and BRCA2 mutations and obesity, high blood pressure and diabetes mellitus in Romanian high-risk breast cancer cases?
  1965. Is there any relation between diabetes therapy and cancer risk?
  1966. Is there evidence for sex differences in the association between diabetes and cancer?
  1967. Is there evidence for sex differences in the association between diabetes and cancer? Reply to Dankner R, Boker LK, Freedman LS
  1968. Is type 2 diabetes a risk factor for pancreatic cancer
  1969. Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study
  1970. Is Type 2 diabetes Mellitus a Risk Factor for Pancreatic cancer and is Metformin Able to Prevent this Risk?
  1971. Is Type 2 diabetes Mellitus Causally Associated with cancer Risk? Evidence from a Two-Sample Mendelian Randomisation Study
  1972. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
  1973. Islet hormone secretion in pancreatic cancer patients with diabetes.
  1974. Islet inflammation: a causal link between diabetes and pancreatic cancer?
  1975. Isoform-and Paralog-Switching in IR-Signaling: When diabetes Opens the Gates to cancer
  1976. Kidney cancer and diabetes mellitus: a population-based case-control study in Taiwan
  1977. Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
  1978. Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
  1979. Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
  1980. Knowledge, attitudes, and practices related to pet contact by immunocompromised children with cancer and immunocompetent children with diabetes
  1981. KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer
  1982. Lactate, a neglected factor for diabetes and cancer interaction
  1983. Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood …
  1984. Late-onset diabetes and the link with pancreatic cancer
  1985. Latest insights into the risk of cancer in diabetes
  1986. LEISURE-TIME PHYSICAL ACTIVITY AND THE ONSET OF TYPE 2 diabetes IN THE MALMÖ DIET AND cancer STUDY COHORT
  1987. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus.
  1988. Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: an unexpected finding?
  1989. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis
  1990. Letter to the Editor-The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes
  1991. Letter to the Editor: Comments on “Use of metformin and risk of kidney cancer in patients with type 2 diabetes”, Chin‐Hsiao Tseng, Eur J cancer 2016; 52: 19 …
  1992. Lifestyle factors and mortality among adults with diabetes: findings from the European Prospective Investigation into cancer and Nutrition–Potsdam study
  1993. Lifestyle interventions for four conditions: type 2 diabetes, metabolic syndrome, breast cancer, and prostate cancer
  1994. Linking type 2 diabetes and gynecological cancer: an introductory overview
  1995. Links among type 2 diabetes, cancer and metformin use: What have we learned?
  1996. Links between obesity, diabetes and ethnic disparities in breast cancer among Hispanic populations
  1997. LIVER cancer PREDICTION FOR TYPE-II diabetes USING CLASSIFICATION ALGORITHM.
  1998. Liver cirrhosis with high IgG4 in a patient with, diabetes mellitus, ulcerative colitis with papillary thyroid cancer, is it all related? which one to blame& is it time to raise …
  1999. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
  2000. Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes
  2001. Long-standing diabetes and its effects on outcomes in colon cancer.
  2002. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
  2003. Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a meta-analysis
  2004. Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study
  2005. Long-term diabetes risk among ovarian cancer survivors in a population-based cohort study
  2006. Long-term exposure to low-level arsenic in drinking water and diabetes incidence: a prospective study of the diet, cancer and health cohort
  2007. Long-term follow-up for type 2 diabetes mellitus after gastrectomy in non-morbidly obese patients with gastric cancer: the legitimacy of onco-metabolic surgery
  2008. Long-term Mortality in cancer Patients With Preexisting diabetes
  2009. Long-term Mortality in cancer Patients With Preexisting diabetes—Reply
  2010. Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes
  2011. Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus
  2012. Loss of microRNA expression is involved in the development and prognosis of breast cancer complicated by Type 2 diabetes mellitus
  2013. Low cancer death rate in chronic dialysis patients with diabetes mellitus
  2014. Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong diabetes Registry
  2015. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
  2016. Low National Breast and Cervical cancer Screening Rates in American Indian and Alaska Native Women with diabetes
  2017. Low national breast and cervical cancer-screening rates in American Indian and Alaska Native women with diabetes
  2018. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmö Diet and cancer study
  2019. Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong diabetes Registry
  2020. Low-dose aspirin reduces breast cancer risk in women with diabetes: a nationwide retrospective cohort study in Taiwan
  2021. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes
  2022. Lung cancer and diabetes: A role for advanced glycation end‐products?
  2023. Lung cancer presenting as Central diabetes Insipidus
  2024. Lung cancer risk, diabetes, and diabetes treatments.
  2025. MA06. 07 Impact of Type 2 diabetes Mellitus and Its Metabolic Control on Prognosis of Unresectable Non-Small Cell Lung cancer Patients
  2026. Machine Learning in Healthcare: Breast cancer and diabetes Cases
  2027. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer
  2028. Mammary Adipose Tissue Control of Breast cancer Progression: Impact of Obesity and diabetes
  2029. Management of colorectal cancer and diabetes
  2030. Management of comorbid diabetes and cancer in the elderly
  2031. Management of comorbid diabetes and cancer.
  2032. Management of diabetes and pancreatic cancer.
  2033. Management of diabetes in patients with cancer
  2034. Management of diabetes mellitus in terminally ill cancer patients
  2035. Managing diabetes in cancer patients
  2036. Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines
  2037. Managing people with diabetes during the cancer palliation in the era of simultaneous care
  2038. Mandibular reconstruction using 2-step bone transport in an irradiated cancer patient with type 2 diabetes mellitus
  2039. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension
  2040. Mass spectrometry in the analysis of peptides involved in cancer, diabetes and long-term memory
  2041. Maternal diabetes and incidence of childhood cancer–a nationwide cohort study and exploratory genetic analysis
  2042. Maternal diabetes and risk of childhood cancer in the offspring
  2043. Maternal perceptions of paediatric cancer and diabetes in Cameroon
  2044. Maternal pre-pregnancy and gestational diabetes, obesity, gestational weight gain, and risk of cancer in young children: a population-based study in California
  2045. Mathematical Medicine: Modeling Disease and Treatment Key words: Immune dynamics; cancer; diabetes; Ordinary differential equations
  2046. Matricaria Chamomile Protective Effect Against Type-2 diabetes Mellitus and cancer Cell Linings
  2047. Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus
  2048. Measures of impact: diabetes and urothelial cancer
  2049. Mechanism (s) of pancreatic cancer-induced diabetes
  2050. Mechanism of protein kinase B activation by insulin IGF1 revealed by specific inhibitors of the phosphoinositide 3-kinase. Significance for diabetes and cancer
  2051. Mediation of black/white disparities in triple negative breast cancer by socioeconomic position, reproductive factors and diabetes in the Nurses’ Health Study Cohorts I …
  2052. Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer
  2053. Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into cancer and Nutrition (EPIC) study: the InterAct project
  2054. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 diabetes and cancer
  2055. Meta-analysis of androgen deprivation therapy for prostate cancer related with diabetes
  2056. Meta-analysis of mitochondrial T16189C polymorphism for cancer and Type 2 diabetes risk
  2057. Meta-analysis of the relationship between type 2 diabetes and the risk of kidney cancer
  2058. Meta‐analysis of the association between sodium‐glucose co‐transporter‐2 inhibitors and risk of skin cancer among patients with type 2 diabetes
  2059. Metabolic Adaptations in diabetes Mellitus and cancer
  2060. Metabolic reprogramming in type 2 diabetes and the development of breast cancer
  2061. Metabolic syndrome and diabetes mellitus in childhood cancer survivors.
  2062. Metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways
  2063. Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition-Potsdam Study
  2064. Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer
  2065. Metabolic syndrome, type 2 diabetes, and cancer: epidemiology and potential mechanisms
  2066. Metastatic breast cancer presenting with diabetes insipidus
  2067. Metastatic breast cancer presenting with diabetes insipidus.
  2068. Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among US veterans.
  2069. Metformin ameliorates testicular damage in diabetes and prostate cancer model
  2070. Metformin and biliary tract cancer in patients with type 2 diabetes
  2071. Metformin and breast and gynecological cancer risk among women with diabetes
  2072. Metformin and cancer in type 2 diabetes
  2073. Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
  2074. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan
  2075. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
  2076. Metformin and Gastrointestinal cancer Development in Newly Diagnosed Type 2 diabetes: A Population-Based Study in Korea
  2077. Metformin and lung cancer risk in patients with type 2 diabetes mellitus
  2078. Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta‑analysis
  2079. Metformin and pancreatic cancer risk in patients with type 2 diabetes
  2080. Metformin and pancreatic cancer risk in Taiwanese patients with type 2 diabetes
  2081. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal cancer and diabetes in Mice
  2082. Metformin and reduced risk of cancer in the Hong Kong diabetes registry: real effect or immortal time bias?
  2083. Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis
  2084. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus
  2085. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies
  2086. Metformin and the incidence of cancer in patients with diabetes: a nested case-control study
  2087. Metformin and the incidence of prostate cancer in patients with type 2 diabetes
  2088. Metformin and the incidence of prostate cancer in patients with type 2 diabetes
  2089. Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives
  2090. Metformin as a risk factor of pathogenesis of colorectal cancer in type 2 diabetes patients: a Meta-analysis
  2091. Metformin associated with increased survival in type 2 diabetes patients with pancreatic cancer and lymphoma
  2092. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16
  2093. Metformin Associates With Aggressive Features of Endometrial cancer in Women With Type 2 diabetes
  2094. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis
  2095. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
  2096. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus
  2097. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes
  2098. Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes
  2099. Metformin effect on clinical course of non-small cell lung cancer (NSCLC) in patients (pts.) with concomitant diabetes mellitus (DM) after radical resection.
  2100. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis
  2101. Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population
  2102. Metformin for Reducing Racial/Ethnic Difference in Prostate cancer Incidence for Men with Type 2 diabetes Running title: Metformin for Reducing Prostate cancer …
  2103. Metformin for reducing racial/ethnic difference in prostate cancer incidence for men with type II diabetes
  2104. Metformin has a positive therapeutic effect on prostate cancer in patients with type 2 diabetes mellitus
  2105. Metformin Impacts the Prognosis of cancer Patients with Type 2 diabetes
  2106. Metformin improves overall survival of colorectal cancer patients with diabetes: a meta-analysis
  2107. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer
  2108. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis
  2109. Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer
  2110. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
  2111. Metformin Inhibits Thyrocyte Growth and Increases Complete Responses in Differentiated Thyroid cancer in Patients with diabetes
  2112. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: a retrospective cohort analysis
  2113. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes
  2114. Metformin is associated with reduced odds for colorectal cancer among persons with diabetes
  2115. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  2116. Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: a meta-analysis
  2117. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis
  2118. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
  2119. Metformin May Cut Risk of cancer in Type 2 diabetes
  2120. Metformin may reduce bladder cancer risk in patients with type 2 diabetes
  2121. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
  2122. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes
  2123. Metformin may reduce oral cancer risk in patients with type 2 diabetes
  2124. Metformin Prevents cancer in Type 2 diabetes
  2125. Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs
  2126. Metformin protects against diabetes–induced heart injury and dunning prostate cancer model
  2127. Metformin reduces colon cancer risk in patients with type 2 diabetes: a retrospective cohort analysis
  2128. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
  2129. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus
  2130. Metformin Reduces Radiation-Induced Cardiac Toxicity Risk in Patients Having diabetes and Breast cancer: Results from the Taiwan National Cohort and Basic …
  2131. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National diabetes Program Cohort
  2132. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes
  2133. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus
  2134. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
  2135. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
  2136. Metformin therapy associated with survival benefit in lung cancer patients with diabetes
  2137. Metformin treatment and cancer risk: Cox regression analysis, with time-dependent covariates, of 320,000 persons with incident diabetes mellitus
  2138. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
  2139. Metformin use and cervical cancer risk in female patients with type 2 diabetes
  2140. Metformin use and its effect on gastric cancer in patients with type 2 diabetes: a systematic review of observational studies
  2141. Metformin use and kidney cancer outcomes in patients with diabetes: a propensity score analysis
  2142. Metformin use and lung cancer risk in patients with diabetes
  2143. Metformin use and pancreatic cancer survival among non-Hispanic White and African American US veterans with diabetes mellitus
  2144. Metformin use and pancreatic cancer survival in US veterans with diabetes mellitus: Are there racial differences?
  2145. Metformin use and renal cell cancer outcomes among patients with diabetes.
  2146. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural …
  2147. Metformin use and risk of lung cancer in patients with diabetes.
  2148. Metformin Use and the Incidence of Colorectal and Lung cancer in Patients with Type 2 diabetes Mellitus
  2149. Metformin use and the risk of cancer in patients with diabetes: A nationwide sample cohort study
  2150. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
  2151. Metformin Use for diabetes May Reduce cancer Risk in DM1
  2152. Metformin use is associated with better survival of breast cancer patients with diabetes: a meta-analysis
  2153. Metformin—mode of action and clinical implications for diabetes and cancer
  2154. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells
  2155. Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis
  2156. Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells
  2157. Metformin, diabetes, and survival among US veterans with colorectal cancer
  2158. Metformin, diabetes, and Survival among US Veterans with Colorectal cancer
  2159. Metformin, diabetes, and Survival among US Veterans with Colorectal cancer—Response
  2160. METFORMIN, STATINS AND THE RISK AND PROGNOSIS OF ENDOMETRIAL cancer IN WOMEN WITH TYPE 2 diabetes
  2161. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity
  2162. Metformin: a bridge between diabetes and prostate cancer
  2163. Metformin: a salutary candidate for colorectal cancer treatment in patients with diabetes
  2164. Metformin: on ongoing journey across diabetes, cancer therapy and prevention
  2165. Metformin: Possible Use of a diabetes Drug in Treatment of cancer
  2166. Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
  2167. Metrics of diabetes risk are only minimally improved by exercise training in postmenopausal breast cancer survivors
  2168. Metrics of diabetes risk are only minimally improved by exercise training in postmenopausal breast cancer survivors
  2169. MicroRNA-30b is involved in the pathological process of diabetes mellitus induced by pancreatic cancer by regulating plasminogen activator inhibitor-1
  2170. MicroRNA, diabetes Mellitus and Colorectal cancer
  2171. MicroRNAs 103 and 107 link type 2 diabetes and post-menopausal breast cancer
  2172. MicroRNAs 103 and 107: potential molecular links between diabetes and cancer
  2173. Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer
  2174. Microvascular reconstruction in elderly oral cancer patients: does diabetes status have a predictive role in free flap complications?
  2175. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
  2176. Midlife cancer/diabetes and risk of dementia and mild cognitive impairment: A population-based prospective cohort study in Japan
  2177. Milk intake and the risk of type 2 diabetes mellitus, hypertension and prostate cancer
  2178. MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus
  2179. miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the ‘minute and miracle’molecule moving as a monitor in the ‘genomic galaxy’
  2180. Mitochondrial dynamics in type 2 diabetes and cancer
  2181. Modalities for assessing the nutritional status in patients with diabetes and cancer
  2182. Model Checking a Synchronous diabetes–cancer Logical Network
  2183. Model Checking of a diabetes‐cancer Model
  2184. Model to determine risk of pancreatic cancer in patients with new-onset diabetes
  2185. Model to Determine Risk of Pancreatic cancer in Patients with New-onset diabetes Running title: END-PAC Risk Stratification Score
  2186. Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer
  2187. Modeling effects of diabetes and obesity co-morbidities in endometrial cancer development and progression
  2188. Moderating effects of sleep duration on diabetes risk among cancer survivors: Analysis of the National Health Interview Survey in the USA
  2189. Modern Eggs, Not Wild Type Eggs, Predispose Risk of Cardiovascular Disease, diabetes and cancer?
  2190. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
  2191. Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival
  2192. Modifications of fibronectin in age-related diseases: diabetes and cancer
  2193. Molecular Correlations between Breast cancer and diabetes Mellitus Type 2 Examined by In Silico analyses and Drug Inhibitory Effects
  2194. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
  2195. Molecular mechanisms and therapeutic effects of (−)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration
  2196. Molecular mechanisms of metformin for diabetes and cancer treatment
  2197. Molecular mechanisms of the cross-impact of pathological processes in combined diabetes and cancer. Research and clinical aspects
  2198. Molecular mechanisms underlying curcumin-mediated therapeutic effects in type 2 diabetes and cancer
  2199. Molecular targets of functional foods and bioactive compounds in the prevention of type 2 diabetes and colon cancer
  2200. MON-008 Use of National Death Index to Assess cancer Mortality and diabetes Relationship
  2201. MON-116 Metabolic Parameters in cancer Patients with and Without diabetes Mellitus
  2202. MON-678 Worsening diabetes Control in Breast cancer Patients Treated with Alpelisib
  2203. MON-LB306 Association Between cancer Related Beliefs and diabetes Medication Adherence Among Breast cancer Survivors With Comorbid Type 2 diabetes
  2204. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
  2205. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based …
  2206. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based on …
  2207. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
  2208. Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer
  2209. Mortality and glycemic control among patients with gastric and esophageal cancer and diabetes mellitus.
  2210. Mortality causes in cancer patients with type 2 diabetes mellitus
  2211. Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level
  2212. MP-1.06: Is diabetes Mellitus Associated with Aggressive Characteristics in Prostate cancer?
  2213. MP36-16 EFFECTS OF diabetes ON RENAL cancer PROGNOSIS
  2214. MP37-08 THE ASSOCIATION BETWEEN diabetes AND PROSTATE cancer-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER …
  2215. MP54-12 diabetes MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OF cancer-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL …
  2216. MP59-12 IS diabetes MELLITUS ASSOCIATED WITH cancer SPECIFIC AND OVERALL SURVIVAL IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA?
  2217. MP72-13 OUTCOMES OF RADICAL CYSTECTOMY IN PATIENTS WITH BLADDER cancer AND UNCONTROLLED diabetes: A POPULATION-BASED STUDY
  2218. MP77-03 diabetes MELLITUS INCREASES BLADDER cancer RECURRENCE RISK IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
  2219. MP77-14 diabetes MELLITUS, METFORMIN AND PROSTATE cancer: RESULTS OF A PROSTATE cancer DATABASE ANALYSIS
  2220. mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer
  2221. mTOR: from growth signal integration to cancer, diabetes and ageing
  2222. Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type II diabetes
  2223. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  2224. Multivariate analysis on the effects of diabetes and related clinical parameters on cervical cancer survival probability
  2225. Mutant p53 and HbA1c in Type 2 diabetes Melitus Patients With and Without cancer
  2226. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer
  2227. Mycobacterium neoaurum Bloodstream Infection Associated with a Totally Implanted Subclavian Port in an Adult with diabetes and History of Colon cancer
  2228. Myelotoxicity of cyclophosphamide, methotrexate and 5-fluorouracil regimen in the early stage breast cancer patients with diabetes mellitus
  2229. Nanomedicine: cancer, diabetes, and cardiovascular, central nervous system, pulmonary and inflammatory diseases
  2230. Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: cancer, diabetes, and Cardiovascular Disease
  2231. Nanowires for early cancer and diabetes diagnosis via micro-RNA detection in urine extracellular vesicles
  2232. NATIONAL ESTIMATES OF UTILIZATION AND EXPENDITURES FOR PATIENTS WITH diabetes AND cancer
  2233. Nationwide trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors
  2234. NCOA5, a molecular link between type 2 diabetes and liver cancer
  2235. Neither hormonal factors nor AGEs explain lower prostate cancer risk in older men with diabetes mellitus
  2236. Nephrogenic diabetes insipidus. An unusual presentation of recurrent rectal cancer
  2237. Nerve growth factor as an important possible component of novel therapy for cancer, diabetes and cardiovascular diseases
  2238. Neurogenic diabetes insipidus: an unusual clinical presentation of small cell lung cancer.
  2239. Neuronatin gene: imprinted and misfolded: studies in Lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream …
  2240. New diabetes drug: Colon cancer friend or foe?
  2241. New insight into metformin action: diabetes, prostate cancer, ion channels
  2242. New insights in the molecular pathways linking obesity, type 2 diabetes and cancer
  2243. New insights into pancreatic cancer-induced paraneoplastic diabetes
  2244. New onset of type 2 diabetes as a complication after cancer diagnosis: A systematic review
  2245. NEW ONSET TYPE 1 diabetes AFTER DOUBLE IMMUNOTHERAPY FOR NEUROENDOCRINE LUNG cancer
  2246. New resveratrol analogues for potential use in diabetes and cancer
  2247. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes
  2248. New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study
  2249. New-onset diabetes and pancreatic cancer
  2250. New-onset diabetes as an early sign of pancreatic cancer
  2251. New-Onset diabetes Confers Increased Risk for Pancreatic cancer in a Large Cohort of US Veterans: 732
  2252. New-onset diabetes in pancreatic cancer: a study in the primary care setting
  2253. New-onset diabetes mellitus and risk of pancreatic cancer: A systematic review and meta analysis.
  2254. New-onset diabetes patients need pancreatic cancer screening?
  2255. New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer
  2256. New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population
  2257. New-onset diabetes: a clue to the early diagnosis of pancreatic cancer
  2258. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
  2259. New-onset diabetes: aclue to the early diagnosis of pancreatic cancer/Mechanism (s) of pancreatic cancer-induced diabetes
  2260. New-Onset or Exacerbation of diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic cancer
  2261. New-onset type 2 diabetes mellitus–a high-risk group suitable for the screening of pancreatic cancer?
  2262. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
  2263. Newly Diagnosed diabetes Mellitus With Pancreatic cancer Manifested as Hyperglycemic Hyperosmolar State
  2264. Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer
  2265. News Briefs: Advances in Diagnosis/Treatment Options For diabetes, cancer, Incontinence, Peyronie’s Disease
  2266. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer
  2267. NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer
  2268. No Association of Obesity and Type 2 diabetes Mellitus Related Genetic Variants With Colon cancer
  2269. No association of risk variants for diabetes and obesity with breast cancer: the Multiethnic Cohort and PAGE studies
  2270. No association of type 2 diabetes risk variants and prostate cancer risk: the multiethnic cohort and PAGE
  2271. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
  2272. No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and …
  2273. Non-coding RNAs in IGF-1R signaling regulation: the underlying pathophysiological link between diabetes and cancer
  2274. Non-enzymatic glycation of proteins: from diabetes to cancer
  2275. Non-enzymatic glycation of proteins: from diabetes to cancer
  2276. Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
  2277. Novel blood biomarkers of pancreatic cancer–associated diabetes mellitus identified by peripheral blood–based gene expression profiles
  2278. Novel cancer therapies and their association with diabetes
  2279. Novel strategies halt cardiovascular, diabetes, and cancer strips
  2280. Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?
  2281. Number of amalgam fillings in relation to cardiovascular disease, diabetes, cancer and early death in Swedish women
  2282. Nursing evaluation on early enteral nntrition after operation inpatients of careinoma of stomach cancer complicated with diabetes [J]
  2283. Nursing for 49 Cases of Lung cancer Complicated with diabetes Mellitus at Chemotherapy [J]
  2284. Nursing intervention on senile rectal cancer complicated with diabetes
  2285. Nursing on cancer patients with diabetes treated by chemotherapy regimen including taxanes agents
  2286. Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis
  2287. Nutrient Regulation of Transcription & Signaling by O-GlcNAc: Fundamental Roles in diabetes, Neurodegeneration and cancer
  2288. Nutrition and triple major risk of abdominal obesity: type 2 diabetes mellitus, cardiovascular diseases and cancer.
  2289. Nutrition Interventions and Self-Management in Patients with Comorbid cancer and diabetes: A Narrative Review
  2290. Nutrition Update: Pancreatic cancer and diabetes
  2291. Nutrition, diabetes, and cancer
  2292. Nutritional care with diabetes and ENT cancer
  2293. Nutritional fats and the risk of type 2 diabetes and cancer
  2294. Nutritional status and survival of 8247 cancer patients with or without diabetes mellitus—results from a prospective cohort study
  2295. Nutritional therapy of cancer with diabetes mellitus [J]
  2296. O-GlcNAc signaling: a metabolic link between diabetes and cancer?
  2297. Obesity and diabetes as prognostic factors in patients with colorectal cancer
  2298. Obesity And diabetes Can Cause cancer
  2299. Obesity and diabetes: the increased risk of cancer and cancer-related mortality
  2300. Obesity and the risk of type 2 diabetes mellitus and certain types of cancer
  2301. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence
  2302. Obesity as a factor in the development of cancer in type 2 diabetes
  2303. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus
  2304. Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis
  2305. Obesity, diabetes and Breast cancer: Defining Metabolic Oncogenesis
  2306. Obesity, diabetes and cancer: a mechanistic perspective
  2307. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency
  2308. Obesity, diabetes and the risk of colorectal adenoma and cancer
  2309. Obesity, diabetes and the Risk of Colorectal Adenoma and cancer
  2310. Obesity, diabetes mellitus and vascular disease: a complex relationship with prostate cancer
  2311. Obesity, diabetes mellitus, and cancer
  2312. Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China
  2313. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis
  2314. Obesity, diabetes, and risk of cancer
  2315. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial
  2316. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
  2317. Obesity, diabetes, cancer and cardiovascular risk: a trans-generational network
  2318. Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study
  2319. Obesity, diabetes, the cardiorenal syndrome, and risk for cancer
  2320. OBESITY, HYPERINSULINEMIA, IGF-1, AND HYPERGLYCEMIA AS RISK FACTORS FOR COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes …
  2321. Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer
  2322. Obesity, type 2 diabetes and cancer
  2323. Obesity, Type 2 diabetes and cancer Risk
  2324. Obesity, type 2 diabetes and risk of digestive cancer
  2325. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
  2326. Obesity, Type 2 diabetes, and cancer: The Insulin and Insulin-Like Growth Factor Connection.
  2327. Obesity, type-2 diabetes and cancer: mechanistic insights
  2328. Obesity: Is it an Independent Risk Factor for diabetes and cancer
  2329. Observation of application mode of insulin in perioperative colon cancer patients with diabetes mellitus
  2330. Observation of different infusion methods of insulin in TPN in gastric cancer patients with diabetes after operation
  2331. Occult colon cancer in a patient with diabetes and recurrent Klebsiella pneumoniae liver abscess
  2332. Older adults with diabetes and cancer: Impact on diabetes self-management
  2333. Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breast cancer patients with hepatitis B infection or diabetes …
  2334. On the Correlation Between the” Corrected” cancer and diabetes Deathrates
  2335. On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment
  2336. Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer
  2337. Oncogenic Function of a diabetes Target SHIP2 Presents Novel cancer Therapeutic and Preventive Opportunities
  2338. Opioids and risk of type 2 diabetes in adults with non-cancer pain
  2339. Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus
  2340. Optimal glycemic target level for colon cancer patients with diabetes
  2341. OPTIMIZING LIFESTYLE REDUCES THE RISK OF cancer IN diabetes
  2342. Oral cancer in Taiwan: is diabetes a risk factor?
  2343. ORAL CONDITIONS OF cancer PATIENTS ASSOCIATED WITH diabetes AND ARTERIAL HYPERTENSION: CASE REPORT
  2344. Oral Glucose Lowering Agents and cancer in Type 2 diabetes Mellitus: Focus on Sulphonylurea Derivatives
  2345. Oral Insulin Secretagogues and cancer Risk in Type 2 diabetes Mellitus: An Updated Review
  2346. Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus
  2347. Orbital Cellulitis Following Hordeolum in an Immunocompromised Patient with diabetes and Breast cancer-A Case Report
  2348. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN
  2349. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
  2350. Our experience with pancreatic cancer and its relation to diabetes mellitus
  2351. Outcome after curative surgery for gastric cancer patients with type 2 diabetes
  2352. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes
  2353. Outcome effectiveness of therapeutic recreation camping program for adolescents living with cancer and diabetes
  2354. Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer
  2355. Ovarian cancer Increases the Risk of Stroke, but Not in Patients with Hypertension, diabetes or Both
  2356. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts
  2357. Overall Survival Found Worse in Study of Prostate cancer Patients with diabetes, but Applicability for Now Probably Limited
  2358. Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle
  2359. Oxidative Stress and its Clinical Consequences: Relationship between diabetes and cancer
  2360. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer
  2361. P-238 Metformin reduces biliary tract cancer in patients with type 2 diabetes
  2362. P-268 diabetes and risk of pancreatic cancer
  2363. P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up
  2364. P0194 Association between abdominal obesity and type 2 diabetes and HSP70-2 (+ 1267) gene mutation in colorectal cancer
  2365. P0293 PANDORA’S BOX–diabetes INSIPIDUS UNVEILS METASTATIC cancer
  2366. P1-08-06: Breast cancer among Patients with diabetes, Obesity and Abnormal Blood Lipids–A Population-Based Register Study in Sweden.
  2367. P5496 Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review …
  2368. Painful neuropathy in a diabetic patient resulting from lung cancer and not diabetes: A case report
  2369. Pan-PPAR Agonists as Potential Treatments for Type 2 diabetes, and the Effect of Adipocyte-derived Fatty Acids in Breast cancer Therapy
  2370. Pancreatic cancer and diabetes
  2371. Pancreatic cancer and diabetes
  2372. Pancreatic cancer and diabetes
  2373. Pancreatic cancer and diabetes mellitus
  2374. Pancreatic cancer and diabetes mellitus
  2375. Pancreatic cancer and diabetes mellitus
  2376. Pancreatic cancer and diabetes mellitus: A retrospective cohort study.
  2377. Pancreatic cancer and diabetes: a two-way relationship in the perspective of diabetologist
  2378. Pancreatic cancer and diabetes: Is diabetes a risk factor or the outcome?
  2379. Pancreatic cancer and diabetes: is there a relationship? A case‐controlled study
  2380. Pancreatic cancer and its Relationship to New-onset Type 2 diabetes Mellitus
  2381. Pancreatic cancer and sugar diabetes
  2382. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
  2383. Pancreatic cancer following incident diabetes in African Americans and Latinos: the multiethnic cohort
  2384. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
  2385. Pancreatic cancer manifesting as Sister Mary Joseph nodule during follow up of a patient with type 2 diabetes mellitus: A case report
  2386. Pancreatic cancer presenting as new-onset diabetes
  2387. Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
  2388. Pancreatic cancer–association with diabetes mellitus and smoking
  2389. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications
  2390. Pancreatic cancer-Associated diabetes: Is a Nihilistic Approach Justifiable
  2391. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?
  2392. Pancreatic cancer-induced diabetes: a call to action
  2393. Pancreatic cancer–associated diabetes is an “exosomopathy”
  2394. Pancreatic cancer–Associated diabetes is Clinically Distinguishable From Conventional diabetes
  2395. Pancreatic cancer–associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer
  2396. Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease
  2397. Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes
  2398. Pancreatic cancer: The importance of screening in atypical diabetes presentations.
  2399. Pancreatic expression of immunoglobulin G in human pancreatic cancer and associated diabetes
  2400. Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus
  2401. Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized …
  2402. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop
  2403. Pancreatitis, pancreatic cancer, and diabetes
  2404. Partial cranial diabetes insipidus in breast cancer: invisible pituitary metastases or uncanny coincidence
  2405. Pathogenegenetic mechanisms of oncogenesis in diabetes mel litus and analysis of cancer incidence in patients w ith diabetes mellitus in the Precarpathian region
  2406. Pathogenesis of Pancreatic cancer-Related diabetes Mellitus: Quo Vadis?
  2407. Pathogenic bacteria distribution and drug resistance of postoperative infection in elderly patients with gastric cancer complicated with diabetes mellitus
  2408. Pathologic and molecular characteristics of colorectal cancer in patients with type 2 diabetes
  2409. Pathophysiological link between diabetes and colorectal cancer: effect of diabetic microenvironment, metformin and 5-fluorouracil on AMPK activation, apoptosis and …
  2410. Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study
  2411. Patient-centered prevention strategies for cardiovascular disease, cancer and diabetes
  2412. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer
  2413. Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer – a population-based nationwide case-control study
  2414. Pay more attention to the study of the relationship between diabetes mellitus and cancer
  2415. PCN173 EFFECT OF METFORMIN ON SURVIVAL AMONG OVARIAN cancer PATIENTS WITH COMORBID diabetes: A SYSTEMATIC REVIEW AND …
  2416. PD12-4: THE IMPACT OF diabetes MELLITUS ON PATIENTS RECEIVING ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR PROSTATE cancer
  2417. PD13-09 diabetes SEVERITY AND METFORMIN ARE ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN OUTCOMES IN NON MUSCLE …
  2418. PD19-02 diabetes MELLITUS AND PROSTATE cancer RISK IN A SINGLE INSTITUTIONAL BIOPSY SERIES
  2419. PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
  2420. Peer Reviewed: A diabetes Pay-for-Performance Program and Risks of cancer Incidence and Death in Patients With Type 2 diabetes in Taiwan
  2421. Peer Reviewed: Associations Between Colorectal cancer Screening and Glycemic Control in People With diabetes, Boston, Massachusetts, 2005-2010
  2422. Peer reviewed: diabetes status and being up-to-date on colorectal cancer screening, 2012 behavioral risk factor surveillance system
  2423. Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer
  2424. Perceived Determinants of cancer Screenings in Women with diabetes
  2425. Perceived experiences of discrimination in health care: a barrier for cancer screening among American Indian women with type 2 diabetes
  2426. Perceived impact of cancer treatment on diabetes self-management
  2427. Perceived impact of diabetes management in patients with cancer: the experience of a tertiary referral center
  2428. Perceived medical discrimination in American Indian women: Effect on health care decisions, cancer screening, diabetes services and diabetes management
  2429. Performance analysis of Machine learning classifiers for predicting diabetes and prostate cancer
  2430. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
  2431. Periodontal pathogens as risk factors of cardiovascular diseases, diabetes, rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease—is there cause for …
  2432. PERIOPERATIONAL MANAGEMENT OF CARDIAC cancer & ITS CONCOMITANT diabetes MELLITUS
  2433. Perioperative Management for Patients with Esophageal and Cardiac cancer Complicated with diabetes Mellitus [J]
  2434. Perioperative Management of 288 Cases with Esophageal cancer or Cardiac cancer Complicated with diabetes Mellitus
  2435. Perioperative management of colonrectal cancer patients with diabetes mellitus
  2436. Perioperative management of esophageal cancer patients concomitent with diabetes
  2437. Perioperative management of esophageal cancer patients concomitent with diabetes [J]
  2438. Perioperative management of gastric cancer with diabetes [J]
  2439. Perioperative management of large bowel cancer patients with diabetes mellitus
  2440. Perioperative management of patients of colonorectal cancer with diabetes mellitus
  2441. Perioperative Nursing for the Patients with Breast cancer Combined with diabetes Mellitus [J]
  2442. Perioperative nursing in patients with rental cancer complicated with diabetes [J]
  2443. Perioperative nursing of cervical cancer patients with diabetes mellitus
  2444. Perioperative nutrition support for esophageal cancer complicated with diabetes mellitus
  2445. Perioperative Treatment of Gastrointestinal cancer Combined with diabetes
  2446. Perioperative treatment of patients with colorectal cancer and diabetes [J]
  2447. Perioperative treatment of patients with gastric cancer complicated with diabetes
  2448. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer
  2449. Peroxisome proliferator-activated receptor gamma (PPARγ) as a target for concurrent management of diabetes and obesity-related cancer
  2450. Personal history of diabetes as important as family history of colorectal cancer for risk of colorectal cancer: a nationwide cohort study
  2451. Personalized diabetes and cancer medicine: A rationale for anti-diabetic nutrition (bitter melon) in a supportive setting
  2452. Personalized indicator thrombocytosis shows connection to staging and indicates shorter survival in colorectal cancer patients with or without type 2 diabetes
  2453. Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases
  2454. Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies
  2455. Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer
  2456. Pharmacotherapy of diabetes and cancer risk
  2457. Phosphate diabetes associated with bone metastases of oat cell lung cancer.
  2458. Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
  2459. Phosphorylation of Protein Kinase Akt by Mtorc2 in Peripheral Blood Mononuclear Cells of Patients with cancer and diabetes.
  2460. Physical activity and mental distress among Veteran cancer survivors with heart disease and diabetes
  2461. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response …
  2462. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis
  2463. Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies
  2464. Picture quiz: diabetes insipidus in a woman with breast cancer
  2465. Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
  2466. Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes
  2467. Pioglitazone and oral cancer risk in patients with type 2 diabetes
  2468. Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world …
  2469. Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2
  2470. Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes
  2471. Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
  2472. Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis
  2473. Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes
  2474. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
  2475. Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
  2476. Pituitary metastasis from breast cancer presenting as diabetes insipidus
  2477. Pituitary metastasis: lung cancer presenting as bitemporal hemianopsia with diabetes insipidus and anterior pituitary deficiency
  2478. Pituitary stalk metastasis from lung cancer, preceding diabetes insipidus–case report and clinical review of the literature
  2479. Plasma adropin as a potential marker predicting obesity and obesity-associated cancer in Korean patients with type 2 diabetes mellitus
  2480. Plasma Lipidome and Prediction of Type 2 diabetes in the Population-Based Malmö Diet and cancer Cohort
  2481. Plasma metals and cancer incidence in patients with type 2 diabetes
  2482. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality
  2483. Plasma-free amino acid profiles are predictors of cancer and diabetes development
  2484. Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer
  2485. Platelet Hyperactivity and Dysfunction in diabetes and cancer
  2486. Pleiotropic effects of single nucleotide polymorphophisms of EDIL3 gene: Association with cancer, obesity, and type 2 diabetes
  2487. Pleiotropy and pathway analyses of genetic variants associated with both type 2 diabetes and prostate cancer
  2488. Pneumonia, diabetes and prostate cancer
  2489. PO-240 WWOX suppressor gene regulate glucose metabolism and warburg effect in case of gestational diabetes mellitusas well as breast cancer
  2490. POD-11.08: diabetes and risk of death from cancer of the prostate, kidney, and urinary bladder
  2491. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study
  2492. Poor glycemic control might compromise the efficacy of chemotherapy in non‐small cell lung cancer patients with diabetes mellitus
  2493. Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population
  2494. Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the …
  2495. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states
  2496. Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune
  2497. Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune
  2498. Population‐based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women
  2499. POS-03.118: Influence of diabetes mellitus on the prognosis of prostate cancer patients
  2500. Positive association between diabetes mellitus and risk of colorectal cancer.
  2501. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: National cohort study
  2502. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
  2503. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men
  2504. Poster# 0598–Type 2 diabetes Mellitus-A risk indicator for colorectal cancer
  2505. Postmenopausal women with diabetes risk breast cancer
  2506. Postmenopausal women with medically treated diabetes have increased risk of lung cancer
  2507. Postoperative diabetes mellitus following resection of the body and tail of the pancreas for secondary invasion by gastric cancer
  2508. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis
  2509. Postoperative serum carcinoembryonic antigen levels cannot predict survival in colorectal cancer patients with type II diabetes
  2510. Postpancreatitis diabetes confers higher risk for pancreatic cancer than type 2 diabetes: Results from a nationwide cancer registry
  2511. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer
  2512. PP28 Exploring the Associations between diabetes and Site-Specific cancer Mortality: Evidence from the Health Survey for England and Scottish Health Survey linked …
  2513. PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
  2514. PPAR-γ: A multifaceted transcription factor important in diabetes, cardiovascular disease, and cancer
  2515. Practical aspects of large register studies: Multiple states and multiple timescales: The diabetes and cancer study.
  2516. Pre-and post-diagnosis diabetes as a risk factor for all-cause and cancer-specific mortality in breast, prostate, and colorectal cancer survivors: A prospective …
  2517. Pre-diabetes and breast cancer outcomes: Abrogating the confounding effect of anti-diabetic therapy.
  2518. Pre-existing diabetes and breast cancer prognosis among elderly women
  2519. Pre-existing diabetes and lung cancer prognosis
  2520. Pre-existing diabetes in early stage breast cancer patients is associated with lack of improvement in quality of life 2 years after diagnosis
  2521. Pre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia
  2522. Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis
  2523. Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai
  2524. Pre-existing type 2 diabetes and survival among patients with colorectal cancer
  2525. Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type II diabetes Mellitus and Colorectal cancer
  2526. Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort.
  2527. Prediabetes and type 2 diabetes mellitus and risk of thyroid cancer
  2528. Prediabetes, diabetes, and risk of breast cancer: a case-control study
  2529. Prediagnostic diabetes, body mass index, and survival of endometrial cancer: A prospective study.
  2530. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes
  2531. Predictive factors for differentiating pancreatic cancer-associated diabetes mellitus from common type 2 diabetes mellitus for the early detection of pancreatic cancer
  2532. Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
  2533. Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus
  2534. Predictors of the Onset of Type 1 diabetes Obtained from Real-World Data Analysis in cancer Patients Treated with Immune Checkpoint Inhibitors
  2535. Preexisting diabetes and risks of morbidity and mortality after gastrectomy for gastric cancer: a nationwide database study
  2536. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer
  2537. Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes
  2538. Prevalence and clinical profile of pancreatic cancer–associated diabetes mellitus
  2539. Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes
  2540. Prevalence and predictors of comorbid diabetes among newly diagnosed Hispanic cancer patients in Connecticut
  2541. Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes
  2542. Prevalence of diabetes in a cancer population in a Malaga hospital
  2543. Prevalence of diabetes in Japanese patients with cancer
  2544. Prevalence of diabetes in patients admitted to a cancer hospital
  2545. Prevalence of diabetes Mellitus and Metabolic Syndrome in Prostate cancer Patients given Androgen Deprivation Therapy
  2546. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers
  2547. Prevalence of diabetes mellitus in pancreatic cancer patients
  2548. Prevalence of diabetes mellitus in patients with newly evaluated papillary thyroid cancer
  2549. Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among US adults with diagnosed diabetes: findings from the …
  2550. Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: A cohort study
  2551. Prevalence, awareness, control, and treatment of hypertension and diabetes in korean cancer survivors: a cross-sectional analysis of the fourth and fifth Korea …
  2552. PREVALENCE, METABOLIC CONTROL, AND SURVIVAL IN AN ACADEMIC ONCOLOGY PRACTICE: cancer WITH diabetes
  2553. Preventable diabetic complications after a cancer diagnosis in patients with diabetes: a population-based cohort study
  2554. Preventing cancer, cardiovascular disease, and diabetes
  2555. Preventing cancer, Cardiovascular Disease, and diabetes: A Common Agenda
  2556. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American cancer Society, the American diabetes Association, and the American …
  2557. Prevention and treatment effects of edible berries for three deadly diseases: Cardiovascular disease, cancer and diabetes
  2558. Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic
  2559. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone
  2560. Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis
  2561. Primary care cancer and diabetes complications screening of black women with type 2 diabetes
  2562. Primary study of the relationship between diabetes and pancreatic cancer
  2563. Primate-specific long non-coding RNA (LncRNA) genes as regulators and drug target candidates in human cancer and diabetes
  2564. Probability of pancreatic cancer following diabetes: a population-based study
  2565. Prognosis of colorectal cancer patients with diabetes according to medication adherence: A population-based cohort study
  2566. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
  2567. Prognosis of Patients with Colorectal cancer with diabetes According to Medication Adherence: A Population-Based Cohort Study
  2568. Prognosis of small cell lung cancer patients with diabetes treated with metformin
  2569. Prognostic factors for resected non‐small cell lung cancer in patients with type 2 diabetes mellitus
  2570. Prognostic Impact of diabetes Mellitus on Colorectal cancer
  2571. Prognostic Impact of diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic cancer
  2572. Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
  2573. Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
  2574. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
  2575. Prognostic Significance of Obesity and diabetes Mellitus in Women With Brain Metastases From Breast cancer Should Be Revisited
  2576. Prognostic significance of type 2 diabetes in patients treated with surgery and irradiation for gingival cancer
  2577. Prognostic value of metformin for non-small cell lung cancer patients with diabetes
  2578. Program/Abstract# 48 A fly approach to cancer and diabetes
  2579. Progress in the relationship between diabetes and prognosis of colorectal cancer
  2580. Progress in the study on the correlation between Type 2 diabetes mellitus and colorectal cancer
  2581. Progress of relationship between diabetes and papillary thyroid cancer
  2582. Prohibitin–At the crossroads of obesity-linked diabetes and cancer
  2583. Prolonged survival in lung cancer patients with diabetes mellitus
  2584. Prolonged survival in patients with lung cancer with diabetes mellitus
  2585. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes
  2586. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study
  2587. Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women
  2588. Prospective study of a diabetes risk reduction diet and the risk of breast cancer
  2589. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
  2590. Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka diabetes Registry
  2591. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
  2592. Prospective study of diabetes mellitus and liver cancer in Japan
  2593. Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
  2594. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men
  2595. Prostate cancer patients with unmanaged diabetes or on insulin have worse outcomes and toxicities after treatment with radiation therapy
  2596. Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy
  2597. Prostate cancer risk among men with diabetes mellitus (Spain)
  2598. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review
  2599. Prostate cancer, diabetes Link Points to Potential Treatment with Metformin
  2600. Prostate cancer: diabetes and prostate cancer—an open debate
  2601. Prostate cancer: Hormone Therapy Associated with diabetes, Cardiovascular Disease
  2602. Protective effect of diabetes against metastasis in patients with non–small cell lung cancer
  2603. Protein-bound glycosaminoglycans in serum of patients with lung cancer and patients with diabetes mellitus
  2604. Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes
  2605. Proteomic analysis of pancreatic cancer associated with diabetes mellitus
  2606. Proteomics Analysis of Gastric cancer Patients with diabetes Mellitus
  2607. Psychological distress, resilience, social support and help-seeking behaviors in patients with type ii diabetes, breast cancer and hypertension
  2608. PTEN link between cancer and diabetes
  2609. PUK4 COMPARISON OF POSTTRANSPLANT NEW-ONSET diabetes AND cancer BETWEEN PERITONEAL AND HEMODIALYSIS RECIPIENTS …
  2610. PWE-159 diabetes and Pancreatic cancer–Cause or Association?
  2611. pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer
  2612. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer
  2613. Quality and outcomes of diabetes care in patients diagnosed with cancer
  2614. Quality of diabetes care among cancer survivors with diabetes
  2615. Quality of diabetes care in breast, colorectal, and prostate cancer
  2616. Quality of diabetes care in cancer: a systematic review
  2617. Quantitative aspects of mitochondrial genome in cancer and diabetes
  2618. Racial disparities and colorectal cancer survival in older adults with and without diabetes mellitus
  2619. Racial disparities in breast cancer mortality among women with diabetes mellitus.
  2620. Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status
  2621. Racial Variation in the Relationship of diabetes with Pancreatic cancer Risk
  2622. Racial/ethnic disparities in the risk of posttraumatic stress disorder symptoms among mothers of children diagnosed with cancer and Type-1 diabetes mellitus.
  2623. Racial/Ethnicity Disparities In The Association Between diabetes And Pancreatic cancer In The Elderly Medicare Population
  2624. Radiation Dose and Volume to the Pancreas and Subsequent Risk of diabetes Mellitus: A Report from the Childhood cancer Survivor Study
  2625. Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the Childhood cancer Survivor study.
  2626. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study
  2627. Radical gastrectomy combined with modified gastric bypass surgery for gastric cancer patients with type 2 diabetes
  2628. Raised glucose concentrations and diabetes are associated with cancer risk
  2629. Rapid biochemical profiling of endothelial dysfunction in diabetes, hypertension and cancer metastasis by hierarchical cluster analysis of Raman spectra
  2630. Rapid progression of breast cancer cell proliferation in diabetes: Role of polyamines
  2631. Rare case of manifestation of erectile dysfunction soon after thyroidectomy because of thyroid cancer in 56-year-old man with diabetes mellitus type 2 and diabetic …
  2632. Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model
  2633. Re: Androgen-Deprivation Therapy and diabetes Control among Diabetic Men with Prostate cancer
  2634. Re: Excess Risk of Primary Liver cancer in Patients With diabetes Mellitus
  2635. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
  2636. Re: prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer in women
  2637. Real life cancer comorbidity in Greek patients with diabetes mellitus followed up at a single diabetes center: an unappreciated new diabetes complication
  2638. Rebuild: Recover from Heart Disease, cancer, diabetes and Other Serious Illness and be Healthier Than Ever Before
  2639. Recent Advances in Histone Glycation: Emerging role in diabetes and cancer
  2640. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer
  2641. Recent advances in the management of thyroid cancer and type 2 diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15 …
  2642. Recent advances in the use of metformin: can treating diabetes prevent breast cancer?
  2643. Recent data on Mediterranean diet, cardiovascular disease, cancer, diabetes and life expectancy.
  2644. Recognition of comorbid diabetes and obesity in hospital records of newly diagnosed cancer patients
  2645. Redefining the role of obesity, race and diabetes in Type I and Type II endometrial cancers: Potential targets for treatment beyond cancer itself
  2646. Redox alterations in inflammatory diseases: diabetes, kidney failure and cancer
  2647. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis
  2648. Reduced risk of prostate cancer among patients with diabetes mellitus
  2649. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients
  2650. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
  2651. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes patients
  2652. Reducing cancer and cancer disparities: lessons from a youth-generated diabetes prevention campaign
  2653. Reducing the gap by focusing the ethnicity and migration lenses: examples in cancer, heart disease and diabetes
  2654. Reference frameworks for the health management of measles, breast cancer and diabetes (type II).
  2655. Regarding measures of impact: diabetes and urothelial cancer
  2656. Regional variations in cancer screening rates found in women with diabetes
  2657. Registry-based analysis of cancer and diabetes combination: prevalence and features
  2658. Related Factors and Risk Prediction of Type 2 diabetes Complicated with Liver cancer
  2659. RELATION BETWEEN COMPLICATIONS OF TYPE II diabetes MELLITUS AND ANEMIA CAUSED BY CHEMOTHERAPY IN WOMEN WITH BREAST cancer
  2660. Relation between dietary calcium and vitamin D and risk of diabetes and cancer: a review and perspective
  2661. Relation of prediabetes and type 2 diabetes mellitus to thyroid cancer
  2662. Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer
  2663. Relationship between diabetes and pancreatic cancer
  2664. Relationship between diabetes and risk of second primary contralateral breast cancer
  2665. Relationship between diabetes Mellitus and Clinicopathological Stages of Breast cancer at Diagnosis
  2666. Relationship between diabetes Mellitus and Colorectal cancer as well as its Metastasis
  2667. Relationship between diabetes Mellitus and Lymphatic Metastasis in Patients with Colorectal cancer
  2668. Relationship between diabetes Mellitus and Risk of Colorectal cancer: A META-ANALYSIS
  2669. Relationship between diabetes mellitus and the site of colorectal cancer
  2670. Relationship between gestational diabetes and endometrial cancer
  2671. Relationship between HbA1c and cancer in people with or without diabetes: a systematic review
  2672. RELATIONSHIP BETWEEN HISTORY OF GESTATIONAL diabetes AND THE RISK OF BREAST cancer: A POPULATION BASED COHORT STUDY
  2673. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis
  2674. Relationship between obesity, diabetes and the risk of thyroid cancer
  2675. Relationship between Obesity, diabetes, and the Risk of Thyroid cancer
  2676. Relationship between pancreatic cancer and diabetes mellitus
  2677. Relationship between pancreatic cancer‐associated diabetes and cachexia
  2678. Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
  2679. Relationship between type 2 diabetes and pancreatic cancer
  2680. Relationship between type 2 diabetes mellitus and risk of breast cancer: a case-control study
  2681. Relationship of diabetes and obesity with cancer incidence; review article
  2682. Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis
  2683. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity
  2684. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
  2685. Relationships of obesity and diabetes mellitus to other primary cancers in surgically treated gastric cancer patients
  2686. Remedial applications of exosomes in cancer, infections and diabetes
  2687. Renal Impairment Increases Serum cancer Antigen 125 Levels in Patients with Type 2 diabetes Mellitus
  2688. Renin angiotensin system inhibitors may attenuate low LDL cholesterol‐related cancer risk in type 2 diabetes
  2689. Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer”
  2690. Reply to the letter by Fujishiro et al. concerning “Controversy regarding gastric cancer and diabetes”
  2691. Report Clarifies Scientists’ Understanding of Association Between diabetes and cancer
  2692. Report of the J apan diabetes Society/J apanese cancer Association joint committee on diabetes and cancer
  2693. Report of the Japan diabetes Society (JDS)/Japanese cancer Association (JCA) joint committee on diabetes and cancer, second report
  2694. Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report
  2695. Report of the JDS/JCA joint committee on diabetes and cancer
  2696. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition
  2697. Research advances on diabetes-associated pancreatic cancer
  2698. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus
  2699. Research Progress in New-onset diabetes and Early Diagnosis of Pancreatic cancer
  2700. Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type II diabetes and cancer
  2701. Research Progress of Correlation between Type 2 diabetes Mellitus And Digestive System cancer Based on Meta-analysis
  2702. Research Progress of Relationship between diabetes and Colorectal cancer [J]
  2703. Research progress on the association of diabetes with pancreatic cancer
  2704. Resectability of pancreatic cancer and diabetes
  2705. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to …
  2706. Resolution of type 2 diabetes after gastrectomy for gastric cancer with long limb Roux-en Y reconstruction: a prospective pilot study
  2707. Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung cancer in Patients With Type 2 diabetes. diabetes Care 2013; 36: 124 …
  2708. Response to Comment on: Torres-Mejía et al. Moderate-Intensity Physical Activity Ameliorates the Breast cancer Risk in Diabetic Women. diabetes Care 2012; 35 …
  2709. Response to Letter to the Editor:” Higher Circulating Adiponectin Concentrations Predict Incident cancer in Type 2 diabetes-The Adiponectin Paradox”
  2710. Response to Yang and Chan. Metformin and the Risk of cancer: Time-Related Biases in Observational Studies. diabetes Care 2012; 35: 2665–2673
  2711. RESPONSE: Re: diabetes Mellitus and Risk of Colorectal cancer in the Singapore Chinese Health Study
  2712. Response: The Association between Type 2 diabetes Mellitus and Colorectal cancer.
  2713. Response: The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012;36:371-8)
  2714. Response: The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012;36:371-8)
  2715. Results of a community survey to assess African American and Latino knowledge, perceptions, and life style practices related to diabetes and cancer
  2716. Results of general internal medicine consultations for diabetes mellitus in 283 cancer patients
  2717. Resveratrol’s potential in the adjunctive management of cardiovascular disease, obesity, diabetes, Alzheimer disease, and cancer
  2718. Retinol binding protein 4: role in diabetes and cancer
  2719. Retinol binding protein 4: role in diabetes and cancer
  2720. Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
  2721. Retraction and republication—Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
  2722. Retraction Notice to: The cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of diabetes
  2723. Retrospective analysis of the relation between diabetes mellitus and endometrial cancer
  2724. Retrospective analysis of the relationship between type 2 diabetes mellitus and colorectal cancer
  2725. Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
  2726. Retrospective evaluation of Middle Eastern patients (pts) with type II diabetes mellitus (DM) and colorectal cancer (CRC): Validation of metformin effect on overall …
  2727. Retrospective evaluation of patients with colorectal cancer (CRC) and type II non-insulin-dependent diabetes (NIDDM).
  2728. Reversal of enhanced pancreatic cancer growth in diabetes by insulin
  2729. Review of Associations Between Type 2 diabetes and cancer
  2730. Risk analysis on diabetes mellitus patients complicating colorectal cancer
  2731. Risk differences between prediabetes and diabetes according to breast cancer molecular subtypes
  2732. Risk established between type II diabetes mellitus and cancer: a review
  2733. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a …
  2734. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age
  2735. Risk factors for cancer development in type 2 diabetes: a retrospective case-control study
  2736. Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus
  2737. Risk factors for papillary thyroid cancer in obesity and diabetes mellitus
  2738. Risk factors for radiation esophagitis and pneumonitis in esophageal cancer patients with diabetes or hypertension
  2739. Risk factors of catheter-related bloodstream infections in cancer patients with diabetes
  2740. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes
  2741. Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study
  2742. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
  2743. Risk of bladder cancer in patients with diabetes: a retrospective cohort study
  2744. Risk of bladder cancer in patients with diabetes: a retrospective cohort study.
  2745. Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women
  2746. Risk of breast cancer among daughters of mothers with diabetes: a population-based cohort study
  2747. Risk of Breast cancer in Patients diagnosed with Type 2 diabetes (T2DM)
  2748. Risk of cancer following hospitalization for type 2 diabetes
  2749. Risk of cancer in a large cohort of US veterans with diabetes
  2750. Risk of cancer in diabetes: the effect of metformin
  2751. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts
  2752. Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia
  2753. Risk of cause‐specific death in individuals with cancer—modifying role diabetes, statins and metformin
  2754. Risk of colon cancer recurrence in relation to diabetes
  2755. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study
  2756. Risk of diabetes after para-aortic radiation for testicular cancer
  2757. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer
  2758. Risk of diabetes Associated With cancer Development
  2759. Risk of diabetes Associated With cancer Development—In Reply
  2760. Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer
  2761. Risk of diabetes, cancer, large vessel disease and mortality in young women with Polycystic Ovary Syndrome: a retrospective database analysis
  2762. Risk of endometrial and breast cancer in patients with diabetes mellitus
  2763. Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies
  2764. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan
  2765. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan
  2766. Risk of Myocardial Infarction or diabetes During Androgen Deprivation Therapy for Prostate cancer: Does Comorbidity Influence Risk?
  2767. Risk of prostate cancer across different racial/ethnic groups in men with diabetes: A retrospective cohort study
  2768. Risk of skin cancer in patients with diabetes mellitus: a nationwide retrospective cohort study in Taiwan
  2769. Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: a retrospective population-based time-dependent cohort study
  2770. Risks of breast and endometrial cancer in women with diabetes: a population-based cohort study
  2771. Risks of Colorectal cancers Associated with diabetes Were Particularly Increased in Middle-aged Men Running title: Colorectal cancer in Diabetic Patients
  2772. Role for diabetes in colorectal cancer risk
  2773. Role of breast cancer inhibitors on diabetes mellitus–an in silico approach
  2774. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
  2775. Role of Heat Shock Protein 90 in diabetes and Pancreatic cancer Management
  2776. Role of Mitochondria in Pancreatic Metabolism, diabetes, and cancer
  2777. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011.
  2778. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011
  2779. Role of signal dynamics in the link between type 2 diabetes and cancer
  2780. Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link between diabetes and cancer
  2781. Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus
  2782. Rosemary leaf extract inhibits glycation, breast cancer proliferation, and diabetes risks
  2783. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
  2784. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
  2785. Rosiglitazone use and the risk of bladder cancer in patients with type 2 diabetes
  2786. SAT-134 Association between Serum Branched-Chain Amino Acids and cancer Risk: The Hong Kong diabetes Register (HKDR)
  2787. Screening for Pancreatic cancer in Individuals With New-onset diabetes Mellitus
  2788. Screening Strategy of Pancreatic cancer in Patients with diabetes Mellitus
  2789. Secondary diabetes associated with 5‐fluorouracil‐based chemotherapy regimens in non‐diabetic patients with colorectal cancer: results from a single‐centre cohort …
  2790. Secondhand Smoke Exposure, diabetes, Elevated Glucose Level Are Risk Factors for Uterine Cervical cancer: A Cross-Sectional Study From the Korea …
  2791. Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006
  2792. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta …
  2793. Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after
  2794. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study
  2795. Self-rated health and type 2 diabetes risk in the European Prospective Investigation into cancer and Nutrition-InterAct study: a case-cohort study
  2796. Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in …
  2797. Self-reported memory problems in adult-onset cancer survivors in the United States with or without: Type 2 diabetes mellitus, hypertension and hyperlipidemia.
  2798. Senile Colon cancer with diabetes Patients Perioperative Features and Nursing Intervention [J]
  2799. Sera anti-p53 antibody provides new information which explains the link between diabetes and cancer
  2800. Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective
  2801. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø …
  2802. Serum HSP70 level in patients with endometrial cancer with and without diabetes
  2803. Serum Levels of 8-Hydroxy-2′-Deoxyguanosine DNA in Patients with Breast cancer and Endometrial cancer with and without diabetes Mellitus
  2804. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
  2805. Serum proteomic analysis of pancreatic cancer associated diabetes
  2806. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes
  2807. Session 4: CVD, diabetes and cancer A dietary portfolio for management and prevention of heart disease: Symposium on ‘Dietary management of disease’
  2808. Session 4: CVD, diabetes and cancer Diet, insulin resistance and diabetes: the right (pro) portions: Symposium on ‘Dietary management of disease’
  2809. Session 4: CVD, diabetes and cancer Evidence for the use of the Mediterranean diet in patients with CHD: Symposium on ‘Dietary management of disease’
  2810. SESSION IA| HEALTHCARE DISPARITIES: TYPE 2 diabetes & BREAST cancer
  2811. Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry
  2812. Severe Visceral Obesity, Fatty Liver and diabetes after Orchiectomy for Prostate cancer
  2813. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
  2814. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and …
  2815. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic …
  2816. Sex-and site-specific differences in colorectal cancer risk among people with type 2 diabetes
  2817. Sex-specific association between family history of diabetes and risk of colorectal cancer: two prospective cohort studies
  2818. SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
  2819. Shaping environments for reductions in type 2 diabetes risk behaviors: A look at CVD and cancer interventions
  2820. Short‐term risk of cancer among women with previous gestational diabetes: a population‐based study
  2821. Should healthcare be guaranteed for cancer but not diabetes?
  2822. Significance of angiotensin targeting on treatment of liver metastasis in colorectal cancer patients with diabetes
  2823. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer
  2824. Significantly increased risk of cancer in diabetes mellitus patients: a meta‐analysis of epidemiological evidence in Asians and non‐Asians
  2825. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
  2826. Sitagliptin and oral cancer risk in type 2 diabetes patients
  2827. Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes
  2828. Sitagliptin may reduce breast cancer risk in women with type 2 diabetes
  2829. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
  2830. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes
  2831. Sitagliptin use may reduce oral cancer risk in patients with type 2 diabetes
  2832. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study
  2833. Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
  2834. Site-specific cancer risk in people with type 2 diabetes: Nationwide population-based cohort study in Korea
  2835. Skeletal muscle microRNAs in human cancer cachexia and Type 2 diabetes
  2836. Sleep apnea: a common mechanism for the deadly triad—cardiovascular disease, diabetes, and cancer?
  2837. Small cell lung cancer expressing glutamate decarboxylase with latent autoimmune diabetes in adults
  2838. Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review
  2839. Small-cell lung cancer presenting as diabetes insipidus and cushing’s syndrome
  2840. Smoking Despite Lung cancer or diabetes: A Pressing Challenge to Smoking Abstinence
  2841. Smoking, alcohol, diabetes, obesity, socioeconomic status, and the risk of colorectal cancer in a population-based case–control study
  2842. Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients
  2843. Social Welfare Approaches for Patients with Concurrent diabetes and cancer.
  2844. Socioeconomic characteristics, life style, diabetes, family history of cancer and risk of pancreatic cancer
  2845. Sodium–glucose cotransporter 2 inhibitors and the short-term risk of breast cancer among women with type 2 diabetes
  2846. SOX7 expression correlates with better prognosis in pancreatic cancer patients and is negatively related to pancreatic cancer associated diabetes
  2847. Speaking with one voice on worksite wellness: the American cancer Society, the American diabetes Association, and the American Heart Association
  2848. Spontaneous remission of cranial diabetes insipidus due to concomitant development of ADH-producing lung cancer–an autopsied case
  2849. Sporadic Pancreatic cancer: Glucose Homeostasis and Pancreatogenic Type 3 diabetes
  2850. Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus
  2851. Standard risk factors for lung cancer, cardiac infarct, apoplexy, diabetes mellitus and their changes in psychosocial context
  2852. Statin use and cancer incidence in patients with type 2 diabetes mellitus: a network meta-analysis
  2853. Statin Use and the Risk of Colorectal cancer in Patients with diabetes: 881
  2854. Statins and finasteride use differentially modify the impact of metformin on prostate cancer incidence in men with type 2 diabetes
  2855. Statins and the risk of gastric cancer in diabetes patients
  2856. Statistical analysis of the effect of metformin use on endometrial cancer incidence in patients with type 2 diabetes
  2857. Stem cell-based approach in diabetes and pancreatic cancer management
  2858. Steroid-induced diabetes in cancer patients
  2859. Storage of vitamin D in adipose tissue and associations between vitamin D related genetic variants and diabetes, myocardial infarction, cancer, death, and low bone …
  2860. Stratification of cancer and diabetes based on circulating levels of formate and glucose
  2861. Stratification of cancer and diabetes based on circulating levels of formate and glucose
  2862. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
  2863. Stroke, lung cancer, and diabetes health beliefs and lifestyle practices of Vietnamese elders: Implications for geriatric rehabilitation
  2864. Structural and Biophysical Characterization of SPOP-Client Interactions Involved in diabetes and cancer
  2865. Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
  2866. Studies on the relationships between blood trace metal concentrations and the clinical status of patients with cerebrovascular disease, gastric cancer and diabetes …
  2867. Study of correlation between pancreatic cancer and diabetes mellitus [J]
  2868. Study of serum IGF-1, IGFBP-3 and insulin levels in patients with type 2 diabetes mellitus and their relationship with colorectal cancer
  2869. Study of the Association Between Antihyperglycemic Therapy and cancer in Patients with Type 2 diabetes Mellitus
  2870. Study of the Prevalence of Chronic Diseases (cancer, diabetes, Heart Disease) and Its Relationship with the Elderly’s Quality Of Life
  2871. Study on the association between the different levels of C-peptide of type 2 diabetes and colorectal cancer risk
  2872. Study on the effect of metformin in patients of metastatic renal cell cancer with diabetes receiving tyrosine kinase inhibitor therapy
  2873. Study On The Prevalence Of Various Forms Of cancer In Diabetic Patients Hospitalized In The National Institute Of diabetes, Nutrition And Metabolic …
  2874. STUDY ON THE RELATIONSHIP BETWEEN PANCREATIC cancer AND diabetes MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
  2875. STUDY ON THE RELATIONSHIP BETWEEN PANCREATIC cancer AND diabetes MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
  2876. Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and …
  2877. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
  2878. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan
  2879. Substitutions between dairy product subgroups and risk of type 2 diabetes: the Danish Diet, cancer and Health cohort
  2880. Successful use of endoscopic argon plasma coagulation for patients with early gastric cancer and diabetes mellitus
  2881. SUN-675 Breast cancer Treatment Causes diabetes
  2882. SUN-688 Pancreatic cancer in Longstanding diabetes
  2883. Superior Mesenteric Artery Syndrome Preceded by diabetes Insipidus in Advanced Lung cancer with Pituitary Metastasis–A Case Report
  2884. Superoxide dismutases: significances in aging, diabetes, ischemia and cancer
  2885. Supplemental Material The Association of Arsenic Metabolism with cancer, Cardiovascular Disease and diabetes: A Systematic Review of the Epidemiological …
  2886. Surgical treatment of gastric cancer in elderly patients combinded with diabetes
  2887. Surgical Treatment of Large Bowel cancer with diabetes Mellitus
  2888. Survival advantage associated with metformin usage in patients with colorectal cancer (CRC) and type II noninsulin-dependent diabetes (NIDDM).
  2889. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
  2890. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
  2891. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus
  2892. Survival and glycemic control in patients with colorectal cancer and diabetes mellitus
  2893. Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus
  2894. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
  2895. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis
  2896. Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer
  2897. Survival of colorectal cancer patients with diabetes mellitus: A meta-analysis
  2898. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
  2899. Survival of non-small cell lung cancer (NSCLC) patients with and without diabetes mellitus (DM): Findings from the cancer Care Outcomes Research and Surveillance …
  2900. Survival of patients with cervical cancer and diabetes: An exploratory study.
  2901. Survival of patients with lung cancer and diabetes mellitus
  2902. Survival of patients with stage IV lung cancer with diabetes treated with metformin
  2903. Survival of resectable pancreatic cancer patients with diabetes
  2904. Suva Residents’ Views on cancer, diabetes and HIV in The Fiji Times
  2905. Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage
  2906. SYMPOSIUMS: diabetes AND cancer: CAN RESVERATROL BE A GOOD CANDIDATE IN THIS TSUNAMI?
  2907. Syndecan as a messenger to link diabetes and cancer
  2908. Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong diabetes Registry
  2909. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes
  2910. Synthesis of Tin Oxide Nanofibers for Lung cancer, diabetes and Kidney Malfunction Detection
  2911. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus
  2912. Systematic review and meta‐analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
  2913. Systematic Survey of the Role of IGF in the Link Between diabetes and cancer
  2914. Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic‐induced diabetes insipidus
  2915. Targeting acidity in cancer and diabetes
  2916. Targeting dipeptidyl peptidase-4 (DPP-4) and fibroblast activation protein (FAP) for diabetes and cancer therapy
  2917. Targeting receptors of advanced glycation end products (RAGE): preventing diabetes induced cancer and diabetic complications
  2918. Targeting unfolded protein response in cancer and diabetes
  2919. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study
  2920. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer
  2921. Technology-Enhanced consultations in diabetes, cancer, and heart failure: protocol for the qualitative analysis of remote consultations (QuARC) project
  2922. Television watching and incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition–Potsdam Study
  2923. Test–retest reliability of self-reported diabetes diagnosis in the Norwegian Women and cancer Study: a population-based longitudinal study (n= 33,919)
  2924. Testing Mice at Risk of Pancreatic cancer for Altered Protein Pathways Found in diabetes
  2925. Texas Health Insurance Coverage for Prevention and Screening of cancer, Cardiovascular Disease, and diabetes
  2926. TGFBIp mediated apoptosis: A role in cancer and diabetes mellitus type II
  2927. TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
  2928. The activation of ERK1/2 and JNK MAPK signaling by insulin/IGF-1 is responsible for the development of colon cancer with type 2 diabetes mellitus
  2929. The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its …
  2930. The American diabetes Association, the American cancer Society, and the American Heart Association
  2931. The American diabetes Association, the American cancer Society, and the American Heart Association: A triumvirate of hope for the nation’s health
  2932. The application of refined nursing in postoperative patients with breast cancer and diabetes
  2933. The assessment of molecular markers of cell interaction and lipid peroxidation in rats with alloxan diabetes and trans-planted liver cancer after intravenous injection of …
  2934. The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6-months post-chemotherapy
  2935. The association between diabetes and breast cancer stage at diagnosis: a population-based study
  2936. The association between diabetes and cancer incidence and mortality in the NIH-AARP study
  2937. The association between diabetes and thyroid cancer risk: a hospital-based case-control study in China
  2938. The Association between diabetes Mellitus and Colorectal cancer Stage at Presentation: Presidential Poster: 1559
  2939. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer
  2940. The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans
  2941. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis
  2942. The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes
  2943. The association between gestational diabetes mellitus and cancer in women: a systematic review and meta-analysis of observational studies
  2944. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
  2945. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
  2946. The association between paternal prostate cancer and type 2 diabetes
  2947. The Association between Patient Characteristics and Use of Statin and Metformin among Elderly Women with Breast cancer and diabetes
  2948. The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study
  2949. The Association between thyroid cancer and type 2 diabetes mellitus
  2950. The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women
  2951. The Association between Type 2 diabetes Mellitus and Colorectal cancer.
  2952. The Association between Type 2 diabetes Mellitus and Colorectal cancer.
  2953. The association between type 2 diabetes mellitus and thyroid cancer
  2954. The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms
  2955. The association of arsenic metabolism patterns with cancer, cardiovascular disease and diabetes: A systematic review of the epidemiological evidence
  2956. The association of arsenic metabolism with cancer, cardiovascular disease, and diabetes: a systematic review of the epidemiological evidence
  2957. The Association of Arsenic Metabolism with cancer, Cardiovascular Disease, and diabetes: A Systematic Review of the Epidemiological Evidence
  2958. The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study
  2959. The association of diabetes and obesity with prostate cancer progression: HCaP‐NC
  2960. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series
  2961. The Association of diabetes Mellitus with Colorectal cancer and Polyps in Asymptomatic Patients Undergoing Screening Colonoscopy: 447
  2962. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
  2963. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
  2964. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast cancer Study Project
  2965. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort
  2966. The association of diabetes with risk of prostate cancer defined by clinical and molecular features
  2967. The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
  2968. The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: a systematic review with meta …
  2969. The association of hyperinsulinemia with cardiovascular risk and cancer poses new challenges in the treatment of the insulin resistance type 2 diabetes patient
  2970. The association of recently-diagnosed diabetes and long-term diabetes with survival in pancreatic cancer patients: a pooled analysis
  2971. The Baltimore Alliance for the Prevention and Control of Hypertension and diabetes: a model for developing a colorectal cancer community outreach program.
  2972. The bidirectional interation between pancreatic cancer and diabetes
  2973. The Biology of the Deadly Love Connection Between Obesity, diabetes, and Breast cancer
  2974. The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
  2975. The clinical dependabilities between type 2 diabetes and lung cancer.
  2976. The clinical effect of metformin on the survival of lung cancer patients with diabetes: a comprehensive systematic review and meta-analysis of retrospective …
  2977. The Clinical Features of Patients with Type 2 diabetes and Colorectal cancer
  2978. The Clinical Observation of diabetes Mellitus Following Cisplatin-based Chemotherapy on Head and Neck cancer [J]
  2979. The Combined Impact of Chronic Kidney Disease and diabetes on the Risk of Colorectal cancer Depends on Sex: A Nationwide Population-Based Study
  2980. The complex dual diagnosis of diabetes and cancer.
  2981. The complex role of branched chain amino acids in diabetes and cancer
  2982. The complexities of obesity and diabetes with the development and progression of pancreatic cancer
  2983. The correlation analysis of primary liver cancer with Type 2 diabetes
  2984. The Correlation Between Dairy Product Consumption and Gastrointestinal Bleed, Ovarian cancer, and diabetes in Infants: A Meta‐Analysis Approach
  2985. The correlation between diabetes and pancreatic cancer and the imaging findings
  2986. The correlation between type-2 diabetes and lung cancer
  2987. The decline in cancer incidence in patients with long-duration type 1 diabetes: what really happens over time?
  2988. The design, synthesis and evaluation of new chemical entities for the development of drugs against cancer, diabetes, autoimmune disorders and infectious …
  2989. The development of fulminant type 1 diabetes during chemotherapy for rectal cancer
  2990. The diabetes Drug Canagliflozin Enhances the Response of Prostate cancer to Radiotherapy
  2991. The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration
  2992. The diabetes–cancer link
  2993. The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel
  2994. The double trouble of metabolic diseases: the diabetes–cancer link
  2995. The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and cancer
  2996. The duration of obesity and the risk of type-2 diabetes, cardiovascular disease, cancer and mortality
  2997. The dysfunction of NK cells in patients with type 2 diabetes and colon cancer
  2998. The early diagnosis of pancreatic cancer and diabetes: what’s the relationship?
  2999. The Effect of Aging Lung cancer Combined with Type Ⅱ diabetes Mellitus by Shenmai Injection
  3000. The effect of Benign Thyroid Disease, diabetes Mellitus and Physical Activity on Breast cancer Risk
  3001. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
  3002. The effect of diabetes mellitus on lung cancer prognosis: a PRISMA-compliant meta-analysis of cohort studies
  3003. The effect of diabetes mellitus on prognosis of patients with non-small-Cell lung cancer: a systematic review and meta-analysis
  3004. The effect of diabetes on the perioperative outcomes of colorectal cancer surgery patients
  3005. The effect of diabetes on the risk of endometrial cancer: an updated a systematic review and meta-analysis
  3006. The effect of diabetes with pharmacotherapy for breast cancer on care resource use
  3007. The effect of exposure to thiazolidinediones on the development of head-and-neck cancer in patients with diabetes mellitus
  3008. The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control
  3009. The Effect of intensive Glycemic Control on Postoperative Gastric cancer Patients Combined with diabetes
  3010. The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index< 35 kg/m2: preliminary results
  3011. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
  3012. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis
  3013. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis
  3014. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis
  3015. The effect of metformin on mortality following cancer among patients with diabetes
  3016. The effect of metformin on oncological outcomes in patients with cervical cancer with type 2 diabetes mellitus
  3017. The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus
  3018. The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes
  3019. The effect of metformin on the clinicopathological features of breast cancer with type 2 diabetes
  3020. The effect of metformin on the progression of non-small cell lung cancer with diabetes mellitus: A review of studies between 2015 and 2017
  3021. The effect of metformin use and the incidence of prostate cancer in type 2 diabetes mellitus patients: A nationwide population-based study
  3022. The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus
  3023. The Effect of Obesity and diabetes on Intermediate to High Grade Prostate cancer Patients Treated with Radical Prostatectomy
  3024. The effect of obesity on the formation of cancer risk in patients with type 2 diabetes mellitus (literature review)
  3025. The Effect of Pre-existing diabetes on the Incidence of Postradiation Retinopathy in Head and Neck cancer Patients
  3026. The Effect of Prostate cancer Diagnosis on Adherence to Medications for Patients with Type 2 diabetes
  3027. The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
  3028. The effect of type 2 diabetes on selected clinical parameters and disease outcome in patients with colorectal cancer
  3029. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy
  3030. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
  3031. The Elusive Link Between cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in diabetes
  3032. The Emerging Link between Metformin Therapy for Type 2 diabetes Mellitus and Colorectal cancer
  3033. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus
  3034. The epidemiologic relationship between diabetes and cancer
  3035. The epidemiologicalcharacteristics of 1205 cancer patients with previous type 2 diabetes mellitus
  3036. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer
  3037. The epidemiology of diabetes and cancer
  3038. The Estimation of Thyroid cancer Risk based on Type 2 diabetes Mellitus and ABO Blood Group.
  3039. The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders
  3040. The evaluation of Entamoeba gingivalis occurrence in samples from patients with cancer and diabetes
  3041. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes—the 2001–2006 ENTRED cohort
  3042. The experience of developing new-onset diabetes after cancer treatments in middle age and older adults
  3043. The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus
  3044. The expression of Transgelin in pancreatic cancer accompanied with diabetes and its effects on the migration and invasion of SW1990 cell line
  3045. The frequency of cancer in diabetes mellitus
  3046. THE GENETICAL ASSOCIATION BETWEEN PROSTATE cancer AND TYPE 2 diabetes
  3047. The global implications of diabetes and cancer.
  3048. The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer
  3049. The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention
  3050. The impact of cancer on diabetes outcomes
  3051. The Impact of Comorbid diabetes on Short-Term Postoperative Outcomes in Stage I/II Colon cancer Patients Undergoing Open Colectomy
  3052. The Impact of Comorbid diabetes Type 2 on Quality of Life in cancer Patients Undergoing Chemotherapy.
  3053. The impact of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
  3054. The impact of diabetes and obesity on endometrial cancer outcomes.
  3055. The impact of diabetes and other metabolic disorders on prostate cancer prognosis
  3056. The impact of diabetes in head and neck cancer
  3057. The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
  3058. The impact of diabetes mellitus and metformin treatment on survival of patients with advanced pancreatic cancer undergoing chemotherapy
  3059. The impact of diabetes mellitus and obesity on pathologic complete response rate of neoadjuvant chemoradation for gastroesophageal cancer: A retrospective review.
  3060. The impact of diabetes mellitus on breast cancer outcomes: a single center retrospective study
  3061. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis
  3062. The impact of diabetes mellitus on early cervical cancer in Αsia: A population-based cohort study.
  3063. The impact of diabetes mellitus on prognosis of early breast cancer in Asia
  3064. The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
  3065. The Impact of diabetes Mellitus on Survival in Men with Clinically Localized Prostate cancer Treated with Permanent Interstitial Brachytherapy
  3066. The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy
  3067. The Impact of diabetes Mellitus on the Second Primary Malignancies in Colorectal cancer Patients
  3068. The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer
  3069. The impact of diabetes on breast cancer treatments and outcomes: a population-based study
  3070. The Impact of diabetes on Breast cancer Treatments and Outcomes: A Population-Based Study
  3071. The Impact of diabetes on Colorectal cancer Stage at Diagnosis: A Population-Based Cohort Study
  3072. The impact of diabetes on gynecologic cancer: Current status and future directions
  3073. The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry
  3074. The impact of diabetes on survival following breast cancer
  3075. The impact of diabetes on survival in women with ovarian cancer
  3076. The impact of diabetes on the risk of prostate cancer development according to body mass index: a 10-year nationwide cohort study
  3077. The Impact of diabetes on the Symptoms of Breast cancer Survivors
  3078. The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
  3079. The Impact of diabetes Treatment on Survival in a Breast cancer/diabetes Model
  3080. The impact of gastrectomy on diabetes and related conditions, coronary heart disease, stroke, cancer, and survival: follow-up from the Honolulu heart program
  3081. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits …
  3082. The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future research
  3083. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
  3084. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
  3085. The impact of physician communication on diabetes management in cancer survivors.
  3086. The Impact of Race and diabetes on Mortality among Breast cancer Patients
  3087. The Impact of Resolution of diabetes After Radical Pancreatic Resection on Long-term Survival of Patients With Pancreatic cancer
  3088. The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: A review and meta-analysis
  3089. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
  3090. The impact of type 2 diabetes mellitus on cancer‐specific survival: a follow‐up study in Sweden
  3091. The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in T aiwan
  3092. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
  3093. The implication of diabetes metabolomics in the early diagnosis and pathogenesis of pancreatic cancer.
  3094. The incidence of cardiovascular disease, cancer and type 2 diabetes comorbidities in HIV infection: A systematic review
  3095. The increased risk of cancer in obesity and type 2 diabetes: potential mechanisms
  3096. The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry
  3097. The individual and combined effects of obesity and type 2 diabetes on cancer predisposition and survival
  3098. The influence of alloxan diabetes on experimental cancer.
  3099. The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
  3100. The influence of diabetes mellitus and metformin on distant metastases in oropharyngeal cancer: a multicenter study
  3101. The Influence of diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal cancer: A Multicenter Study
  3102. The influence of diabetes severity on guideline-concordant treatment for stage I-III breast cancer in the National Program of cancer Registries (NPCR) patterns of care …
  3103. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer
  3104. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
  3105. The influence of psychological stress on the initiation and progression of diabetes and cancer
  3106. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese
  3107. The influence of type 2 diabetes on the risk of cancer
  3108. The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression
  3109. The interface of pancreatic cancer with diabetes, obesity, and inflammation: research gaps and opportunities: summary of a National Institute of diabetes and …
  3110. The Interplay Between Type Two diabetes Mellitus and Prostate cancer
  3111. The intricate relationship between diabetes, obesity and pancreatic cancer
  3112. The levels of interleukin-2 and interleukin-10 in patients with type 2 diabetes and colon cancer
  3113. The link between personality dimensions and pain perception in patients with diabetes mellitus or cancer
  3114. The links between insulin resistance, diabetes, and cancer
  3115. The management of diabetes in patients with advanced cancer
  3116. The management of diabetes in terminal illness related to cancer
  3117. The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes
  3118. The Mechanistic Link Between Type 2 diabetes and Colorectal cancer
  3119. The metformin effect on survival in Middle Eastern patients (pts) with type II diabetes (DM) and colorectal cancer (CRC).
  3120. The modern nutritional diseases: Heart disease, stroke, type-2 diabetes, obesity, cancer: and how to prevent them
  3121. The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey
  3122. The mutual aggravation syndrome in pancreatic cancer and diabetes mellitus
  3123. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
  3124. The neglected insulin: IGF-II, a metabolic regulator with implications for diabetes, obesity, and cancer
  3125. The nutritional value and health benefits of pulses in relation to obesity, diabetes, heart disease and cancer
  3126. The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus …
  3127. The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor
  3128. The OMEGA-3 Miracle: The Icelandic Longevity Secret that Offers Super Protection Against Heart Disease, cancer, diabetes
  3129. The orphan nuclear receptors in cancer and diabetes
  3130. The pathway from diabetes and obesity to cancer, on the route to targeted therapy
  3131. The performance of different artificial intelligence models in predicting breast cancer among individuals having type 2 diabetes mellitus
  3132. The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases
  3133. The possible role of diabetes in the etiology of laryngeal cancer
  3134. The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes.
  3135. The potential of glycemic control and body weight change as early markers for pancreatic cancer in patients with long-standing diabetes mellitus: a case-control study
  3136. The potential of lupin as a functional food for the prevention of diabetes and pancreatic cancer
  3137. The predictive effect of body mass index on type 2 diabetes in the Norwegian women and cancer study
  3138. The present state of knowledge on the problem of the relation between diabetes mellitus and breast cancer
  3139. The prevalence of disability among people with cancer, cardiovascular disease, chronic respiratory disease and/or diabetes: a systematic review
  3140. The Prevention and Control of cancer by Metformin in Patients with Type 2 diabetes: A Systematic Mapping Review Protocol
  3141. The Prime Cause of Type-2 (T2D), Type-1 diabetes (T1D) and the Relation Between diabetes and cancer
  3142. The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
  3143. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis
  3144. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones
  3145. The Protein Myth: Significantly Reducing the Risk of cancer, Heart Disease, Stoke and diabetes While Saving the Animals and the Planet
  3146. The quality of diabetes care among cancer survivors: a retrospective cohort study
  3147. The relation between the cancer and diabetes death-rates
  3148. The Relation of diabetes Mellitus with Short-term Outcomes in Patients with Gastric cancer [J]
  3149. The relation of type 2 diabetes and breast cancer incidence in Asian, Hispanic and African American Populations—a review
  3150. The relation of type 2 diabetes and cancer
  3151. The relationship between body mass index, diabetes, and triple-negative breast cancer prognosis.
  3152. The relationship between diabetes and cancer
  3153. The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies
  3154. The relationship between diabetes and pancreatic cancer
  3155. The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer
  3156. The Relationship Between Insulin Therapy and cancer Incidences in Patients with diabetes: Follow up study in Korea
  3157. The relationship between metformin and cancer in patients with type 2 diabetes
  3158. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case–control study
  3159. The relationship between obesity and cancer mortality in type 2 diabetes: a ten-year follow-up study (ZODIAC-21)
  3160. The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
  3161. ThE RElATIONShIp BETwEEN TypE 2 diabetes AND cancer: AN INTEgRATIvE REvIEw
  3162. The Relationship between Type 2 diabetes and cancer: An Integrative Review
  3163. The relationship between type 2 diabetes mellitus and cancer-related mortality and survival using linked CPRD data
  3164. The relationship between vitamin B6, diabetes and cancer
  3165. The Relationship of Neutrophil-to-Lymphocyte Ratio or Platelet-to-Lymphocyte Ratio and Pancreatic cancer in Patients with Type 2 diabetes.
  3166. The Relationship of Type 2 diabetes, Oral diabetes Medications, and Insulin Therapy to Risk for Breast cancer
  3167. The Research Progress of Metformin in Type Ⅱ diabetes Mellitus with Liver cancer
  3168. The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012; 36: 371-8)
  3169. The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012; 36: 371-8)
  3170. The risk of breast cancer in women with diabetes
  3171. The Risk of cancer in diabetes Patients: A Review
  3172. The risk of cancer in people with diabetes and chronic kidney disease
  3173. The risk of colorectal cancer in patients with type 2 diabetes mellitus: associations with treatment stage and obesity
  3174. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity
  3175. The Risk of Onset of the Illnesses Based on Gender, Age, and Monthly Income; Focusing on cancer, hypertension, stroke, diabetes, arthritis, cardiac disorders
  3176. The role of adiposity in the association between type 2 diabetes and the risk of breast cancer.
  3177. The role of diabetes and diabetes treatments in colorectal cancer mortality, incidence, and survival
  3178. The role of diabetes and other co-morbidities on survival after esophageal cancer surgery in a population-based study
  3179. The Role of diabetes in Molecular Pathogenesis of cancer
  3180. The role of diabetes mellitus in the aetiology of renal cell cancer
  3181. The Role of early-life psychological factors in the development of chronic disease: a longitudinal analysis applied to the onset of cancer, diabetes, and asthma in mid …
  3182. The Role of Hypoxia Inducible Factor-1α in Pancreatic cancer and diabetes Mellitus
  3183. The role of insulin and insulin-like growth factors in the increased risk of cancer in diabetes
  3184. The Role of Insulin, IGF-1 and PRAS40 in the Processes of Oncogenesis in Women with Type 2 diabetes Mellitus and Endometrial cancer
  3185. The Role of Islet Amyloid Polypeptide (IAPP) in the diabetes and Anorexia of Pancreatic cancer
  3186. THE ROLE OF METFORMIN AND STATINS IN OVARIAN AND BREAST cancer IN WOMEN WITH TYPE 2 diabetes
  3187. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case–control study
  3188. The Role of Obesity-induced Inflammation During the Pathogenesis of Type 2 diabetes and cancer
  3189. The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study
  3190. The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease
  3191. The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in diabetes and cancer
  3192. The Role of Pre-Existing Type 2 diabetes Mellitus in Colorectal cancer Stage and Survival in Elderly Americans: A Seer-Medicare Population-Based Study 2002 …
  3193. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies
  3194. The Role of RNASE L in Type I diabetes and Development of Quantitative LC-MS/MS Methods for the Pharmacological Studies of Anti-cancer Drug Candidates
  3195. The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases, cancer and diabetes mellitus type 2
  3196. The role of the pentose phosphate pathway in diabetes and cancer
  3197. The role of type 2 diabetes mellitus in colorectal cancer patients
  3198. The study of the etiology and pathogenesis of schizophrenia, the psychosomatic illnesses, diabetes mellitus and cancer.
  3199. The study of the relationship between diabetes mellitus and pancreatic cancer [J]
  3200. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer
  3201. The temporal relationship between diabetes and cancer: A population‐based study
  3202. The type 2 diabetes-associated Th17 cytokines IL-21 and IL-22 promote breast cancer cell survival.
  3203. The use of glyburide compared with other sulfonylureas and the risk of cancer in patients with type 2 diabetes
  3204. The Use of Long-Acting Insulin Analogs and the Risk of Colorectal cancer Among Patients with Type 2 diabetes: A Population-Based Cohort Study
  3205. The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus
  3206. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes
  3207. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
  3208. Therapeutic Nanotechnology and Immunoengineering for Cellular Therapy in Autoimmune diabetes and cancer
  3209. Therapeutic use of metformin in diabetes and survival outcomes in endometrial cancer patients with diabetes
  3210. Therapeutic uses of epicatechin in diabetes and cancer
  3211. Therapeutically and pharmacological virtues of god’s mushroom-Agaricus blazei Murill. inhibitory effects in infection, cancer and diabetes.
  3212. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
  3213. Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis
  3214. Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
  3215. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
  3216. Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus
  3217. Thousands of cases of diseases such as cancer and diabetes could go on diagnosed if we put off visiting the doctor since the start of the covert crisis, GPS have …
  3218. Thyroid hormones in diabetes, cancer, and aging
  3219. Time perspective in healthy individuals and patients suffering from cancer and diabetes
  3220. Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults
  3221. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
  3222. Time-varying risk for breast cancer following initiation of glucose-lowering therapy in women with type 2 diabetes: Exploring detection bias
  3223. TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
  3224. Total pancreatectomy for pancreatic head cancer–trading pancreatic fistulas for diabetes
  3225. Total-Body Irradiation is a Major Risk Factor for Young Adult Onset diabetes Mellitus and Hyperlipidemia in Childhood cancer Survivors after Hematopoietic Stem …
  3226. Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation
  3227. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus
  3228. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study
  3229. Traditional diabetes risk factors in pancreatic cancer associated diabetes (PacDM): A prospective study of 512 patients
  3230. Traditional knowledge for modern ailments plants used for the treatment of diabetes and cancer in Northern Peru
  3231. Trans fatty acids and lipid profile: a serious risk factor to cardiovascular disease, cancer and diabetes
  3232. Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer
  3233. Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic cancer With Concomitant diabetes
  3234. Transforming growth factor‐β signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?
  3235. Trastuzumab-related cardiotoxicity in patients with breast cancer with comorbidities of obesity, dyslipidemia, and diabetes.
  3236. Treament-related diabetes and cardiovascular disease in prostate cancer survivors
  3237. Treatment and outcome in non-Hodgkin’s lymphoma patients with and without prevalent diabetes mellitus in a population-based cancer registry
  3238. Treatment outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) and cardiovascular disorders or diabetes: The Prostate cancer Registry.
  3239. Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes
  3240. Treatment with insulin (analogues) and breast cancer risk in women with diabetes; a systematic review and meta-analysis of in vitro, animal and human …
  3241. Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells
  3242. Trends in breast cancer incidence among women with type-2 diabetes in British general practice
  3243. Trends in cancer mortality among people with vs without diabetes in the USA, 1988–2015
  3244. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between …
  3245. trouble, deafness, spider bite, diabetes, cancer and other con¬
  3246. Tuesday, November 14, 2000-3: 00 PM Abstract# 8961 Enabling the nation’s schools to prevent cardiovascular disease, cancer, and diabetes: A CDC initiative
  3247. Two diseases with one hit: inhibiting a potential diabetes target to reduce cancer risk and to improve anti-cancer therapy
  3248. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
  3249. Two-year Changes of Adiponectin after Bariatric Surgery and Their Association with Incident Type 2 diabetes, Cardiovascular Disease, cancer and Mortality: Results …
  3250. Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39 811 French dialyzed patients
  3251. Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies
  3252. Type 1 diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric cancer: A Case Report
  3253. Type 2 diabetes and Breast cancer Survivorship: A Case Report
  3254. Type 2 diabetes and breast cancer-the role of hyperinsulinaemia in breast cancer development and mortality
  3255. Type 2 diabetes and breast cancer: the interplay between impaired glucose metabolism and oxidant stress
  3256. Type 2 diabetes and cancer
  3257. Type 2 diabetes and cancer as redox diseases?
  3258. Type 2 diabetes and cancer–cancer incidence and mortality among 457,473 persons with type 2 diabetes compared to 2,287,365 matched controls in Sweden: an …
  3259. Type 2 diabetes and cancer: an overview of epidemiological evidence and potential mechanisms
  3260. Type 2 diabetes and cancer: Should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
  3261. Type 2 diabetes and cancer: The Nitric Oxide Connection
  3262. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
  3263. Type 2 diabetes and cancer: what is the connection?
  3264. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing
  3265. Type 2 diabetes and colorectal cancer survival: The multiethnic cohort
  3266. Type 2 diabetes and gender differences in liver cancer by considering different confounding factors: a meta-analysis of cohort studies
  3267. Type 2 diabetes and glycemic traits in relation to colorectal cancer risk: a Mendelian randomization study
  3268. Type 2 diabetes and increased risk of estrogen receptor-negative breast cancer in African American women
  3269. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort
  3270. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy
  3271. Type 2 diabetes and Pancreatic cancer–A Possible Reason
  3272. Type 2 diabetes and prostate cancer risk in Korean men with low PSA
  3273. Type 2 diabetes and risk of cancer
  3274. Type 2 diabetes and risk of colorectal cancer in two large US prospective cohorts
  3275. Type 2 diabetes and risk of incident cancer in China: a prospective study among 0.5 million Chinese adults
  3276. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
  3277. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study
  3278. Type 2 diabetes and the risk of mortality among patients with prostate cancer
  3279. Type 2 diabetes and the risk of renal cell cancer in women
  3280. Type 2 diabetes as a potential risk marker for early onset colorectal cancer.
  3281. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort
  3282. Type 2 diabetes associated with abnormal p53 immunohistochemical patterns in colorectal cancer
  3283. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population …
  3284. Type 2 diabetes may increase breast cancer risk
  3285. Type 2 diabetes May Increase Breast cancer Risk in African-American Women
  3286. Type 2 diabetes mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastric cancer
  3287. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy
  3288. Type 2 diabetes mellitus and characteristics of breast cancer in China
  3289. Type 2 diabetes Mellitus and Colorectal cancer Risk and Survival in Oman
  3290. Type 2 diabetes mellitus and colorectal cancer risk: is homocysteine the missing link?
  3291. Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences
  3292. Type 2 diabetes mellitus and gastrointestinal cancer: Disease, drugs, or distortion?
  3293. Type 2 diabetes mellitus and habits lifestyle increases the risk of cervical cancer: a cross-sectional population-based study
  3294. Type 2 diabetes mellitus and kidney cancer risk: a retrospective cohort analysis of the National Health Insurance
  3295. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
  3296. Type 2 diabetes mellitus and pancreatic cancer
  3297. Type 2 diabetes mellitus and pancreatic cancer in related family
  3298. Type 2 diabetes mellitus and prognosis in early stage breast cancer women
  3299. Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta‐analysis of observational studies
  3300. Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies
  3301. Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: a meta-analysis of observational studies
  3302. Type 2 diabetes mellitus and the risk of colorectal cancer
  3303. Type 2 diabetes mellitus as a risk factor for female breast cancer in the population of Northern Pakistan
  3304. Type 2 diabetes mellitus as risk factor for colorectal cancer
  3305. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in …
  3306. Type 2 diabetes mellitus does not increase the risk of lung cancer among never-smokers: a nationwide cohort study
  3307. Type 2 diabetes Mellitus Increases Economic Burden of Colorectal cancer Surgery: 2252
  3308. Type 2 diabetes Mellitus Induced Paracrine Effects on Breast cancer Metastasis Through Extracellular Vesicles Derived from Human Mesenchymal Stem Cells
  3309. Type 2 diabetes Mellitus Is Associated With Increased Mortality in Chinese Asian Patients Receiving Curative Surgery for Colon cancer
  3310. Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer
  3311. Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: a veteran administration registry study
  3312. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the …
  3313. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome
  3314. Type 2 diabetes mellitus, glycemic control, and cancer risk
  3315. Type 2 diabetes mellitus, insulin‐use and risk of bladder cancer in a large cohort study
  3316. Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk
  3317. Type 2 diabetes mellitus, smoking, and colorectal cancer
  3318. Type 2 diabetes mellitus: a marker or a risk factor for pancreatic cancer?
  3319. Type 2 diabetes mellitus: a risk indicator for colorectal cancer
  3320. Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies
  3321. Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
  3322. Type 2 diabetes, antidiabetic medications, and colorectal cancer risk: two case–control studies from Italy and Spain
  3323. Type 2 diabetes, Body Mass Index and cancer Mortality: A Population-Based Matched Cohort Study of 1.0 Million Adults in England
  3324. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor …
  3325. Type 2 diabetes, but not insulin (analog) treatment, is associated with more advanced stages of breast cancer: a national linkage of cancer and pharmacy registries
  3326. Type 2 diabetes, insulin treatment and prognosis of breast cancer
  3327. Type 2 diabetes, metformin, and the risk of mortality in patients with prostate cancer
  3328. Type 2 diabetes, obesity, and breast cancer risk among Japanese women of the atomic bomb survivor cohort
  3329. Type 2 diabetes, Obesity, and cancer Share Some Common and Critical Pathways
  3330. Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001–2007
  3331. Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms
  3332. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
  3333. Type 3c diabetes and Pancreatic cancer
  3334. Type II diabetes and breast cancer.
  3335. Type II diabetes and incidence of estrogen receptor negative breast cancer in African American women
  3336. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort
  3337. Type II diabetes, obesity, and breast cancer risk: the Multiethnic Cohort
  3338. Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer
  3339. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
  3340. UCP 2 gene polymorphisms in obesity and diabetes, and the role of UCP 2 in cancer
  3341. UNDERSTANDING ROLE OF 9P21 GENE DESERT SNPS IN cancer, AGING, diabetes, AND CARDIO-VASCULAR DISEASES
  3342. Understanding the association of type 2 diabetes mellitus in breast cancer among African American and European American populations in South Carolina
  3343. Understanding the Relationship Between Type 2 diabetes and Bladder cancer
  3344. Undiagnosed diabetes in breast, colorectal, lung, and prostate cancer: incidence and risk factors
  3345. Unfolding link between diabetes and cancer
  3346. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer
  3347. Unravelling the link between diabetes, insulin treatment and breast cancer
  3348. Upregulation of REG Ia accelerates tumor progression in pancreatic cancer with diabetes
  3349. Upregulation of REG Iα accelerates tumor progression in pancreatic cancer with diabetes
  3350. Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes
  3351. Use of an α-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based cohort study
  3352. Use of Anti-Diabetic Medication is Not Associated with cancer Risk in Chinese Patients with Type 2 diabetes
  3353. Use of family history in clinical guidelines for diabetes and colorectal cancer
  3354. Use of insulin and mortality from breast cancer among Taiwanese women with diabetes
  3355. Use of Insulin and Risk of cancer among Patients with diabetes Mellitus: A Nonconcurrent Prospective Study
  3356. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish diabetes Research Network Epidemiology Group
  3357. Use of metformin and risk of kidney cancer in patients with type 2 diabetes
  3358. Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes
  3359. Use of sulphonylurea and cancer in type 2 diabetes—the Hong Kong diabetes Registry
  3360. Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry
  3361. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
  3362. Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study
  3363. Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes
  3364. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
  3365. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
  3366. Using mouse and Drosophila models to investigate the mechanistic links between diet, obesity, type II diabetes, and cancer
  3367. Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 diabetes in the Etiology of Colon cancer
  3368. Vacuolar H+-ATPase in cancer and diabetes
  3369. Validation of Breast cancer and Bladder cancer Among Patients With Type 2 diabetes Mellitus in US Medicare: A Pilot Study
  3370. Validation of the enriching new-onset diabetes for pancreatic cancer model in a diverse and integrated healthcare setting
  3371. Validation of the survival benefit from metformin use in patients with type 2 diabetes and colorectal cancer.
  3372. Validation of the survival benefits of metformin in middle Eastern patients with type II diabetes mellitus and colorectal cancer
  3373. Value of adipokines in the diagnosis and prognosis of pancreatic cancer complicated with diabetes
  3374. Value of glycated hemoglobin in the diagnosis of diabetes and prediabetes in cancer patients
  3375. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse
  3376. Venous thromboembolism and risk of cancer in patients with diabetes mellitus
  3377. Ventures with venoms: several toxin-based products are in the running as treatments for cancer, stroke, and diabetes
  3378. Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead to diabetes and cancer
  3379. Video consultations between patients and clinicians in diabetes, cancer, and heart failure services: Linguistic ethnographic study of video-mediated interaction
  3380. VIewpoInt sectIon reference fraMeworks for the health ManaGeMent of Measles, Breast cancer and diabetes (type II)
  3381. Visit-to-visit hemoglobin A1c variability is associated with later cancer development in patients with diabetes mellitus
  3382. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer
  3383. VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress
  3384. Waist circumference, body mass index, and colorectal cancer risk according to diabetes status: A Korean nationwide population‐based cohort study
  3385. Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study
  3386. Weight cycling, diabetes and risk of postmenopausal breast cancer.
  3387. Weight loss precedes cancer specific symptoms in pancreatic cancer associated diabetes mellitus
  3388. Weight loss, diabetes, fatigue, and depression preceding pancreatic cancer
  3389. Weight Status and All-Cause Mortality in Older Adults: A Study of Patients With Type 2 diabetes Undergoing Subtotal Gastrectomy for cancer
  3390. Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes
  3391. Werner syndrome and diabetes mellitus accompanied by adrenal cortex cancer
  3392. What do cancer, diabetes, and cardiovascular disease have in common?
  3393. What every dentist should know about metformin, diabetes, and cancer
  3394. White blood cell count and renin–angiotensin system inhibitors for the risk of cancer in type 2 diabetes
  3395. Why are diabetes, stomach cancer and circulatory diseases more common in Northern Sweden?
  3396. Why diabetes patients are more prone to the development of colon cancer?
  3397. Why does diabetes offer protective effects against prostate cancer? The possible role of its microvascular complications
  3398. Why should you care about free radicals? Because these molecules appear to play a role in the development of heart disease, cancer, diabetes, and other diseases …
  3399. WITHDRAWN: Association of Type 2 diabetes Mellitus with the Histopathological Features of Early-Stage Breast cancer Patients: A Retrospective Cross-Sectional …
  3400. Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55)–a study protocol
  3401. Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes
  3402. US-JAPAN CONFERENCE: INFLAMMATION, diabetes AND cancer held at the Beckman Research Institute of City of Hope, Duarte, CA, USA
  3403. … -6-phenylimidazo (4, 5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer
  3404. … -control study of the association between metabolic syndrome and colorectal cancer: a comparison of International diabetes Federation, National Cholesterol …
  3405. … -free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer
  3406. … -persistent environmental pollutants and risk of type 2 diabetes in a Spanish sub-cohort from the European Prospective Investigation into cancer and Nutrition study
  3407. … -Spectrum Biomarkers for Atherosclerosis, Acute Ischemic Stroke, Cardiovascular Disease, diabetes Mellitus, Chronic Kidney Disease, and Digestive Organ cancer
  3408. … -term effects of gestational diabetes on bone mineral density and fracture risk: Analysis of the Norfolk cohort of the European Prospective Investigation into cancer …
  3409. … ‐Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in …
  3410. … , adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer
  3411. … , and Practices Related to Noncommunicable Diseases Among Korean Adults Residing in Urban and Rural Areas-Focusing on Hypertension, diabetes, and cancer
  3412. … , but What About Pancreatic cancer?: Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 diabetes …
  3413. … , gonadotrophins and SHBG by type 2 diabetes in postmenopausal women: Clinical implications for the incidence of breast cancer, and cardiovascular risk in diabetic …
  3414. … , Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activity in cultured cancer cells. diabetes Metab Res Rev …
  3415. … , such as obesity and malnutrition, respectively (Rodríguez-Arauz et al., 2016). In western countries hypertension, cancer, diabetes and cardiovascular diseases …
  3416. … , Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into cancer and Nutrition–Potsdam …
  3417. … ; Hematology: Metachronous Double cancer Included B-Cell Chronic Lymphocytic Leukemia and Pancreatic cancer That Diagnosed After Progression of diabetes
  3418. … : Ethnic differences in the relationship between diabetes, early age adiposity, and mortality among breast cancer survivors: The Breast cancer Health Disparities Study
  3419. … : glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer …
  3420. … : TP-65; diabetes Mellitus Predicts Poor Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase inhibitor (TKI) in Non-Small Cell Lung cancer …
  3421. … : WHAT WE ARE LEARNING ABOUT HOW TO TREAT AND BEAT LUNG cancer: The Impact Of Hba1c Levels On Survival Of Lung cancer Patients With diabetes …
  3422. … . 02c-019 The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung cancer and Type 2 diabetes: Topic: Targeted Therapy
  3423. … (BMA) has increased over the last decade due to its association with, and potential role, in a range of diseases (osteoporosis, diabetes, anorexia, cancer) as well as …
  3424. … (Curcuma longa): from a variety of traditional medicinal applications to its novel roles as active antioxidant, anti-inflammatory, anti-cancer, and anti-diabetes
  3425. … (f) chromen-3-one as a potential inhibitor of NF-κB: A key regulatory molecule in inflammationmediated pathogenesis of diabetes, Alzheimer’s, and cancer
  3426. … (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes …
  3427. … (to RAR); a fellowship from a NIH diabetes, Endocrinology and Metabolism Training Grant (NIH DK07217)(to GT); an American diabetes Association mentor Based …
  3428. … 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into cancer (EPIC)-Norfolk cohort and …
  3429. … 2SI “VP Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine”, Kyiv BREAST cancer IN WOMEN WITH diabetes MELLITUS TYPE 2
  3430. … 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer
  3431. … a high index of suspicion for endometrial malignancy or hyperplasia with atypia in Hispanic patients who have hypertension, diabetes, history of hormone …
  3432. … A. ferox leaf gel may show promise in alleviating symptoms associated with/or prevention of cardiovascular diseases, cancer, neurodegeneration, and diabetes …
  3433. … activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer–a narrative review
  3434. … acute recurrent and chronic pancreatitis: Protocol of a multicenter randomized controlled trial from the study of chronic pancreatitis, diabetes and pancreatic cancer …
  3435. … al.(2010) Associations of Hyperglycemia and Insulin Usage With the Risk of cancer in Type 2 diabetes: The Hong Kong diabetes Registry. diabetes; 59: 1254–1260
  3436. … And Assessment of Small Molecules as Free Radical Scavengers and Potential Multi-Target Therapeutic Agents against Alzheimer’s Disease, diabetes and cancer
  3437. … and evaluation of the curriculum for BOLD (Bronx Oncology Living Daily) Healthy Living: a diabetes prevention and control program for underserved cancer survivors
  3438. … and harmonized International diabetes Federation criteria tools to assess impact on cardiovascular risk assessmentRole of primary care management in cancer …
  3439. … and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes …
  3440. … and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer
  3441. … and Mechanisms of diabetes Resolution According to the Range of Gastric Resection and the Length of Anastomosis in Animal Models: Implication for Gastric cancer …
  3442. … and Mortality Risk in Individuals With Pancreatic cancer–Related diabetes and Postpancreatitis diabetes: A Nationwide Cohort Study. diabetes Care 2019; 42: 1675 …
  3443. … and Mortality Risk in Individuals With Pancreatic cancer–Related diabetes and Postpancreatitis diabetes: A Nationwide Cohort Study. diabetes Care 2019; 42: 1675 …
  3444. … and Risks Associated With Use of Social Media by People With Health Issues: Focusing on Mental Illness, HIV/AIDS, cancer, Intellectual Disability, and diabetes
  3445. … and Yoga in prediabetic and type 2 diabetes under the National Programme for Prevention and Control of cancer, diabetes, Cardiovascular Diseases and …
  3446. … antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125I seed brachytherapy for prostate cancer
  3447. … as simulated patientsCaring and communicating in critical casesImplementation of the expanded chronic care model for the management of diabetes in a community …
  3448. … assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer
  3449. … association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont diabetes Information System Study
  3450. … Atlas of Major Disease Mortalities for Cities, Towns and Villages in Japan: All Causes of Death, cancer, Cardiovascular Diseases, diabetes Mellitus, Liver Cirrhosis …
  3451. … Beneficial Effect of this Adipokine? Commentary to: Higher circulating adiponectin concentrations predict incident cancer in type 2 diabetes–the adiponectin paradox
  3452. … Beneficial Effect on Breast cancer by Study Design Re:“Low-Dose Aspirin Reduces Breast cancer Risk in Women with diabetes: A Nationwide Retrospective Cohort …
  3453. … between non-permanent migration and non-communicable chronic disease outcomes for cancer, heart disease and diabetes–a systematic review
  3454. … between type of dietary fish and seafood intake and the risk of incident type 2 diabetes: the European prospective investigation of cancer (EPIC)-Norfolk cohort study
  3455. … blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 …
  3456. … by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into cancer and Nutrition (EPIC) …
  3457. … cancer in diabetics and clinical characteristics of diabetes-associated with pancreatic cancer–comparison between diabetes with and without pancreatic cancer
  3458. … cancer resistance protein expression and function at the blood–brain barrier and blood–cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes …
  3459. … cancer Society, American diabetes Association, and American Heart Association joint statement on preventing cancer, cardiovascular disease, and diabetes: where …
  3460. … cascade in the mononuclear cells of peripheral blood: association with insulin and insulin-like growth factor levels in the blood of patients with cancer and diabetes
  3461. … cause and cause-specific mortality among Medicaid-insured women with preexisting type 2 diabetes diagnosed with breast cancer: A cancer registry-Medicaid linkage
  3462. … circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes
  3463. … concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, cancer and Health cohort
  3464. … cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into cancer and Nutrition (EPIC) …
  3465. … D levels are associated with greater all-cause and cancer-related mortality among Australian adults: findings from the Australian diabetes, Obesity and Lifestyle Study …
  3466. … D, Wilde J, Schubert P: Mu-tations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005; 51 …
  3467. … dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmö Diet and cancer …
  3468. … diabetes as risk factor for pancreatic cancer: miRNA expression profiling in plasma uncovers a role for miR-20b-5p, miR-29a, and miR-18a-5p in diabetes of …
  3469. … diabetes mellitus induced by immune checkpoint inhibitor therapy in an insulinoma-associated antigen-2 autoantibody-positive patient with advanced gastric cancer
  3470. … diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer …
  3471. … diabetes mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer
  3472. … diabetes mellitus, glycated haemoglobin and incidence of and mortality from cancer: analysis of longitudinal data from England and Scotland linked to cancer …
  3473. … diabetic retinopathy and diabetic kidney disease on all‐cause, cancer, vascular and non‐cancer non‐vascular mortality in patients with type 2 diabetes: A real‐world …
  3474. … diagnosis of endometrial precancer and cancer by combined use of progesterone test and transvaginal ultrasonography in high risk groups of patients with diabetes …
  3475. … DIE ANOTHER DAY: WHAT WE ARE LEARNING ABOUT HOW TO TREAT AND BEAT LUNG cancer: The Impact Of diabetes And Its Treatment On Lung cancer …
  3476. … dietary intake, lifestyle and incident symptomatic peripheral arterial disease among individuals with diabetes mellitus: insights from the Malmö Diet and cancer study
  3477. … disease, arthritis, cerebralstroke, diabetes, cardiovasculardisease, cancer, andotherconditions. The consequencesformanyarenumerousexpensivemedications …
  3478. … drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary …
  3479. … education programmes for patients with type 1 and 2 diabetes, asthma and COPD, coronary heart disease, hypertension, congestive heart failure, and breast cancer …
  3480. … et al.(2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes Registry. diabetes; 59: 1254–1260
  3481. … Exploration of the Relationship Between Insulin Glargine and Incident cancer: A Retrospective Cohort Study of Older Medicare Patients. diabetes Care 2011; 34 …
  3482. … Exploration of the Relationship Between Insulin Glargine and Incident cancer: A Retrospective Cohort Study of Older Medicare Patients. diabetes Care 2011; 34 …
  3483. … fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC) …
  3484. … for a CuRE (INSPPIRE 2) Cohort Study: Design and Rationale From the Consortium for the Study of Chronic Pancreatitis, diabetes, and Pancreatic cancer
  3485. … for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography: the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer
  3486. … for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes
  3487. … for vitamin D. Many observational and some interventional studies have linked vitamin D to car-diovascular disease, cancer, and diabetes. In addition, reduced levels …
  3488. … Furthermore, it is well documented that obesity is a risk factor for certain chronic diseases, especially heart diseases, hypertension, diabetes and some forms of cancer …
  3489. … gastrointestinal reconstruction methods after distal subtotal gastrectomy on nutritional status and blood glucose in patients with type 2 diabetes and gastric cancer
  3490. … genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into cancer (EPIC) …
  3491. … has identified numerous functional compounds in peanuts that promote health and may reduce the risk of cardiovascular disease, cancer, and diabetes.
  3492. … Heart Attack, Stroke, cancer, Ovarian cancer, Lung cancer, diabetes, Dementia, Colon cancer, Pneumonia, Pancreatic cancer, Emphysema and More
  3493. … impact of newly diagnosed diabetes mellitus on cancer-free survival in patients without colorectal polyps: A secondary analysis of Korean multicenter cancer …
  3494. … importance of Cannabis sativa L. in regulation of insulin and IL-6R/MAO-A in cancer cell progression and migration of breast cancer patients with diabetes
  3495. … important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer?
  3496. … in glioma and acute myeloid leukemia 398 Circulating tumour cells in cancer patients: challenges and perspectives 407 The emerging genetics of type 2 diabetes
  3497. … in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1beta gene and prostate cancer: a systematic review and …
  3498. … in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population …
  3499. … in Type 2 diabetes, Coronary Heart Disease and cancer Subgroups in the UK Biobank, and Their Modification by Smoking. diabetes Care,[dc172508]. https …
  3500. … insulin-using diabetes mellitus patients, non-insulin-using diabetes mellitus patients and patients without diabetes mellitus after partial gastrectomy for gastric cancer
  3501. … Learning from Genetically Modified Animals Guest Editor: Junichi FujiiThioredoxin binding protein (TBP)-2/Txnip and. ALPHA.-arrestin proteins in cancer and diabetes …
  3502. … level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer–Norfolk prospective study
  3503. … levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible …
  3504. … Lifestyle and Metabolic Health Status With New-Onset diabetes and Major Cardiovascular Events: The China Cardiometabolic Disease and cancer Cohort (4C) Study
  3505. … Lipoic Acid Breakthrough: The Superb Antioxidant that May Slow Aging, Repair Liver Damage, and Reduce the Risk of cancer, Heart Disease, and diabetes
  3506. … LONG-TERM OUTCOMES IN LIVE KIDNEY DONORS: PREVALENCE OF ISCHEMIC HEART DISEASE, diabetes, cancer AND CEREBROVASCULAR DISEASE …
  3507. … Lung cancer: diabetes Mellitus Predicts Poor Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase inhibitor (TKI) in Non-Small Cell Lung cancer …
  3508. … matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer
  3509. … measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes
  3510. … medicinal property of sage (Salvia) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer
  3511. … metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose …
  3512. … metformin use and cancer stage at diagnosis among elderly medicare beneficiaries with preexisting type 2 diabetes mellitus and incident prostate cancer
  3513. … morphometric studies on pancreatic endocrine cells, including IAPP in the normal pancreas and in pancreatic tissues from type 2 diabetes and pancreatic cancer
  3514. … Natural products for diabetes and its complication as nephropathyA study to assess the effectiveness of informative booklet regarding knowledge of breast cancer …
  3515. … new‐onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen‐deprivation therapy for prostate cancer
  3516. … nutrition and total parenteral nutrition on the nutritional status and blood glucose in patients with gastric cancer complicated with diabetes mellitus after radical …
  3517. … O’Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014; 65 …
  3518. … of artificial sweetener in packets or tablets and type 2 diabetes risk: evidence from the E3N-European prospective investigation into cancer and nutrition study
  3519. … of common comorbidities, such as hypertension, dyslipidemia, diabetes mellitus, cardiovascular disease, cerebrovascular disease and cancer, in older Japanese …
  3520. … of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer …
  3521. … of dietary and lifestyle interventions in elderly or people diagnosed with diabetes, metabolic disorders, cardiovascular disease, cancer and micronutrient deficiency on …
  3522. … of genetic association of Thyroid cancer with Parkinsons disease, Osteoporosis, chronic heart failure, Chronic kidney disease, Type 1 diabetes and Type 2 diabetes
  3523. … of Hospitalization for Pancreatic cancer in the First 8 Years after a Gestational diabetes Mellitus regardless of Subsequent Type 2 diabetes: A Nationwide Population …
  3524. … of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?
  3525. … of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer
  3526. … of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase—significance for diabetes and cancer
  3527. … of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer …
  3528. … of serum markers of oxidative stress with incident major cardiovascular events, cancer incidence, and all-cause mortality in type 2 diabetes patients: pooled results …
  3529. … of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review
  3530. … of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways in cancer and diabetes: A Narrative Review.
  3531. … of total energy consumption and activity-related energy expenditure with risks of cardiovascular disease, cancer, and diabetes among postmenopausal women
  3532. … on Chronic Diseases: Cardiovascular Diseases, Oxidative Stress, Dyslipidemia, diabetes Mellitus, Blood Pressure, cancer, Neurodegenerative Disease and …
  3533. … patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer
  3534. … PEPTIDASE-4 INHIBITORS ON CISPLATIN-INDUCED ACUTE NEPHROTOXICITY IN cancer PATIENTS WITH diabetes MELLITUS: A RETROSPECTIVE …
  3535. … pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapy––Are we underestimating diabetes?––Turkish oncology group (TOG)/Lung cancer …
  3536. … polyunsaturated fatty acids intake and risk of all-cause mortality, cardiovascular disease, breast cancer, mental health, and type 2 diabetes: a systematic review …
  3537. … preferred components for physical activity interventions in African-American survivors of breast or endometrial cancer with type 2 diabetes: the SUCCESS framework
  3538. … primary androgen deprivation therapy: validation of Japan cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes …
  3539. … procedures for biospecimen collection, processing, and storage: from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer
  3540. … review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes
  3541. … RHEUMATOID ARTHRITIS37 PATTERNS OF CARDIOVASCULAR RISK AND DISEASE AMONG PEOPLE WITH TYPE 2 diabetes STARTING INSULIN: BASELINE …
  3542. … RNA cancer susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARγ axis in diabetes …
  3543. … Roux-en-Y Construction Really Bring Benefit of Type 2 diabetes Mellitus Remission After Gastrectomy in Patients with Gastric cancer? A Systematic Review …
  3544. … Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladder cancer in Older US Adults with Type 2 diabetes
  3545. … self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer
  3546. … senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin …
  3547. … Society of Gastroenterology& SLDDS 2035: Slide Session; K-BP-25: Pancreatobiliary; Is diabetes a Useful Diagnostic Clue to Detect Early Stage of Pancreatic cancer …
  3548. … Stat3 pathways respectively promotes and inhibits diabetes‐associated centrosome amplification by targeting at the ROCK1/14‐3‐3σ complex in human colon cancer …
  3549. … strategies for addressing high levels of ‘I don’t know’responding to risk perception questions for colorectal cancer and diabetes: an experimental investigation
  3550. … Stress, Blood Sugar, Blood Lipid, Body Mass Index, Fat Mass, and Body Weight in Patients with Type 2 diabetes. Journal of diabetes Nursing and Midwifery …
  3551. … Study to Establish a New-Onset diabetes (NOD) Cohort: From the Consortium for the Study of Chronic Pancreatitis, diabetes, and Pancreatic cancer
  3552. … that shed new light on the possible pathogenesis of a disease or an adverse effect: Atypical early onset of diabetes, deafness and lung cancer in a male …
  3553. … the novel effect in relief, prevention, and treatment of a number of serious illnesses such as diabetes, cardiovascular disease, Alzheimer’s disease, and cancer
  3554. … the synergistic interaction of diabetes, tobacco smoking, alcohol consumption, and hypercholesterolemia on the risk of pancreatic cancer: a case-control …
  3555. … the Ten-Step Action Plan Scientifically Proven to Prevent or Reverse Obesity, Memory Loss, Alzheimer’s, diabetes, Autoimmunity, cancer, and Heart Disease
  3556. … the validity and reliability of the health literacy questionnaire in Iran: Recognizing the risk factors for cardiovascular diseases, diabetes, and cancer
  3557. … theory as a possible mechanism of action for the remission of type 2 diabetes in low body mass index patients undergoing subtotal gastrectomy for gastric cancer
  3558. … time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
  3559. … to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis possible …
  3560. … to incidence of type 2 diabetes: results from the Greek cohort of the population-based European Prospective Investigation into cancer and Nutrition (EPIC)
  3561. … to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J cancer, 2016, No. 52, pp …
  3562. … to prevent hospital admission and delay chemotherapy treatment in patient with a small cell lung cancer. Kamal Abouglila diabetes centre, University Hospital of …
  3563. … Translational StuDies (PROCEED): Rationale and Study Design From the Consortium for the Study of Chronic Pancreatitis, diabetes, and Pancreatic cancer
  3564. … vitamin D deficiency, part 2: deficiency and its association with autoimmune disease, cancer, infection, asthma, dermopathies, insulin resistance, and type 2 diabetes.
  3565. … With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung cancer: Analysis of Safety and Efficacy in Patients With diabetes
  3566. … with Incidence of Type 2 diabetes after Adjustment for Overall Dietary Quality in the European Prospective Investigation into cancer and Nutrition–Netherlands (EPIC …
  3567. … women with preexisting type 2 diabetes mellitus diagnosed with breast cancer: An epidemiological analysis of linked New York State Medicaid and cancer …
  3568. … workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer
  3569. [Obesity, hypertension and diabetes mellitus in patients with endometrial cancer]
  3570. [PP. 37.06] A GENETIC RISK SCORE FOR TYPE 2 diabetes IS INDEPENDENTLY ASSOCIATED WITH ARTERIAL STIFFNESS: THE MALMO DIET cancer …
  3571. 07 Surgery for Upper Gastrointestinal cancer in a Morbidly Obese Patient with diabetes and Renal Impairment
  3572. 09 Incontinence Developing During Chemotherapy in a Patient with Advanced Ovarian cancer and diabetes
  3573. 1045 Higher Pancreatic cancer Risk Following New Onset of diabetes Mellitus in Non-Obese Patients With Chronic Pancreatitis
  3574. 1095-P: Exendin 4 Decreases Tumor Volume through Attenuation of psma-Induced Activation of NfκB Pathway in HPV-Induced diabetes/cancer Model
  3575. 1110–1082 and TNFa-863 gene polymorphisms may favor the onset of chronic pancreatic diseases and of the associated diabetes, but not pancreatic cancer …
  3576. 120P Breast cancer and diabetes: Retrospective Study
  3577. 128: Androgen Deprivation Therapy and Risk of diabetes Mellitus in Men Undergoing Androgen Deprivation Therapy for Prostate cancer
  3578. 1297-P: Mortality and Glycemic Control among Patients with Endometrial cancer and diabetes Mellitus: A Case-Control Study
  3579. 1347 diabetes MELLITUS PREDICTS POOR RESPONSE TO INDUCTION BCG IN NON-MUSCLE INVASIVE BLADDER cancer
  3580. 137-Quality of diabetes Care Among cancer Survivors
  3581. 14 Obesity, diabetes, and Risk of cancer
  3582. 14.4 A POSITIVE FAMILY HISTORY OF diabetes IS ASSOCIATED WITH ARTERIAL STIFFNESS: THE MALMO DIET cancer STUDY
  3583. 1475-P: CA19-9, miR-200, and GIP in Patients with diabetes Mellitus and Pancreatic cancer
  3584. 1506-P: Breast cancer as a Risk Factor for New diabetes
  3585. 152: The Association between Androgen-Deprivation Therapy and the Incidence of diabetes Among Males with Prostate cancer
  3586. 1550-P: Trends in cancer Mortality among US Adults With and Without diabetes, 1988-2015
  3587. 158 Assessing the impact of diabetes mellitus and end stage renal disease on cervical cancer prognosis in an urban population
  3588. 1597-P: Increased Pancreatic cancer Risk Associated with Dietary Iron in Whites, but Not Blacks with diabetes
  3589. 160-OR: Pretreatment diabetes Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, in cancer Patients with Immune-Check Point Inhibitor
  3590. 1609-P: diabetes and Risk of All-Cause and cancer-Specific Mortality in Breast, Prostate, and Colorectal cancer Survivors
  3591. 1646-P: Role Of Microbiota In diabetes-Associated Colorectal cancer
  3592. 167 SERUM GLUCOSE IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN MEN WITHOUT diabetes TREATED FOR LOCALIZED PROSTATE cancer
  3593. 1685-P: Type 1 diabetes Mellitus and Incident Bladder cancer: A Systematic Review and Meta-analysis
  3594. 1749 IMPACT OF diabetes MELLITUS ON THE RECURRENCE AND PROGRESSION OF PATIENTS WITH NON MUSCLE INVASIVE BLADDER cancer: A …
  3595. 179 INDIVIDUALS WITH diabetes HAVE AN INCREASED RISK OF COLORECTAL cancer.
  3596. 18. Does diabetes have an effect on FDG PET standardized uptake values in lung cancer?
  3597. 191-LB: Comorbid diabetes and cancer: Differences by Patient Characteristics and Symptom Outcomes
  3598. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
  3599. 2157 THE ASSOCIATION OF diabetes MELLITUS AND HIGH-GRADE PROSTATE cancer IN A MULTIETHNIC BIOPSY SERIES
  3600. 216-LB: Risk Factors of Pancreatic cancer in Persons with Advancing diabetes
  3601. 2280-PUB: Cluster of Metabolic Disorders Increases Risk of cancer in Chinese Patients with Type 2 diabetes
  3602. 2283-PUB: Metformin Treatment and Prostate cancer Risk: Cox Regression Analysis with Time-Dependent Covariates of 150,000 Men with Incident diabetes Mellitus
  3603. 25-Hydroxyvitamin D status and risk for colorectal cancer and type 2 diabetes mellitus: a systematic review and meta-analysis of epidemiological studies
  3604. 259 THE IMPACT OF diabetes AND METFORMIN USE IN CLINICALLY LOCALIZED PROSTATE cancer TREATED BY RADICAL PROSTATECTOMY
  3605. 32nd National Medicinal Chemistry Symposium–medicinal chemistry developments for neurodegeneration, diabetes and cancer.
  3606. 335 diabetes MELLITUS AND THE RISK OF HIGH-GRADE PROSTATE cancer: RESULTS FROM THE DUKE PROSTATE CENTER
  3607. 4 The influence of glucose-lowering therapies on cancer risk 5 in type 2 diabetes
  3608. 434-P: diabetes in Patients with Pancreatic cancer: Relationship of Tumor Grade with Glycemic Control
  3609. 487-P: The Activation of mTORC1 in Leukocytes of Patients with cancer and diabetes
  3610. 8-Hydroxydeoxyguanosine: A valuable predictor of oxidative DNA damage in cancer and diabetes mellitus
  3611. 8. Application Of Pharmacogenetics In Dose Individualization In diabetes, Psychiatry, cancer And Cardiology
  3612. 856 Preliminary review of diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy–Roswell Park Comprehensive cancer Center …
Related Posts

Lipolytic Agents

Peel Extract

Potent Antihypertensive

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping